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ABSTRACT FOR DISSERTATION 
 
SYNTHESIS AND CHARACTERIZATION OF ANTIOXIDANT CONJUGATED 
POLY(ΒETA-AMINO ESTER) MICRO/NANOGELS FOR THE SUPPRESSION OF 
OXIDATIVE STRESS 
 
Oxidative stress is a pathophysiological condition defined by an increased production of 
reactive oxygen species (ROS), which can result in the growth arrest of cells followed by 
cell disintegration or necrosis. A number of small molecule antioxidants (e.g. curcumin, 
quercetin and resveratrol) are capable of directly scavenging ROS, thereby short-circuiting 
the self-propagating oxidative stress state. However, poor solubility and rapid 1st pass 
metabolism results in overall low bioavailability and acts as a barrier for its use as a drug 
to suppress oxidative stress efficiently.  
To overcome this limitation, these small molecule antioxidants were covalently conjugated 
into poly(β-amino ester) (PβAE) cross-linked networks to formulate prodrug gel 
microparticles and nanoparticles (nanogels). Being hydrolytically degradable in nature, 
these PβAE crosslinked systems released antioxidants in their original structural form in a 
sustained controlled fashion.  
Both quercetin and curcumin-PβAE nanogels showed prolonged suppression of cellular 
oxidative stress induced by H2O2. Curcumin PβAE nanogels also demonstrated protection 
against mitochondrial oxidative stress induced by H2O2 and polychlorinated biphenyls. 
Curcumin-PβAE gel microparticles were also developed as a platform to treat oral 
mucositis through a local antioxidant delivery route. The same synthesis chemistry was 
transferred to formulate resveratrol PβAE gel microparticles for topical applications, to 
treat UV radiation induced oxidative stress. Both formulations showed suppression of 
induced oxidative stress. An in vivo trial with curcumin-PβAE microparticles further 
showed relatively reduced the severity of induced oral mucositis (OM) in hamster check 
pouch as compared to placebo.   
  
 
Keywords: Poly(β amino esters), antioxidants, oxidative stress, nanogels, microparticles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prachi Gupta 
3/11/16  
 
 
  
 
 
 
 
 
 
 
 
 
 
SYNTHESIS AND CHARACTERIZATION OF ANTIOXIDANT CONJUGATED 
POLY(ΒETA-AMINO ESTER) MICRO/NANOGELS FOR THE SUPPRESSION OF 
OXIDATIVE STRESS 
By 
Prachi Gupta 
 
 
 
 
 
 
                                                                                 
 
 
 
                                                                             Dr. Thomas Dziubla 
                                                                                (Director of Dissertation) 
 
Dr. J. Zach Hilt 
     (Co-director of Dissertation)  
 
Dr. Thomas Dziubla 
    (Director of Graduate Studies) 
 
                        3/17/16  
                                                                                    (Date)
 
 
  
ACKNOWLEDGEMENT 
This dissertation is coming to its existence as a result of positive forces that have always 
surrounded me; motivating parents, encouraging mentors, supportive friends and 
continuous blessings from an unseen force we call God. 
I am sincerely grateful to Dr. Thomas Dziubla, who has been my advisor, a counselor, and 
a boss, who constantly kept my doctoral journey interesting and challenging. 
Accompanying him, I would like to thank Dr. J. Zach Hilt, my co-advisor who has taken 
care of me and my research track with great effort and spirit. I would like to thank both of 
them for instilling in me the skills of an independent and innovative researcher with a very 
positive attitude that no result is negative. This theory surely applies in every phase of our 
day to day life and has transformed me into a better person over the past years.  
I would like to convey my gratitude to my committee members, Dr. Stephen Rankin and 
Dr. Bernard Hennig for giving resourceful insights into my research. I would like to further 
acknowledge Dr. Robert Yokel, my external examiner for taking his time to look into my 
dissertation and pass on valuable suggestions. 
I would like to thank all my research companions Paritosh, Dave, Sundar, Andrew, Nihar, 
Vinod, Mark, Irfan and Carolyn for maintaining a versatile, healthy and supportive work 
environment with a great team spirit. I also thank my undergraduate researchers, Erin, 
Manali, Donavyn, Caroline and John whom I got the opportunity to mentor in their 
research, giving me a wonderful experience throughout.  
iii 
 
  
I am blessed with great friends, and I would like to acknowledge them for their love, 
support and memorable time gifted to me. I am grateful to have immense support from 
Sakshi (Chinki), Abhinav, Rishali, Chetna, Ashwini, Bhakti, Maulik, Mitesh, Prathemesh, 
Manali and Hersh for countless years.  
My special acknowledgement goes to people who became my extended family away from 
home (popularly known as gazette janta) consisting of Shristi, Sonam, Suvid, Rutooj, 
Saket, Anwesha, Pratik Sogani, Amit, Suraj, Ishan, Ashish,, Abhishek, Priyesh, Shreya 
Patel, Raghav, Sumesh, Abhijit, Mini, Russel, Ravinder, and Pratik Rane. Thanks for 
making each and every day full of fun, adventure and innovation in this beautiful town, 
Lexington.  
I would like to acknowledge the blessings of my parents (Mrs. Manju Gupta and Prof. T. 
C. Gupta), and dedicate my dissertation to them. This achievement came to fruition due to 
their support and never ending patience. Their encouraging attitude to explore with creative 
freedom meanwhile instilling values into me, kept me inclined towards science from 
childhood. I am also grateful to my brother (Sudhanshu) and sister-in-law (Liza), who 
always made sure that I cross all the hurdles with confidence and guided me with practical 
advice during challenging times.   
  
  
  
iv 
 
  
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENT ........................................................................................... iii 
LIST OF TABLES ......................................................................................................... x 
LIST OF FIGURES ...................................................................................................... xi 
1. INTRODUCTION ................................................................................................... 1 
2 BACKGROUND: A FREE RADICAL PRIMER .................................................. 7 
2.1 Free radical biology – importance ................................................................... 7 
2.2 RED/Ox Chemistry ....................................................................................... 10 
2.2.1 Oxidation/reduction reactions and voltage potentials ............................ 10 
2.2.2 Thermodynamic treatment (Ellingham diagram)................................... 15 
2.2.3 Combustion sequences and/or metal oxides .......................................... 18 
2.2.4 Fenton/Haber-Weiss chemistry .............................................................. 22 
2.2.5 Thiol Chemistry (-SH-SS-) .................................................................... 24 
2.3 Biological oxidation events ........................................................................... 27 
2.3.1 Oxygen and nitrogen currency ............................................................... 27 
2.3.2 Cellular redox chemistry ........................................................................ 31 
2.3.3 Radical generation in metabolism and role of enzymes in redox cycle . 33 
2.4 Known targets and elements of concern ....................................................... 38 
3 RESEARCH OUTLINE ........................................................................................ 41 
3.1 Overall hypothesis: ............................................................................................. 41 
3.1 Specific aim 1. Synthesis and characterization of quercetin conjugated PβAE 
nanogels (Chapter 4) ................................................................................................. 41 
3.2 Specific aim 2. Synthesis and characterization of curcumin conjugated PβAE 
nanogels (Chapter 5) ................................................................................................. 42 
3.3 Specific aim 3. Curcumin PβAE nanogels for the protection against 
polychlorinated biphenyls (PCBs) induced toxicity (Chapter 6).............................. 43 
3.4 Specific aim 4. Synthesis and characterization of curcumin-PβAE gel 
microparticles to treat oral mucositis (Chapter 7) .................................................... 43 
3.5 Specific aim 5. Synthesis and characterization of resveratrol conjugated PβAE 
gel microparticles (Chapter 8) .................................................................................. 44 
4 SYNTHESIS AND CHARACTERIZATION OF QUERCETIN CONJUGATED 
POLY (β-AMINO ESTERS) NANOGELS ................................................................ 46 
4.1 Introduction ................................................................................................... 47 
4.2 Materials and methods .................................................................................. 50 
v 
 
  
4.2.1 Reagents ................................................................................................. 50 
4.2.2 Quercetin functionalization to quercetin multiacrylate monomer ......... 50 
4.2.3 Quercetin PβAE nanogel (QNG) synthesis ........................................... 51 
4.2.4 Size and yield of nanogel synthesis reaction ......................................... 53 
4.2.5 SEM imaging ......................................................................................... 53 
4.2.6 Analysis of enhanced stability of nanogels after the reaction with 
PEGMEMA4000 ................................................................................................... 54 
4.2.7 PEG content analysis after nanogel formulation ................................... 54 
4.2.8 Antibody Binding studies of Q-PΒAE nanogels using IgG using 
radiolabeling .......................................................................................................... 55 
4.2.9 Quercetin release profile of Q-PΒAE nanogels in PBS ......................... 56 
4.2.10 In vitro antioxidant activity capacity of the degradation products of 
nanogels... .............................................................................................................. 56 
4.2.11 Cell toxicity study of QNGs on Human Umbilical Vein Endothelial Cells 
(HUVECs) ............................................................................................................. 57 
4.2.12 Cellular oxidative stress suppression ..................................................... 57 
4.3 Results ........................................................................................................... 58 
4.3.1 Hydrodynamic radius and yield of reaction of Q-PΒAE nanogels ........ 58 
4.3.2 Analysis of shape and size of nanogels.................................................. 60 
4.3.3 Effect of the acrylate to amine ratio on nanogel size (stoichiometric feed 
ratio)…… .............................................................................................................. 61 
4.3.4 Analysis of enhanced stability of nanogels after the reaction with 
PEGMEMA4000 ................................................................................................... 62 
4.3.5 PEG content analysis after nanogel formulation ................................... 63 
4.3.6 Decrease in QNG-antibody binding by using radiolabeled IgG ............ 64 
4.3.7 Quercetin release profile and antioxidant activity ................................. 65 
4.3.8 Effect of QNGs on human umbilical vein endothelial cells .................. 67 
4.4 Discussion ..................................................................................................... 70 
4.5 Conclusions ................................................................................................... 75 
5 CURCUMIN CONJUGATED POLY (Β- AMINO ESTERS) NANOGELS AND 
SUSTAINED SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS ..... 77 
5.1 Introduction ................................................................................................... 78 
5.2 Methods and materials .................................................................................. 80 
5.2.1 Reagents ................................................................................................. 80 
5.2.2 Curcumin acrylate (CA) synthesis ......................................................... 81 
5.2.3 Synthesis of curcumin PβAE nanogels (CNGs) .................................... 81 
vi 
 
  
5.2.4 Yield of reaction, nanogel size and morphology characterization ......... 82 
5.2.5 Hydrolytic degradation of C-PβAE nanogels and the subsequent curcumin 
release profile ........................................................................................................ 83 
5.2.6 Antioxidant activity of released curcumin ............................................. 83 
5.2.7 Dose dependent cytotoxicity of C-PβAE nanogels (CNGs) towards HUVECs
 84 
5.2.8 Effect of CNGs exposure on H2O2 induced cellular OS: cell viability 
analysis… .............................................................................................................. 85 
5.2.9 Measurement of mitochondrial OS changes after treatment with C-PβAE 
nanogels (CNGs) using XF-96 extracellular flux analyzer. .................................. 85 
5.2.10 Statistical Analysis ................................................................................. 87 
5.3 Results ........................................................................................................... 88 
5.3.1 Curcumin nanogel size, yield and morphology ..................................... 88 
5.3.2 Degradation, curcumin release and its anti-oxidant activity .................. 89 
5.3.3 Dose dependent toxicity of CNGs on HUVECs and protection from oxidative 
stress 92 
5.3.4 Protection from cellular oxidative stress ................................................ 93 
5.3.5 Protection from mitochondrial oxidative stress ..................................... 94 
5.3 Discussion ..................................................................................................... 98 
5.4 Conclusion ................................................................................................... 105 
6 PROTECTION FROM COPLANAR AND NON-PLANAR PCBS INDUCED 
TOXICITY USING CURCUMIN CONJUGATED PβAE NANOGELS ................ 106 
6.1 Introduction ................................................................................................. 107 
6.2 Materials and methods ................................................................................ 108 
6.2.1 Reagents ............................................................................................... 108 
6.2.2 CA monomer and curcumin PβAE nanogels synthesis ....................... 109 
6.2.3 In vitro PCB toxicity ............................................................................ 109 
6.2.4 Effect of CNG treatment on PCB induced toxicity ............................. 110 
6.2.5 Measurement of real-time mitochondrial bioenergetics due to PCB exposure, 
with and without CNG ........................................................................................ 110 
6.3 Results ......................................................................................................... 113 
6.3.1 Measurement of cell toxicity after 24 hour PCB 126 and 153 exposur…113 
6.3.2 Protection from PCB 126 and 153 induced toxicity using CNG ......... 116 
6.4 Discussion ................................................................................................... 119 
6.5 Conclusion ................................................................................................... 121 
vii 
 
  
7 SYNTHESIS AND CHARACTERIZATION OF CURCUMIN PβAE GEL 
MICROPARTICLES TO TREAT ORAL MUCOSITIS .......................................... 123 
7.3 Introduction ................................................................................................. 124 
7.4 Materials ...................................................................................................... 128 
7.5 Methods ....................................................................................................... 129 
7.5.1 Synthesis of curcumin acrylate ............................................................ 129 
7.5.2 Synthesis of poly(curcumin) film ........................................................ 130 
7.5.3 Washing and cryogenic milling of poly(curcumin) Films ................... 131 
7.5.4 Particle size characterization................................................................ 132 
7.5.5 Poly(curcumin) microparticle degradation and curcumin release ....... 132 
7.5.6 Antioxidant activity of released curcumin ........................................... 133 
7.5.7 In vitro cytotoxicity assay .................................................................... 133 
7.5.8 In vitro oxidative injury assay.............................................................. 134 
7.5.9 Pre-clinical study in a Hamster model of OM ..................................... 135 
7.6 Results ......................................................................................................... 139 
7.6.1 Poly(curcumin) microparticles characterization .................................. 139 
7.6.2 Poly(curcumin) powder hydrolytic degradation and curcumin release 
profile…. ............................................................................................................. 141 
7.6.3 Antioxidant activity of the poly (curcumin) powder released products…142 
7.6.4 Tissue adhesion studies with porcine buccal tissue ............................. 143 
7.6.5 Dose dependent NHDF cytotoxicity (In vitro) .................................... 144 
7.6.6 Protection against H2O2 induced injury (In vitro) .............................. 144 
7.6.7 Pre-clinical study in a Hamster model of OM ..................................... 146 
7.7 Discussion ................................................................................................... 150 
7.8 Conclusions ................................................................................................. 155 
8 SYNTHESIS AND CHARACTERIZATION OF RESVERATROL CONJUGATED 
PβAE GEL MICROPARTICLES FOR PROTECTION FROM UV MEDIATED 
OXIDATIVE STRESS .............................................................................................. 157 
8.1 Introduction ................................................................................................. 158 
8.2 Methods ....................................................................................................... 160 
8.2.1 Resveratrol triacrylate (RTA) synthesis (Process developed by Bluegrass 
Advanced Materials LLC.) .................................................................................. 160 
8.2.2 Resveratrol-PEGDA (R- PβAE) film synthesis and microparticles 
formulation .......................................................................................................... 161 
8.2.3 R-PβAE microparticle degradation ...................................................... 163 
viii 
 
  
8.2.4 Dose dependent toxicity and protection against H2O2 induced oxidative stress 
towards normal human dermal fibroblasts (NHDF) ........................................... 164 
8.3 Results ......................................................................................................... 165 
8.3.1 Analysis of RTA and R-PβAE microparticles size .............................. 165 
8.3.2 Degradation of R-PβAE microparticles and antioxidant activity of the 
released products ................................................................................................. 166 
8.3.3 Dose dependent toxicity and protection against H2O2 induced oxidative stress 
towards normal human dermal fibroblasts (NHDF) ........................................... 168 
8.4 Comments and future directions ................................................................. 170 
9 CONCLUSIONS AND FUTURE DIRECTIONS .............................................. 172 
APPENDIX ................................................................................................................ 176 
REFERENCES .......................................................................................................... 192 
VITA .......................................................................................................................... 205 
 
  
ix 
 
  
LIST OF TABLES 
Table 2.1 Potential free radical species ...................................................................... 9 
Table 2.2. Half-cell reduction potentials of biologically significant molecules ..... 15 
Table 2.3 Role of enzymes in carrying out various redox reaction and maintaining 
cell homeostasis .......................................................................................................... 37 
Table 6.1 Mitochondrial bioenergetics after PCB ± CNGs exposure to HUVECs as 
% OCR after protein normalization. ..................................................................... 118 
Table 7.1 Pre-clinical study design and treatment plan. ...................................... 137 
Table 7.2 Scoring guidelines for visual observation of mucositis assessment of 
hamster pouch .......................................................................................................... 137 
Table 8.1 R-PβAE microparticles composition and degradation calculations ... 163 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
  
LIST OF FIGURES 
Figure 1.1 Figure 1.1 PβAE crosslinked prodrug network systems ............................. 6 
Figure 2.1 Lipid peroxidation cycle in presence of hydroxyl radical (OH●) ............... 8 
Figure 2.2 Ellingham’s diagram .................................................................................... 17 
Figure 2.3 Analogous comparison of various stages of combustion zone theory with 
cellular respiration during energy production along with free radical generation .. 21 
Figure 2.4 Correlation between pKa of reacting thiol and rate constant (kRS-
+)/degree of dissociation (θ) where kRS- was calculated using the equation (53), 
considering pKa of R’SH and R’’SH group as 8.5 ...................................................... 27 
Figure 2.5 Free radical production/reactive oxygen species with oxygen as a 
precursor .......................................................................................................................... 29 
Figure 2.6 Reactive nitrogen species production ......................................................... 31 
Figure 2.7 Significant cellular redox molecule interactions. Green: glutathione 
processes. Red: oxidant species reduced by glutathione processes. ........................... 33 
Figure 2.8 Examples of various routes of metabolic free radical production and 
detoxification pathways .................................................................................................. 38 
Figure 2.9 Concept of redox cycle in maintaining the healthy redox state of a cell.. 38 
Figure 4.1 Schematic of Q-PΒAE nanogel synthesis.................................................... 53 
Figure 4.2 Percent reaction yields and size variation of QNGs with respect to 
variable reactant QMA concentration. All samples were analyzed with n=3. .......... 59 
Figure 4.3 QNGs size variation before and after PEGylatio with PEGMEMA4000 59 
Figure 4.4 Scanning electron microscopy of the QNGs synthesized with reactant 
QMA concentration of 2.5 mg/ml .................................................................................. 60 
Figure 4.5 Effect of total acrylate to total reactive amine hydrogen on QNGs size. . 62 
Figure 4.6 Stability analysis of QNGs before and after reaction with 
PEGMEMA4000 and PEGME5000 in PBS. ................................................................ 63 
Figure 4.7 PEG weight percent in QNGs after reaction with 3 wt/vol %.................. 64 
Figure 4.8 Extent of IgG binding to non-PEG coated and PEG coated QNGs 
compared in three different nanogel systems having different PEG wt% in them. . 65 
Figure 4.9 Degradation of QNGs at physiological conditions and subsequent 
analysis. ............................................................................................................................ 67 
Figure 4.10 Dose dependent toxicity of QNGs on HUVECS ....................................... 68 
Figure 4.11 Cell viability of HUVECs treated with two different concentrations of 
QNG (1.25): 5 and 10 µg/ml and/or 0.5mM H2O2. ....................................................... 70 
Figure 4.12 Oxidative stress suppression analysis using 10 µM DCF-DA as an 
oxidative stress marker................................................................................................... 70 
Figure 5.1 Hydrodynamic diameter and SEM of precipitated CNGs after 24-hour 
reaction of CDA with TTD in acetonitrile .................................................................... 89 
Figure 5.2 Degradation of CNGs in PBS buffer with 0.1% SDS (pH=7.4) at 37°C in a 
shaker bath. ..................................................................................................................... 91 
Figure 5.3 Dose dependent cytotoxicity of CNGs towards HUVECs after 24 hours of 
treatment and comparison with free curcumin............................................................ 92 
xi 
 
  
Figure 5.4 HUVECs cell viability and suppression in DCF fluorescence due to CNGs 
(5 mg/ml feed concentration system) with simultaneous treatment of 0.5 mM H2O2.
........................................................................................................................................... 94 
Figure 5.5 Mitochondrial function parameters after pre-treatment of 
curcumin/CNG for 0, 12 and 24 hours followed by 2-hour exposure of 0.25 mM 
H2O2. ................................................................................................................................. 98 
Figure 5.6 Mitochondrial function parameters presented as % OCR post total 
protein content normalization. .................................................................................... 101 
Figure 6.1 HUVECs viability after 24-hour PCB 126 and 153 exposures. .............. 113 
Figure 6.2 Mitochondrial oxygen consumption rate profile observed during 
mitochondrial stress assay. ........................................................................................... 115 
Figure 6.3 Mitochondrial bioenergetics parameters of HUVECs after 24-hour 
exposure to variable concentrations of PCB 126 or PCB 153. .................................. 115 
Figure 6.4 HUVECs viability analyzed after 0, 12 and 24-hour exposure to CNGs 
followed by 24-hour exposure to 50 μM PCB 126 or PCB 153. ................................ 116 
Figure 6.5 Mitochondrial bioenergetics of HUVECs after 12 and 24-hour exposure 
of CNGs followed by 24-hour exposure to 30 μM PCB 126 or 153. ......................... 117 
Figure 6.6 Mechanism of free radical production due to intracellular PCB 
metabolism for coplanar PCBs resulting in mitochondrial oxidative stress and 
finally cell death. ........................................................................................................... 119 
Figure 7.1 Particle size analysis of the poly(curcumin) microparticles with variable 
CA to PEGDA molar ratios. ........................................................................................ 141 
Figure 7.2 Degradation profile of poly(curcumin) microparticles ........................... 142 
Figure 7.3 HPLC analysis of the products from degradation of poly(curcumin) 
microparticles collected at 26 hours. ........................................................................... 143 
Figure 7.4 Dose dependent cytotoxicity of free curcumin and poly(curcumin) 
microparticles towards normal human dermal fibroblasts (NHDF) after 24 hours of 
exposure. ........................................................................................................................ 144 
Figure 7.5 NHDF viability analyzed after exposure to poly(curcumin) 
microparticles/free curcumin and H2O2 to show protection against oxidative injury.
......................................................................................................................................... 146 
Figure 7.6 Protein carbonyl content in hamster cheek tissues. ................................. 147 
Figure 7.7 Histopathological sections of hamster left cheek pouches. ..................... 149 
Figure 7.8 Epithelial layer thickness with corresponding animal scoring on day 11.
......................................................................................................................................... 150 
Figure 8.1 Reaction scheme of acrylate functionalization of resveratrol to 
resveratrol triacrylate (RTA) via reaction with acryloyl chloride. .......................... 161 
Figure 8.2 Photographic schematic of R- PβAE film to microparticle formation .. 163 
Figure 8.3 Treatment sequence timeline of resveratrol/R80-PβAE microparticles + 
H2O2 exposure to NHDF. .............................................................................................. 165 
Figure 8.4 HPLC of RTA and resveratrol .................................................................. 166 
Figure 8.5 Degradation of all R-PβAE microparticles .............................................. 167 
Figure 8.6 Antioxidant activity profile of R-PβAE microparticles .......................... 168 
Figure 8.7 Dose dependent NHDF toxicity after 24-hour exposure to resveratrol or 
R80-PβAE microparticles. ............................................................................................ 169 
xii 
 
  
Figure 8.8 Protection against H2O2 induced toxicity due to R-PβAE microparticles 
exposure. ........................................................................................................................ 169 
Figure 8.9 Protection against H2O2 induced toxicity. ................................................ 170 
xiii 
 
  
1. INTRODUCTION 
Oxidative stress (OS) is a pathophysiological state, which is defined by the imbalance 
of oxidants and antioxidants present in the body. This imbalance can be initiated by 
increasing reactive oxygen species (ROS) and reactive nitrogen species (RNS) 
production in a variety of scenarios, including exposure to environmental toxicants such 
as polychlorinated biphenyls (PCBs), intake of cancer treatment drugs like doxorubicin 
for chemotherapy, and radiation therapies.  The lack of antioxidant capacity to balance 
out this preliminary excess ROS production leads to the cascading ROS production 
cycle involving processes such as ischemia reperfusion and lipid peroxidation. This 
excess production, in turn, leads to the oxidation of cell components, such as cell 
membranes, DNA, lipids etc., ultimately resulting in cell death. Common examples of 
ROS include singlet oxygen (1O2), transition metal ions, superoxide radicals (O2.-), 
hydrogen peroxide, hydroxyl radicals and peroxynitrite (ONOO-).  Mitochondrial 
oxidative stress has been shown to play a vital role in development of several 
neurodegenerative diseases like Alzheimer’s and Parkinson’s disease [1].  
Administration of antioxidants as therapeutics is a potential solution to alleviate the 
steady-state oxidative stress and help metabolism cope beyond its natural antioxidant 
capacity against oxidants/ROS/RNS. Plants and fruit derived dietary small molecule 
antioxidant scavengers, such as curcumin, quercetin, and vitamin E, have gained critical 
interest in the area concerning mitigation of OS. In spite of their excellent self-
sacrificial property to neutralize free radicals, these bioactive compounds have failed 
to substantiate themselves as potential drugs for suppression of OS. Some of the key 
underlying explanations behind this poor performance is due to their limited aqueous 
solubility, structural instability in the physiological environment and hence overall low 
1 
 
  
bioavailability [2]. Taken together, these properties greatly limit bioavailability, 
preventing systemic drug concentrations from reaching the therapeutic window. While, 
these are some interpretations derived from several in vivo and clinical trials, in vitro 
studies shows evidence of suppressing oxidative stress [3]. The extent of this protection 
is again limited due to their very low viable concentrations at the cellular level or 
demonstration of pro-oxidant effects at high administered doses [4]. Thus, high levels 
of antioxidants could be seen as a solution to inhibit cancerous cell growth but not a fix 
for OS in healthy cells. 
As a result, though highly potent, maintaining an effective drug concentration without 
being toxic is a challenge with antioxidants. Further, preserving them in their active 
form after administration is another barrier to effective drug delivery. An antioxidant 
prodrug system with controlled drug release could be a possible solution to this 
challenge and direct polymerization of antioxidants into a poly(β amino ester) (PβAE) 
style polymer could be a possible way to achieve this approach. Synthesized via 
Michael addition reaction of an acrylate with a primary or secondary amine, PβAEs are 
hydrolytically biodegradable systems through their ester linkages. They can be 
formulated into crosslinked networks via reaction of a multiacrylate compound with a 
multifunctional amine [5]. Further utilizing the synthesis chemistry covalently 
conjugating antioxidants into the crosslinked networks would protect the bioactive 
functional groups from getting deactivated until released [6]. Upon hydrolytic 
degradation, these PβAE crosslinked networks would release conjugated antioxidants 
in their original structural form in a controlled manner.  
Owing to these benefits of the synthesis chemistry, formulating the antioxidant PβAE 
systems into microgels or nanogel networks would open up the options to various 
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delivery routes including local, intravenous, inhalation and other injectable approaches. 
Control over drug release kinetics and particle size would further make the system more 
adaptable in drug delivery systems. 
Therefore, development of robust and functionally active antioxidant-PβAE particles 
in the nano to micro size range was pursued for local and systemic therapy applications.  
A single step synthesis chemistry to conjugate polyphenolic antioxidant into PβAE 
crosslinked systems, previously designed in the Dziubla lab, was adopted involving the 
reaction of acrylate functionalized antioxidants with multifunctional amines [6]. While 
the PβAE synthesis processes were modified according to the type of particle system 
desired, different anti-inflammatory polyphenolic antioxidant drug molecules 
(quercetin, curcumin and resveratrol) were also explored to analyze the pliability of the 
formulation processes. Figure 1.1 summarizes the overall idea of the research goals and 
is also discussed below. 
Quercetin-PβAE nanogels (CHAPTER 4) were synthesized using a novel single step 
reaction-precipitation method utilizing the Michael addition chemistry. Allowing 
control over the nanogel diameter as a function of monomer concentration, the synthesis 
process was also amenable to the formulation of curcumin-PβAE nanogels (CHAPTER 
5 and 6). Curcumin-PβAE crosslinked systems were further explored to synthesize 
antioxidant-PβAE gel microparticles systems (10-20 µm) via gel cryomilling method 
(CHAPTER 7). The gel microparticle synthesis process was also successfully 
employed in the formulation of resveratrol-PβAE gel microparticles (CHAPTER 8). 
Being able to synthesize these prodrug systems in different particle sizes and with 
different compounds demonstrated the flexible nature of the synthesis processes in drug 
delivery applications. 
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The hydrolytic degradation rate of these crosslinked systems was studied to analyze the 
antioxidant release rates. Both nano and microsystems showed a uniform and extended 
release of the structurally active antioxidants with no burst release effects, which is a 
critical requirement in most drug delivery applications. Further, tunable antioxidant 
release properties of curcumin and resveratrol microparticle systems were observed due 
to the incorporation of poly(ethylene glycol)diacrylate (PEGDA) as a co-monomer 
during PβAE gel synthesis.  
With control over the above mentioned physicochemical properties of these antioxidant 
conjugated PβAEs, in vitro response of endothelial and dermal fibroblasts showed 
prolonged protection against H2O2 induced cellular oxidative stress. The uniform 
release profile of curcumin-PβAE nanogels with no burst release, in fact, resulted in a 
reduced cytotoxicity of curcumin at higher concentrations, thereby increasing the safety 
limit of the antioxidant. This characteristic allowed the antioxidant to be administered 
at therapeutic levels and work against mitochondrial and cellular OS in endothelial 
cells. The protective effect of these nanogels was also seen at mitochondrial levels with 
cells exposed to PCBs, which are considered environmentally persistent toxicants and 
are known to induce cellular disorders via OS route (CHAPTER 6). 
While nanocarriers are the desired choices for systemic applications through various 
injectable or inhalation routes, use of larger particles i.e. microparticle drug carrier 
systems is not often favored for local drug delivery. Therefore, extending the 
application of antioxidant-PβAE systems, curcumin-PβAE microparticles were 
analyzed as a treatment therapy for oral mucositis through local delivery. Hence, a 
preliminary in vivo study employing the hamster pouch model under induced oral 
mucositis conditions was carried out. Locally delivering suspended curcumin-PβAE 
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microparticles during the developmental stage of oral mucositis showed decreased 
levels of oxidative stress markers and a reduced intensity in epithelial layer damage as 
compared to the placebo. Similarly, resveratrol-PβAE microparticles were also tested 
for their protective application towards UV radiation-induced OS. Although this project 
is currently at a partially completed stage, the system has shown promising results 
towards cellular OS suppression but needs optimization in synthesis processes and 
cleaner demonstration of the intended application. 
Apart from the direct antioxidant conjugation method, another novel route through 
transesterification was identified to chemically conjugate –OH group containing drug 
molecules (detailed discussion in the Appendix). With the concept that an alcohol can 
be substituted into an ester bond to form a new ester, different alcohols were substituted 
into the already existing crosslinked PβAE gel matrix synthesized using PEGDA and 
4, 7, 10-trioxatridecane-1, 13-diamine (TTD). Transesterification rate varied depending 
upon various ambient parameters and showed faster degradation with increasing 
polarity of gel matrix due to amine catalyzing effect. The effect was further enhanced 
by using alcohols of different chemical nature. This approach was applied towards 
conjugation of riboflavin into PEGDA-TTD gels and the rate of conjugation depended 
upon the polar nature of the synthesized gels. 
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Figure 1.1 Figure 1.1 PβAE crosslinked prodrug network systems 
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2 BACKGROUND: A FREE RADICAL PRIMER 
 
Based on the book chapter to be published: 
Prachi Gupta, Andrew Lakes, Thomas Dziubla, Free Radical Chemistry Primer; 
To appear in ‘Oxidative Stress and Biomaterials: The Science, Challenges and 
Opportunities’ (Elsevier)  
2.1 Free radical biology – importance  
Free radicals, represented with a superscript ‘dot’ (A), are defined as any atom or 
molecule containing an unpaired electron which has a strong tendency to gain another 
electron to achieve a non-radical state [7].  These molecules are considered to be highly 
reactive, are capable of reacting with a non-radical molecule in their quest for self-
stabilization. Radical species can be found through a variety of mechanisms, one of 
which is an abstraction of an electron from an atom or a molecule. Radicals can also be 
generated by the splitting of a molecule at a very high-energy state. A classic example 
would be radiation induced homolysis of a water molecule into a hydroxyl radical and 
a hydrogen atom [8](eq 1) 
 𝑯𝑯𝟐𝟐𝑶𝑶 + 𝒆𝒆𝒆𝒆 → 𝑯𝑯+ + 𝑶𝑶𝑯𝑯− (1) 
As these radical ions exist in a high and unstable potential energy state, they can react 
in a variety of ways. For example, two radica species can react with each other to form 
a non-radical molecule or one radical can donate an electron to another yielding two 
stable compounds [9].  
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As oxygen serves as the primary player in most biological free radical reactions, free 
radicals are also commonly known as reactive oxygen species (ROS). In a similar way, 
nitrogen base free radicals are called reactive nitrogen species (RNS). Table 2.1 lists 
some of the most common free radicals/oxidants/ROS important in biology. Most of 
the essential cellular matrix components (protein, cellular membrane, DNA, lipids, 
polyunsaturated fatty acids etc.) in physiological systems are stable non-radical entities 
and perform their regular function of energy production in the form of ATP and 
maintain the cellular redox balance. But, the presence of more than the basal level of 
free radical molecules/ROS can lead to reactions of ROS with alternative cellular 
components in a quest to stabilizing themselves, damaging the chemical integrity of 
cellular biomolecules [10, 11]. One well-known example is lipid membrane damage via 
lipid peroxidation, where highly reactive hydroxyl radical react with polyunsaturated 
fatty acids (PUFAs) of the cellular membrane by extracting an electron yielding a lipid 
free radical. If this reaction phenomenon is not controlled in a timely manner, it can 
initiate a chain reaction of free radical molecules with intact lipids resulting in overall 
cellular membrane damage [12].  
 
 
Figure 2.1 Lipid peroxidation cycle in presence of hydroxyl radical (OH●) 
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Although most of the research concerning the role of ROS/RNS has been done towards 
the potential cellular damage and subsequent pathological events, they do serve as a 
beneficiary to the body under certain conditions. When present in optimum 
concentrations, they help maintain the redox homeostasis in the cellular environment. 
This helps in regulation of cell functioning, cell signaling and appropriate response to 
endogenous and exogenous stimuli [13]. Under normal physiological conditions, a 
balance between generation and elimination of ROS/RNS via endogenous antioxidant 
enzymes/molecules helps the redox-sensitive signaling proteins to function properly 
[14]. Endogenous ROS enzymes like myeloperoxidase, and NADPH oxidase (NOX), 
also known as phagocyte oxidase, actually help the neutrophils perform their 
phagocytic function against microbial intrusion in an event known as respiratory burst. 
To briefly explain, NADPH oxidase catalyzed superoxide production forms hydrogen 
peroxide with the help of superoxide dismutase (SOD), which in turn converts to 
hypochlorous acid (HOCl) having bactericidal properties (eq 2) [15, 16]. 
Reaction:  
 𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑯𝑯 + 𝑶𝑶𝟐𝟐
𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑯𝑯 𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒆𝒆
�⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯�  𝑶𝑶𝟐𝟐−●
𝑺𝑺𝑶𝑶𝑵𝑵
�⎯� 𝑯𝑯𝟐𝟐 𝑶𝑶𝟐𝟐  
𝑴𝑴𝑴𝑴𝑴𝑴𝒐𝒐𝑴𝑴𝒆𝒆𝑴𝑴𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒆𝒆
�⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯�   𝑯𝑯𝑶𝑶𝑯𝑯𝑴𝑴 (2) 
Table 2.1 Potential free radical species  
ROS/RNS Symbol ROS/RNS Symbol 
Superoxide O2- Hydroxyl OH● 
Hydroperoxyl HOO● Peroxyl ROO● 
Nitric oxide NO● Nitrogen oxide NO2● 
Peroxynitrite ONOO- Singlet oxygen 1O2 
Hypochlorous acid HOCl   
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2.2 RED/Ox Chemistry  
2.2.1 Oxidation/reduction reactions and voltage potentials 
Originally, the term ‘oxidation’ was described as a process of any element, primarily 
metals, to combine with oxygen to form metal oxides and ‘reduction’ was defined as a 
process that will convert the metal oxide back to pure metal again. For example, 
conversion of magnesium (Mg) to magnesium oxide is oxidation and back to 
magnesium at high temperature in the presence of carbon is a reduction. Later, the 
discovery of electrons changed the definition of oxidation-reduction to a phenomenon 
of encountering any transfer of electrons from one species to another. As per the law of 
conservation of mass applied to electrons, oxidation and reduction are always linked to 
one another. Meaning, if one species is oxidized, the counter reactant species will be 
reduced [17, 18].  
 
 
(3) 
 
 
 
(4) 
By definition, oxidation of any given element or molecule will involve a loss of an 
electron and the element/molecule will be known as a reducing agent while the 
reduction of any molecule will be a gain of electron and that molecule will be known 
as an oxidizing agent [19]. In reference to free radicals or ROS as such, they are 
commonly known to be strong oxidizing agents or have a tendency to get reduced [20, 
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21]. This is because most radicals have one unpaired electron, and the addition of 
another electron (or getting reduced) with opposite electron spin would help in 
stabilizing the electron pair taking them to a more inert state. However, this is not 
always true. The oxidizing tendency of any free radical will depend on its affinity to 
gain an electron or its own reduction potential against the affinity or potential of the co-
reactant. It is possible that free radical ‘A’ gets reduced in presence of ‘B’ but might 
get oxidized itself by losing another electron in presence of ‘C’ because the reduction 
potential or electron gaining affinity of ‘C’ is greater than ‘A’.  
2.1.1.1 Types of redox reactions 
 
Corrosion and rusting: 
Iron has served as a common example of corrosion, which is the electrochemical 
oxidation of metals in the presence of oxygen to form respective oxides. In reference to 
iron, it is specifically termed as the formation of ‘rust’ (eq 5) [22].  
 4𝐹𝐹𝐹𝐹 + 3𝑂𝑂2  → 2𝐹𝐹𝐹𝐹2𝑂𝑂3  ………………..Oxidation of Fe to Fe+3 (5) 
 
In presence of an acid, iron (II) is oxidized to iron (III) by reaction with hydrogen 
peroxide, which acts as an oxidizing agent [23], although iron (III) can be reduced back 
to iron (II) in presence of stronger reducing agents or free radicals such as superoxide 
anion [24]. This oxidation-reduction chemistry of iron, popularly known in terms of the 
Fenton or Haber-Weiss reaction mechanism, is very critical in maintaining the redox 
state of the cell. 
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 2𝐹𝐹𝐹𝐹+2 + 𝐻𝐻2𝑂𝑂2 + 2𝐻𝐻+  → 2𝐹𝐹𝐹𝐹+3 (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝐹𝐹𝑜𝑜) +
2𝐻𝐻2𝑂𝑂(𝑟𝑟𝐹𝐹𝑜𝑜𝑟𝑟𝑟𝑟𝐹𝐹𝑜𝑜) ………………….Oxidation of Fe+2 to Fe+3 (6) 
Nitrification and Denitrification:  
Nitrification often occurs naturally and is a biologically oxidative process where 
ammonia is oxidized to nitrite followed by formation of nitrate by nitrifying bacteria. 
On the other hand, reduction of nitrate to nitrogen in the presence of an acid is termed 
as denitrification and is often used as water purification process [25]. These nitrates 
have the ability to diffuse through the cellular membrane and play a significant role in 
the production of RNS in a cellular environment. 
Nitrification: 
 
 
𝑁𝑁𝐻𝐻3 + 𝑂𝑂2 → 𝑁𝑁𝑂𝑂2−(𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝐹𝐹𝑜𝑜) + 3𝐻𝐻+ + 2𝐹𝐹− (Ammonia 
to nitrite) 
(6) 
 𝑁𝑁𝑂𝑂2− + 𝐻𝐻2𝑂𝑂 → 𝑁𝑁𝑂𝑂3−(𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝐹𝐹𝑜𝑜) + 2𝐻𝐻+ + 2𝐹𝐹− (Nitrite to 
nitrate) 
(7) 
 
Denitrification: 2𝑁𝑁𝑂𝑂3− + 10𝐹𝐹− + 12H+ → N2 (reduced) + 6H2O (Oxidized) (8) 
Dismutation reaction: 
Dismutation or disproportionation is a specific kind of redox reaction where both 
oxidized and reduced forms of a chemical species are produced. For example, 
superoxide free radicals produced in mitochondria dismutate to hydrogen peroxide and 
oxygen (equation 9) [26] or ascorbyl radical to ascorbate (vitamin C) and 
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dehydroascorbate (DHA) (eq 10) in order to maintain intracellular nutrient 
requirements for the cells [27, 28]. 
 2𝑂𝑂2− + 2𝐻𝐻+  → 𝐻𝐻2𝑂𝑂2(𝑟𝑟𝐹𝐹𝑜𝑜𝑟𝑟𝑟𝑟𝐹𝐹𝑜𝑜) + 𝑂𝑂 2(𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝐹𝐹𝑜𝑜) (9) 
 2𝑎𝑎𝑎𝑎𝑟𝑟𝑜𝑜𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎● + 𝐻𝐻+  → 𝑎𝑎𝑎𝑎𝑟𝑟𝑜𝑜𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝐹𝐹 (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝐹𝐹𝑜𝑜) + 𝐷𝐷𝐻𝐻𝐷𝐷 (𝑟𝑟𝐹𝐹𝑜𝑜𝑟𝑟𝑟𝑟𝐹𝐹𝑜𝑜) (10) 
Cellular respiration: 
Oxidation of glucose to carbon dioxide with simultaneous reduction of oxygen to water 
is another kind of natural oxidation-reduction reaction required for energy production 
in living organisms. [29]. 
 𝐶𝐶6𝐻𝐻12𝑂𝑂6 + 6𝑂𝑂2  → 6𝐶𝐶𝑂𝑂2 + 6𝐻𝐻2𝑂𝑂 (11) 
All the reactions (equation 5-11) showed their tendency to either undergo oxidation or 
reductions is controlled by their reduction potential. Reduction potential (Eo) is defined 
as a tendency of a chemical species to be reduced by gaining an electron and is defined 
with electrochemical reference of hydrogen, which is globally given the reduction 
potential of zero [30]. As this is an electric potential, it is measured in volts and each 
chemical species has its own intrinsic reduction potential. Numerically, the more 
positive the potential, the stronger is the affinity of the species to acquire an electron 
and get reduced. 
2.1.1.2 Redox potential: 
 
A normal redox reaction example could be as given below (eq 12): 
 𝐹𝐹𝐹𝐹+3 + 𝐶𝐶𝑟𝑟+  → 𝐹𝐹𝐹𝐹+2 + 𝐶𝐶𝑟𝑟+2 (12) 
 
And this can be broken down into two parts: 
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 𝐹𝐹𝐹𝐹+3 + 𝐹𝐹− → 𝐹𝐹𝐹𝐹+2 …………reduction (13) 
 𝐶𝐶𝑟𝑟+ → 𝐶𝐶𝑟𝑟+2 + 𝐹𝐹−……………oxidation (14) 
For a combined redox reaction, the overall redox potential is estimated by: 
 ∆𝐸𝐸 = 𝐸𝐸𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 − 𝐸𝐸𝑑𝑑𝑎𝑎𝑑𝑑𝑎𝑎𝑎𝑎𝑎𝑎  (15) 
The electrochemical potential or reduction potential stated above is directly related to 
the Gibbs free energy (∆𝐺𝐺) of the reaction: 
 (∆𝐺𝐺) = −𝑛𝑛𝐹𝐹∆𝐸𝐸 (16) 
where 
n: number of electrons associated with the reaction 
F: Faraday’s constant 
For a reaction to proceed total Gibb’s free energy (∆𝐺𝐺) must be negative or ∆𝐸𝐸 should 
be positive. In equation 14, Cu is the electron donor with redox potential of Cu+2 to Cu+ 
is +0.16 V and that of Fe+3 to Fe+2 is 0.77 V. Therefore overall redox potential becomes 
+0.61 V. 
To state this simply, for a system to undergo a redox reaction, the redox potential of a 
species to be reduced should be higher than the species to be oxidized. Table 2 lists 
some of the common redox potentials of certain half-cell redox couples and of some 
biomolecules important to physiological redox environment. 
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Table 2.2. Half-cell reduction potentials of biologically significant molecules 
Redox couple Eo (v) 
𝑂𝑂2 + 4𝐻𝐻+ + 4𝐹𝐹−  → 2𝐻𝐻2𝑂𝑂 +0.816 
𝑁𝑁𝑂𝑂2 + 𝐹𝐹−  → 𝑁𝑁𝑂𝑂2− + 1.04 
𝑁𝑁𝑂𝑂3− + 4𝐻𝐻+ + 3𝐹𝐹− → 𝑁𝑁𝑂𝑂 + 𝐻𝐻2𝑂𝑂 + 0.96 
𝐻𝐻2𝑂𝑂2 + 2𝐻𝐻+ + 2𝐹𝐹− → 2𝐻𝐻2𝑂𝑂 + 0.82 
𝐹𝐹𝐹𝐹+3 + 𝐹𝐹−  → 𝐹𝐹𝐹𝐹+2 + 0.77 
𝑂𝑂2 +  2𝐻𝐻+ + 2𝐹𝐹−  → 𝐻𝐻2𝑂𝑂2 + 0.68 
2𝐼𝐼2 + 2𝐹𝐹−  → 2𝐼𝐼− + 0.54 
2𝐻𝐻2𝑂𝑂 + 𝑂𝑂2 + 4𝐹𝐹−  → 4𝑂𝑂𝐻𝐻− + 0.40 
2𝐶𝐶𝑟𝑟+2 + 2𝐹𝐹−  → 𝐶𝐶𝑟𝑟 + 0.34 
2𝐶𝐶𝑎𝑎𝑎𝑎𝑜𝑜𝑟𝑟ℎ𝑜𝑜𝑟𝑟𝑜𝑜𝐹𝐹 𝑟𝑟+3 + 2𝐹𝐹−  → 2 𝑟𝑟𝑎𝑎𝑎𝑎𝑜𝑜𝑟𝑟ℎ𝑜𝑜𝑟𝑟𝑜𝑜𝐹𝐹 𝑟𝑟+2 +0.254 
2𝐶𝐶𝑎𝑎𝑎𝑎𝑜𝑜𝑟𝑟ℎ𝑜𝑜𝑟𝑟𝑜𝑜𝐹𝐹 𝑎𝑎+3 + 2𝐹𝐹−  → 2 𝑟𝑟𝑎𝑎𝑎𝑎𝑜𝑜𝑟𝑟ℎ𝑜𝑜𝑟𝑟𝑜𝑜𝐹𝐹 𝑎𝑎+2 +0.070 
𝐹𝐹𝑟𝑟𝑜𝑜𝑎𝑎𝑟𝑟𝑎𝑎𝑎𝑎𝐹𝐹 + 2𝐻𝐻+ + 2𝐹𝐹−  → 𝑎𝑎𝑟𝑟𝑟𝑟𝑟𝑟𝑜𝑜𝑛𝑛𝑎𝑎𝑎𝑎𝐹𝐹 +0.031 
2𝐻𝐻+ + 2𝐹𝐹−  → 𝐻𝐻2 0.00 
𝐹𝐹𝐷𝐷𝐷𝐷+ + 2𝐻𝐻+ + 2𝐹𝐹−  → 𝐹𝐹𝐷𝐷𝐷𝐷𝐻𝐻2 (free coenzyme) -0.22 
𝑂𝑂𝑜𝑜𝑎𝑎𝑎𝑎𝑜𝑜𝑎𝑎𝑟𝑟𝐹𝐹𝑎𝑎𝑎𝑎𝑎𝑎𝐹𝐹 + 2𝐻𝐻+ + 2𝐹𝐹−  → 𝑜𝑜𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝐹𝐹 -0.166 
𝑃𝑃𝑎𝑎𝑟𝑟𝑟𝑟𝑃𝑃𝑎𝑎𝑎𝑎𝐹𝐹 + 2𝐻𝐻+ + 2𝐹𝐹−  → 𝑎𝑎𝑎𝑎𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝐹𝐹 -0.185 
𝑁𝑁𝐷𝐷𝐷𝐷+ + 2𝐻𝐻+ + 2𝐹𝐹−  → 𝑁𝑁𝐷𝐷𝐷𝐷𝐻𝐻 + 𝐻𝐻+ -0.320 
𝑁𝑁𝐷𝐷𝐷𝐷𝑃𝑃+ + 2𝐻𝐻+ + 2𝐹𝐹−  → 𝑁𝑁𝐷𝐷𝐷𝐷𝑃𝑃𝐻𝐻+ + 𝐻𝐻+ -0.324 
𝑂𝑂2 + 𝐹𝐹−  → 𝑂𝑂2− -0.33 
𝑆𝑆𝑟𝑟𝑟𝑟𝑟𝑟𝑜𝑜𝑛𝑛𝑎𝑎𝑎𝑎𝐹𝐹 + 𝐶𝐶𝑂𝑂2 + 2𝐻𝐻+ + 2𝐹𝐹−  
→ 𝛼𝛼 − 𝑘𝑘𝐹𝐹𝑎𝑎𝑜𝑜𝑘𝑘𝑎𝑎𝑟𝑟𝑎𝑎𝑎𝑎𝑟𝑟𝑎𝑎𝑎𝑎𝐹𝐹 + 𝐻𝐻2𝑂𝑂 
-0.324 
𝑁𝑁𝑎𝑎+ + 𝐹𝐹−  → 𝑁𝑁𝑎𝑎 -2.71 
 
2.2.2 Thermodynamic treatment (Ellingham diagram) 
A voltage potential is not the only way to determine the direction of the reaction. As 
stated earlier, for a reaction to proceed, ∆𝐺𝐺 should be negative which requires ∆𝐸𝐸 to be 
positive, but ∆𝐺𝐺 is also a function of temperature (Equation 17). An alternative to 
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determine the direction of a reaction can be obtained by a thermodynamic analysis of 
the reaction equilibrium. 
 ∆𝐺𝐺 =  ∆𝐻𝐻 − 𝑇𝑇∆𝑆𝑆 (17) 
Where 
T: reaction temperature 
ΔS: Entropy change 
ΔH: Enthalpy change 
The temperature dependence of a reaction using equation (17) above is also utilized in 
redox chemistry to drive the direction of reactions of metal oxides and sulfides to pure 
metal. This phenomenon is usually illustrated in the form of an Ellingham’s diagram, 
which represents the stability of a metal oxide as a function of temperature in reference 
to ΔG (Figure 2.2). Each line for a particular metal shows the free energy values for its 
metal oxide formation where slope depicts the ΔS values while the y-intercept gives 
ΔH. The position of the line of a metal with reference to another helps in depicting the 
metal oxide reduction ability in presence of another metal. To illustrate, the lower the 
position of metal (𝑀𝑀𝑘𝑘 + 𝑂𝑂 → 𝑀𝑀𝑘𝑘𝑂𝑂) is on Elligham’s diagram, the more stable its oxide 
is at a particular temperature than the one that lies above it (4
3
𝐷𝐷𝑎𝑎 + 𝑂𝑂2 →
2
3
𝐷𝐷𝑎𝑎2𝑂𝑂3).  
Therefore, magnesium can reduce aluminum oxide to metallic aluminum. Looking at 
the diagram, all the metal oxide formations have a positive slope while carbon oxidation 
to carbon monoxide has a negative slope and it cuts across many of the metals at 
particular temperatures. Therefore, carbon becomes very useful as a reducing agent for 
metal oxides at higher temperature. For example, carbon can reduce manganese oxide 
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(MnO) to its metallic form Mn once the reaction temperature goes above 1400oC while 
it will be able to reduce TiO2 to Ti above 1600oC [31-33].  
Therefore, with an analogous theory, the way reduction potential of two reacting 
molecules decide their possibility to get reduced or oxidized, in a similar way, ΔG of 
metal oxides of two interacting metal decides the fate of one getting reduced in presence 
of another. 
 
         Figure 2.2 Ellingham’s diagram [34] 
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2.2.3 Combustion sequences and/or metal oxides 
Combustion is a classic example of free radical reactions and generation. It is a high 
temperature exothermic process involving multiple redox reactions of a fuel 
(hydrocarbons) with an oxidant, mostly oxygen, resulting in oxidized products 
primarily carbon dioxide and water, to generate heat and light. The overall combustion 
process of oils is described by the reaction below: 
 
𝐶𝐶𝑑𝑑𝐻𝐻2(𝑑𝑑+1) + (4𝑛𝑛 +
𝑛𝑛 + 1
2
)𝑂𝑂2 → 𝑛𝑛𝐶𝐶𝑂𝑂2 + (𝑛𝑛 + 1)𝐻𝐻2𝑂𝑂 (18) 
While this equation is simple and describes the process in a general fashion, the exact 
chemistry of combustion is highly complex, multifaceted and not easy to describe. 
As such molecular oxygen in its ground state is a very stable molecule and unreactive 
to hydrocarbons until a catalyst is introduced but at elevated temperature as high as 
2200oC, oxygen converts into highly reactive singlet oxygen (O21) [35] and is known 
to have high oxidizing power. Singlet oxygen can react with and break carbon-carbon 
or carbon-hydrogen bonds of large hydrocarbons into smaller molecules and, 
subsequently, hydrogen and water. In the process, it is also capable of initiating 
numerous radical chain reactions via reaction with molecular hydrogen (H2) resulting 
in the hydroxyl radical (OH●) and a proton (H+). The combination of many such 
reactions results in the generation and simultaneous consumption of hydroperoxyl 
(HCOO●), formyl (HCO●) radicals, carbon monoxide [36, 37]. As for hydrocarbon 
pyrolysis, the process involves generation of various aliphatic and aromatic radicals.  
Below are some of the common series of radical reactions that can occur during 
combustion process: 
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 𝑂𝑂2 + 𝐻𝐻+ → 𝑂𝑂.− + 𝑂𝑂𝐻𝐻● (19) 
 𝑂𝑂21 + 𝐻𝐻2 → 𝐻𝐻+ + 𝑂𝑂𝐻𝐻● (20) 
 𝐶𝐶3𝐻𝐻8 + 𝑀𝑀 → 𝐶𝐶2𝐻𝐻5● + 𝐶𝐶𝐻𝐻3● + 𝑀𝑀 (21) 
 𝐶𝐶2𝐻𝐻5● + 𝑀𝑀 → 𝐶𝐶2𝐻𝐻4 + 𝐻𝐻+ + 𝑀𝑀 (22) 
 𝐶𝐶3𝐻𝐻8 + 𝑂𝑂𝐻𝐻● → 𝐶𝐶3𝐻𝐻7● + 𝐻𝐻2𝑂𝑂 (23) 
 𝐶𝐶3𝐻𝐻8 + 𝐻𝐻+ → 𝐶𝐶3𝐻𝐻7● + 𝐻𝐻2 (24) 
 𝐶𝐶3𝐻𝐻8 + 𝑂𝑂●− → 𝐶𝐶3𝐻𝐻7● + 𝑂𝑂𝐻𝐻● (25) 
 𝐶𝐶3𝐻𝐻7● → 𝐶𝐶3𝐻𝐻6 + 𝐻𝐻+ 
Decay to unsaturated hydrocarbons 
(26) 
These radical react with oxygen radical to produce formyl radical and formaldehyde 
and CH3●, CH2, H2CO finally oxidize to CO2 and H2O. 
 𝐶𝐶3𝐻𝐻6 + 𝑂𝑂●− → 𝐶𝐶2𝐻𝐻5 + 𝐻𝐻𝐶𝐶𝑂𝑂 (27) 
 𝐶𝐶2𝐻𝐻4 + 𝑂𝑂2 → 2𝐶𝐶𝑂𝑂 + 𝐻𝐻2 (28) 
 𝐶𝐶𝑂𝑂 + 1/2𝑂𝑂2 → 𝐶𝐶𝑂𝑂2 (29) 
Production of oxygen radicals also result in nitrogen oxide species production via 
reaction with atmospheric nitrogen as shown below: 
 𝑂𝑂●− + 𝑁𝑁2 → 𝑁𝑁𝑂𝑂 + 𝑁𝑁 (30) 
 𝑁𝑁 + 𝑂𝑂2 → 𝑁𝑁𝑂𝑂 + 𝑂𝑂 (31) 
 𝑁𝑁 + 𝑂𝑂𝐻𝐻● → 𝑁𝑁𝑂𝑂 + 𝐻𝐻+ (32) 
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Therefore, looking at all the reactions above that are involved in the process of 
producing heat energy via oxidation of long/short chain hydrocarbon fuels it is clear, a 
milieu of free radicals are generated. Analogously, a host of free radicals are produced 
in the process of carbohydrate, glucose, or fructose metabolism to generate cellular 
energy in the form ATP. These free radicals play a critical part in maintaining cell 
function depending on their local and overall concentrations. 
To explain this combustion further, a spatial relationship can also be generated 
described by the ‘zone theory’. This concept divides the combustion process into four 
distinct zones: zone 1-free flame zone (fuel zone), zone 2-high temperature flame zone 
(>1200o C), zone 3-post flame thermal zone (600-1200o C) and zone 4-gas quench cool 
and surface catalysis zone (<600o C) [38]. Usually radical formation and consumption 
takes place during zone 3 and zone 4 combustion. As the process reaches the lower 
temperature in the cool down zone (150 to 400o C), free radicals, mostly phenoxyl and 
semiquinone exists. These aromatic compounds have resonating electrons and hence 
tend to stabilize via surface-mediated reactions with any surrounding transition metal 
ions. They tend to form a metal oxide complex and are known as persistent free radicals. 
These radicals are sometimes very stable in ambient conditions and can become 
environmentally persistent free radicals (EPFRs) [39]. These aromatic compounds 
generated during combustion also known as organic aerosols, mostly come from 
biomass ignition processes. The fact that EPFRs are stabilized due to interaction with 
metal oxides, their half-lives consistently depend upon the kind of metal oxide they 
interact with. As per the studies, EPFRs associated with zinc oxide (ZnO) were found 
to have the longest half-lives ranging from 3 to 73 days depending on the adsorbate 
[39].  
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The combination of radicals/oxidants generated during cellular metabolism and 
subsequent reaction combinations with transition metal ions also plays a similar role in 
accelerating the production of more radicals just like EPFRs. Figure 2.3 illustrates an 
analog of combustion zone theory with cellular respiration/metabolism at various 
stages, where oxidative phosphorylation process can be compared with the flame zone 
as the energy production step, heat energy for combustion and ATP for cellular 
respiration. Following that, just like the post flame zone defines incomplete combustion 
and initial production of radicals, partial oxygen reduction or proton leak during 
phosphorylation processes results in superoxide generation, which subsequently lead to 
H2O2 formation. In both cases, the role of radicals produced at this stage are boosted by 
the presence of a transition metal ion. With combustion, transition metal ion 
combination with radicals makes more environmentally stable EPFRs and are reactive 
to other biological species. During cellular metabolism, transition metal ions act as a 
catalyst towards production of more reactive and damaging oxidants namely hydroxyl 
radical (OH●). 
 
Figure 2.3 Analogous comparison of various stages of combustion zone theory with 
cellular respiration during energy production along with free radical generation [3] 
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2.2.4 Fenton/Haber-Weiss chemistry  
Both the Fenton and Haber-Weiss reactions are associated with iron and the production 
of hydroxyl radicals. The Fenton reaction describes the formation of  hydroxide (OH-) 
and hydroxyl (OH●) radical by reaction between of Iron (II) (Fe+2) with hydrogen 
peroxide (H2O2) [40], Haber-Weiss reaction is where hydroxyl and hydroxide ions are 
generated from the reaction of H2O2 and superoxide ion (O2●-) catalyzed by iron [41]. 
 𝐹𝐹𝐹𝐹+2 + 𝐻𝐻2𝑂𝑂2  → 𝐹𝐹𝐹𝐹+3 + 𝑂𝑂𝐻𝐻− + 𝑂𝑂𝐻𝐻●………………….Fenton 
reaction 
(33) 
 𝑂𝑂2●− + 𝐻𝐻2𝑂𝑂2 → 𝑂𝑂𝐻𝐻− + 𝑂𝑂𝐻𝐻● + 𝑂𝑂2………………………..Haber-
Weiss reaction 
(34) 
The Haber-Weiss cycle is actually a two-step reaction, where the ferric ion reduces to 
ferrous ion via reaction with superoxide, which, in turn, reacts with H2O2 to form OH- 
and OH● ions, converting ferrous back to ferric ion.  
 𝑂𝑂2●− + 𝐹𝐹𝐹𝐹+3 → 𝐹𝐹𝐹𝐹+2 + 𝑂𝑂2   (35) 
  𝐹𝐹𝐹𝐹+2 + 𝐻𝐻2𝑂𝑂2  → 𝐹𝐹𝐹𝐹+3 + 𝑂𝑂𝐻𝐻− + 𝑂𝑂𝐻𝐻● (36) 
Though these reactions are named after these three scientists, there is a lot of history 
associated with the naming, discovery, and progression of this concept of iron redox 
reaction involvement in radical production. Henry J. H. Fenton reported for the 1st time 
the oxidation power of H2O2 and Fe+2 towards tartaric acid in 1876 but never mentioned 
the existence of the hydroxyl radical intermediate in the oxidation process although the 
reaction was named after him [42]. The existence of OH● was 1st proposed by two 
German chemists, Fritz Haber and Joseph Joshua Weiss in 1934 via reaction of 
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hydrogen peroxide and superoxide in presence of iron as a catalyst [43]. Formation of 
this hydroxyl radical via transition metal catalyzed reaction has gained plenty of 
attention over the years and is considered to be one of the key processes for the 
production of the highly reactive OH● in the cellular redox chemistry. 
Not only hydroxyl radicals, but Fenton/Haber-Weiss chemistry involving redox 
coupling between iron and hydrogen peroxide gives rise to several other oxidizing 
intermediates including hydro peroxides (HOO●), superoxide (O2-) etc during various 
chain initiation and propagation reactions shown in equations 38-46. OH● act as the 
chain carrier with the ability to react with Fe+2, H2O2 or any other organic species to 
propagate the reaction. But in some instances chain termination also comes into effect 
via combination of two radicals (OH●/OH● or OOH●/OH●) producing just hydrogen 
peroxide, water and oxygen as shown in equation 45 and 46 [44]. The existence and 
propagation of any of these reactions highly depends on the density of iron in its 
required oxidation state as well as the rate constant. An important condition for iron 
induced reduction of hydrogen peroxide is the low pH requirement between 3 and 6.  
 𝐹𝐹𝐹𝐹+2 + 𝐻𝐻2𝑂𝑂2 → 𝐹𝐹𝐹𝐹+3 + 𝑂𝑂𝐻𝐻− + 𝑂𝑂𝐻𝐻● K=5.7x102 M-1s-1 (37) 
 𝐹𝐹𝐹𝐹+3 + 𝐻𝐻2𝑂𝑂2 → 𝐹𝐹𝐹𝐹+2 + 𝐻𝐻+ + 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− K=2.6x10-3 M-1s-1 (38) 
 𝑂𝑂𝐻𝐻● + 𝐻𝐻2𝑂𝑂2 → 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− + 𝐻𝐻2𝑂𝑂 K=3.3x107 M-1s-1 (39) 
 𝐹𝐹𝐹𝐹+3 + 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− → 𝐹𝐹𝐹𝐹+2 + 𝑂𝑂2 + 𝐻𝐻+ K=3.1x105 M-1s-1 (40) 
 𝐹𝐹𝐹𝐹+2 + 𝑂𝑂𝐻𝐻● → 𝐹𝐹𝐹𝐹+3 + 𝑂𝑂𝐻𝐻− K=3.2x108 M-1s-1 (41) 
 𝐹𝐹𝐹𝐹+2 + 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− → 𝐹𝐹𝐹𝐹+3 + 𝐻𝐻2𝑂𝑂2 K=6.6x106 M-1s-1 (42) 
23 
 
  
 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− + 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− → 𝐻𝐻2𝑂𝑂2 K=2.3x106 M-1s-1 (43) 
 𝑂𝑂𝑂𝑂𝐻𝐻●/𝑂𝑂2− + 𝑂𝑂𝐻𝐻● → 𝐻𝐻2𝑂𝑂 + 𝑂𝑂2 K=8.9x109 M-1s-1 (44) 
 𝑂𝑂𝐻𝐻● + 𝑂𝑂𝐻𝐻● → 𝐻𝐻2𝑂𝑂2 K=5.2x109 M-1s-1 (45) 
Chain propagation and termination reactions associated with iron and hydrogen 
peroxide with rate constant measured at pH=5 [45-47]. 
Fenton chemistry is utilized commercially to treat water pollution, contaminated soils, 
sludge etc by oxidizing the pollutants like benzene, formaldehyde, rubber chemicals, 
pesticides etc. The rate constant for the initial reaction between Fe+2 and H2O2 is 
generally observed to be around 102 M-1s-1 but in biological systems, this rate of 
reaction with free Fe+2 is not enough for the oxidation to occur. However, when bound 
to ADP, ATP or citrate as a backbone, the oxidation rate goes up by at least two orders 
of magnitude giving a significant rate of reaction for the iron-catalyzed redox process 
to occur [48]. 
2.2.5 Thiol Chemistry (-SH -SS-) 
Thiol-disulfide reactions are one of the most important redox reactions. In biology, 
oxidation/reductions govern the metabolic redox state of a cell. Thiol-disulfide 
interchange/exchange reaction is significant in itself where a thiol (RSH) reacts with  a 
disulfide molecule (R’SSR’’) to give a new oxidized disulfide (R’SSR) and the 
corresponding reduced thiol (R’’SH) [49]. The reaction is base catalyzed and is proposed 
to proceed through SN2, 2 step reactions as follows [50, 51]: 
 𝑅𝑅𝑆𝑆𝐻𝐻 ⇄ 𝑅𝑅𝑆𝑆− + 𝐻𝐻+ (46) 
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 𝑅𝑅𝑆𝑆− + 𝑅𝑅′𝑆𝑆𝑆𝑆𝑅𝑅′′ ⇄ 𝑅𝑅′𝑆𝑆𝑆𝑆𝑅𝑅 + 𝑅𝑅′′𝑆𝑆− (47) 
 𝐻𝐻+ + 𝑅𝑅′′𝑆𝑆− ⇄ 𝑅𝑅′′𝑆𝑆𝐻𝐻 (48) 
 𝑜𝑜[𝑅𝑅′′𝑆𝑆−]
𝑜𝑜𝑎𝑎
= 𝑘𝑘𝑅𝑅𝑅𝑅−[𝑅𝑅𝑆𝑆−][𝑅𝑅′𝑆𝑆𝑆𝑆𝑅𝑅′′] (49) 
 𝑜𝑜[𝑅𝑅′′𝑆𝑆−]
𝑜𝑜𝑎𝑎
= 𝑘𝑘𝑎𝑎𝑜𝑜𝑜𝑜[𝑅𝑅𝑆𝑆𝐻𝐻]𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡[𝑅𝑅′𝑆𝑆𝑆𝑆𝑅𝑅′] (50) 
 𝑘𝑘𝑅𝑅𝑅𝑅− = 𝑘𝑘𝑎𝑎𝑜𝑜𝑜𝑜(1 + 10𝑎𝑎𝑝𝑝𝑎𝑎−𝑎𝑎𝑝𝑝) (51) 
R: Attacking group, R’: central group, R’’: leaving group 
𝑘𝑘𝑅𝑅𝑅𝑅− : calculated rate constant dependent on thiolate concentration but independent of 
pH 
kobs: : observed rate constant dependent on total thiol concentration and pH 
In the reaction mechanism, thiolate anion (RS-) acts as the active nucleophile or reactive 
species to propagate the reaction. Concerning the cellular environment, glutathione 
plays a key role in the thiol redox chemistry as it is the most abundant small molecule 
cellular antioxidant (see section 2.3.2 for an in-depth discussion on glutathione redox 
reactions). One of the important factors that contribute towards the occurrence of this 
thiol exchange reaction is the pKa of the corresponding thiol and the pH of the reaction 
environment [52]. For example, a thiol with pKa value of 10, 0.1% of the total thiol 
will form thiolate at pH 7 while at pH 8, 10 times higher thiolate ions would be present 
in comparison [50]. In other words, we can say that thiol-disulfide interchange is most 
favorable at pHs near to the pKa values of the thiol.  For example, oxidation of 
glutathione (GSH) (pKa=9.33) to its oxidized form (GSSG) is faster at a higher pH of 
9.43 with a rate constant k=45 L/mol.s as compared to at pH of 8.46 with k=9.1 L/mol.s 
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[53]. As pKa is a function of the structure of the thiol molecule, chemical properties of 
thiol molecules involved in the reaction will dictate the extent of reaction and their 
existence in reduced or oxidized form.  For instance, reaction of 2-mercaptoethanol 
(pKa=10.14) with Ellman’s disulfide (5-(3-Carboxy-4-nitrophenyl)disulfanyl-2-
nitrobenzoic acid) (pKa=4.5) is faster than mercaptoethanol with oxidized glutathione 
(GSSG) (pKa=9.33) by the order of 104 in water [54, 55]. Also, the exchange reaction 
is faster when the pKa of a nucleophilic thiol (RSH) is as high as possible and that of 
the corresponding disulfide molecule ((R’SH/R’’SH) is as low as possible.  Stearic 
interference is another factor that would affect the rate constants of the thiol-disulfide 
exchange reactions. It is most pronounced when there is any carbon substitution at the 
α-position to sulfur. For instance, reaction of bis (t-butyl) disulfide with 1-butylthiolate 
(k=0.26 M-1s-1) is 106 times faster than that with t-butyl thiolate (k=10-7 M-1s-1). 
Similarly, charge on the thiolate anion also affects the rate constants [56]. The effect is 
higher when the charged entity is near to the sulfur group [57].  
The rate of reaction is often correlated with the Bronsted plot, which display the 
relationship between pKa of the reacting thiols/disulfide and the rate constant. The 
slope of the plot is defined by the bronsted coefficient (β), which normally lies between 
0.4-0.5 for different thiol-disulfide exchange reaction. Equation 53 is generally 
recommended for calculating kRS- values for the thiolate content [58] and figure 2.4 
shows the graphical association between pKa of thiol v/s log (kRS-) at pH 7 for a thiol-
disulfide exchange reaction. Figure 2.4 also shows the degree of dissociation (θ) of the 
thiol and observed rate constant for the thiol/disulfide exchange reaction be predicted 
by equation 54. Therefore, the highest observed rate constant for exchange reaction is 
observed at pKaRSH equivalent to pH of the solution, pH=7 in the figure. 
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 log(𝑘𝑘𝑅𝑅𝑅𝑅−) = 6.3 + 0.59𝑝𝑝𝑝𝑝𝑎𝑎𝑅𝑅𝑅𝑅𝑝𝑝 − 0.40𝑝𝑝𝑝𝑝𝑎𝑎𝑅𝑅
′𝑅𝑅𝑝𝑝 − 0.59𝑝𝑝𝑝𝑝𝑎𝑎𝑅𝑅′′𝑅𝑅𝑝𝑝 (52) 
 𝑘𝑘𝑎𝑎𝑜𝑜𝑜𝑜 = 𝜃𝜃𝑘𝑘𝑅𝑅𝑅𝑅− (53) 
 
Figure 2.4 Correlation between pKa of reacting thiol and rate constant (kRS-+)/degree 
of dissociation (θ) where kRS- was calculated using the equation (53), considering 
pKa of R’SH and R’’SH group as 8.5 [50] 
2.3 Biological oxidation events 
2.3.1 Oxygen and nitrogen currency 
Oxygen and nitrogen are the most abundant diatomic gaseous molecules in the 
atmosphere and play a significant role in regulating both, human and plant metabolism. 
Nitrogen is known to be highly inert and even oxygen (O2) in its ground state is a stable 
molecule. But O2 at a higher energy state form, such as singlet oxygen (O21) [59] or in 
the reduced form of superoxide (O2●−), it can become an active source of free radical 
generation leading to disruption of the cellular redox state [60], while oxide forms of 
nitrogen (NO, NO2) generally produced during combustion process can diffuse and lead 
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to the formation of intracellular free radicals or RNS. The age old Superoxide Theory 
of Oxygen Toxicity stated that the partially reduced form of oxygen i.e. superoxide via 
enzyme, auto-oxidation, mitochondrial electron transport chain, heme proteins etc is a 
primary cause of cellular toxicity [61].  Oxygen upon its one electron reduction to 
superoxide can further yield hydrogen peroxide via the dismutation process [62]. 
Hydrogen peroxide can reduce to the hydroxyl radical in the presence of transition 
metal ions like Fe+2/ Cu+2, a highly reactive radical in cellular biology capable of 
reacting with DNA, lipid membranes, proteins etc.[7]. Reactivity and reduction 
potential at various stages of oxygen radical production chains are different is shown in 
figure 2.5 and these reactions are often enzyme catalyzed. For example, dismutation of 
superoxide to hydrogen peroxide mainly occurs via superoxide dismutase (SOD) 
catalyzed reaction [63, 64], but a part of hydrogen peroxide production also takes place 
via a 2-step route of oxygen conversion to peroxyl radical followed by further reduction 
to H2O2. In an oxygen derived free radical production chain, H2O2 is although not a 
very reactive molecule species but serves as an intermediate to the production of 
hydroxyl radical (OH●) [65] via the Fenton reaction, which is highly reactive towards 
all cellular components and can lead to complete cell damage. Similarly, superoxide 
ion by itself is not very reactive towards non radical species but it can react very quickly 
with NO● or phenoxyl radicals [66]. This radical has a unique selectivity towards its 
oxidizing properties. For example, it is not very reactive towards oxidation of NADH/ 
NAD+ but can readily oxidize enzyme-bound (lactate degydrogenase) NADH to NAD+ 
[67]. Apart from being an oxidizing agent (oxidation of ascorbate to ascorbyl radical), 
superoxide can also act as a reducing agent where it can reduce cytochrome c or Fe+3 
to Fe+2 which is one of the steps in cellular redox cycling discussed later in section 2.3.3 
[68, 69]. 
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In reference to biological free radical production, oxygen nucleated free radicals are 
produced from all the oxygen that is inhaled or consumed by organisms and 
mitochondrion is considered to be the main source of superoxide radical production due 
to oxygen leakage in electron transport chain during ATP production and is reported to 
be produced by complex I and III [70-72]. Reported in vitro studies show that about 4% 
of the oxygen consumed gets converted into superoxide, though in vivo analysis have 
reported about 10-fold lower production i.e. about 0.4% of the total consumed which is 
still a significant amount of production leading to about 10 µM of intracellular 
concentration [73]. This charged radical readily diffuses through the mitochondrial 
membrane to react with other biological entities like proteins, PUFAs or produce other 
reactive species (H2O2, OH●). 
 
Figure 2.5 Free radical production/reactive oxygen species with oxygen as a 
precursor [7] 
Although nitrogen is a stable and inert molecule by itself but its oxide form such as 
nitric oxide (NO), act as precursor to a variety of free radicals collectively known as 
reactive nitrogen species (RNS), which are equally capable of carrying out cell damage 
if produced in excess. Nitric oxide (NO●), due to its lipophilic property readily diffuses 
through cell membranes from the atmosphere where it is a byproduct of various 
combustion processes [74] (figure 2.6). In cellular metabolism, it is also a product of 
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the reaction of L-arginine and oxygen with NADPH in the presence of nitric oxide 
synthase (NOS) to give nitric oxide, L-citrulline and NADP+ [75]. Nitric oxide by itself, 
is not very reactive towards non-radical species similar to superoxide anion, but can 
generate highly reactive free radicals such as, nitrogen dioxide (NO2●) via slow reaction 
with oxygen (O2) [76]. NO2●  with the Eo value of 1.04 V is a potent oxidant in metabolic 
redox system and in RNS chains, it further reacts with NO● leading to the production 
of N2O3, which eventually decomposes to give another reactive nitrite (NO2-) free 
radical [77]. In the presence of superoxide, NO● reacts to form peroxynitrite (ONOO-), 
which in itself is also a powerful oxidizing molecule [78, 79]. It is present in the form 
of acidified peroxynitrous acid (ONOOH) or its activated form (●NO2…OH●), both 
forms are capable of oxidizing most biological molecules such as DNA, proteins and 
lipids. NO● also takes part in the modification of some biological molecules with thiols 
or amine groups during the process called nitrosation via direct reaction with thiols or 
via  metal bound NO● reaction with thiols/amines resulting in formation of nitrosothiols 
(RSNO) or nitrosamine (RN2O) which are also regarded as non-radical RNS [80, 81]. 
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Figure 2.6 Reactive nitrogen species production  
2.3.2 Cellular redox chemistry 
Within the cellular environment, there exists an equilibrium between oxidants and 
antioxidants. Major players of these processes are defined in Figure 2.7. Of particular 
note is the small molecule antioxidant, glutathione (GSH), which contains an 
antioxidant thiol group and is the most abundant small molecule in eukaryotic cells, 
roughly found intracellularly from 1-10 mM and about 1-10 µM extracellular. [82-85] 
Synthesized within the cell from the three amino acids, glutamate, glycine, and 
cysteine, GSH production is rate limited by cysteine content, a semi-essential amino 
acid in biology. Cysteine is transported from extracellular space in the disulfide form, 
cystine. [86] Reaction of cysteine with glutamic acid in the presence of glutamate-
cysteine-ligase (GCL) followed by reaction with glycine via glutathione synthetase 
(GSS) results in GSH production. [86] GSH may act in several mechanisms as an 
antioxidant, whether directly through electron donation to reactive oxygen or nitrogen 
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species in the intracellular or extracellular space, or via enzymatic routes such as with 
glutathione S-transferase (GST) to irreversibly reduce toxic species like lipid peroxides 
and protein carbonyls. [87] In addition to direct chemical reaction with oxidative 
species, GSH participates in several mechanisms to regenerate other important 
antioxidant enzymes such as glutathione peroxidase (GPx), glutaredoxin (GRX), and 
peroxiredoxins non-specifically. Oxidized glutathione (GSSG) may be reduced back to 
GSH via glutathione reductase (GR), which is driven by NADPH and the glucose-6-
phosphate dehydrogenase (G6PD) cycle via oxidation of NADPH to NADP+. There are 
also other thiol-based oxidoreductases such as thioredoxin, which utilizes cysteine 
thiol-disulfide exchange (instead of GSH), and is regenerated with thioredoxin 
reductase, similarly utilizing NADPH for regeneration akin to GSSG with GR. 
Depending on the cellular compartment, redox equilibrium may vary. For instance, the 
cytosol (GSH:GSSG 100:1) and nucleus (GSH:GSSG >100:1) maintain a reducing 
environment [83, 88], whereas there are high concentrations of oxidants in the 
endoplasmic reticulum (GSH:GSSG of 1-3:1 [89], where disulfide bonds fortify the 
protein structures), mitochondria (GSH: GSSG of 20-40:1 [88]), secretory pathways, 
and extracellular space (GSH:GSSG 20:1 [85]). It is important to note that 
extracellularly while the GSH:GSSG ratio is around 10-20:1, cysteine and cystine are 
in greater concentration by about an order of magnitude, and maintain the oxidative 
environment around cysteine:cystine of 0.2:1 [85].  In a similar manner, NADPH is a 
reducing coenzyme involved in processes like fatty acid synthesis and is required to 
drive various redox reactions in the metabolic pathway. Therefore, NADPH:NADP+ 
(200:1) ratios are found to be in same order of magnitude as for GSH/GSSG redox 
equilibrium to drive the reaction forward. On the other hand, another coenzyme NADH 
plays an essential part in both reduction and oxidation in general, hence a significant 
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concentration of both oxidized and reduced form is maintained in the cell with NAD+ 
at higher concentrations. Cytoplasmic NADH which is produced by oxidation of 
cytoplasmic NAD+ acts as an electron donor and is transported to the mitochondrion to 
reduce mitochondrial NAD+ to NADH, which in turn is oxidized again during oxidative 
phosphorylation processes to generate ATP.  It is postulated via several experimental 
studies that the NAD+/NADH ratio in the cytoplasm is around 700:1 though the overall 
cellular ratio varies between 0.5:1 to 4:1. This ratio is involved in regulation of several 
metabolic enzymes such as glyceraldehyde 3-phosphate dehydrogenase, and pyruvate 
dehydrogenase used in the conversion of pyruvate to acetyl-CoA. 
 
Figure 2.7 Significant cellular redox molecule interactions. Green: glutathione 
processes. Red: oxidant species reduced by glutathione processes. 
2.3.3 Radical generation in metabolism and role of enzymes in redox cycle 
ROS/RNS production takes place in a cellular environment via multiple metabolic 
pathways with the aid of specific enzymes at various sites in a cellular matrix and its 
organelles. In that, mitochondria are one of the most important cellular components 
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with the highest potential to produce free radicals ranging from hydroxyl to 
peroxynitrite to hypochlorite radicals. Figure 2.8 depicts the role of mitochondrion in 
the redox of cycle of a cell. Mitochondria are known to be the energy producer or ATP 
production center of the cell which takes place via tetravalent reduction of oxygen (O2) 
in the presence of mitochondrial cytochrome c oxidase (COX) also called complex IV 
[90]. About 2-4% of this oxygen taken by mitochondria undergoes univalent reduction 
to superoxide ion (O2.-) via the complex I enzyme (NADH-ubiquinone oxidoreductase) 
to a concentration of about 10 µM [73, 91].  Oxidation of NADPH to NADP+ by O2 in 
the presence NADPH oxidase is another source of O2●−which occurs as an important 
inflammatory response in phagocytes against bacterial infection and this process is 
often termed as oxidative burst [92-94]. NADPH oxidase also facilitates O2●− 
production in non-phagocytic systems like fibroblasts, endothelial cells, smooth muscle 
cells, although the rate of O2●− production here is 1/3rd than that in neutrophils [13, 95, 
96]. This superoxide anion is further converted to hydrogen peroxide by mitochondrial 
manganese superoxide dismutase (MnSOD) [97, 98]. Apart from controlling the O2●− 
concentrations inside the mitochondrion, cytosolic CuZn-SOD also catalyzes the 
superoxide dismutation to H2O2, 104 times faster than an uncatalyzed reaction (k=2x109 
M-1s-1) [99]. Hydrogen peroxide is also known to be formed by two electron reduction 
of O2 by cytochrome P-450 or acetyl coenzyme A oxidase [100-102].  
Hydrogen peroxide is relatively stable and a membrane permeable non radical ROS, 
which either decomposes to water and oxygen with the help of catalase, glutathione 
peroxidase (GPx) etc [103, 104] or can further reduce to a highly reactive hydroxyl 
radical under transition metal ion catalytic conditions (oxidation of Fe+2 or Cu+2 to Fe+2 
or Cu+3) (Figure 2.9) [105]. In this pathway, oxidized iron or copper (Fe/Cu+3) is 
reduced back to ferrous or cuprous ions (Fe+2/Cu+2) by superoxide ions present in the 
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vicinity, which in turn produce more hydroxyl radicals. The concentrations of 
superoxide anion, and transition metal ions significantly define the free radical 
production rates [106, 107]. Other active route of OH● production is through 
disproportionation of peroxynitrous acid intermediate (HO…NO2) to hydroxyl and 
nitrous oxide (NO2) radicals [108]. Due to the extremely high reactivity of the hydroxyl 
radical, it is very difficult to monitor its real-time concentration in vivo.  
Peroxynitrite is a product of reaction of superoxide with endogenously generated nitric 
oxide (NO●) radical [109],[110]. NO is also generated in the cellular matrix via 
reduction of L-arginine in presence of nitric oxide synthase (NOS). As such NOS has 
three isoforms namely: (i) NOS1 (NOS I) found in neural tissues, (ii) NOS II or iNOS, 
inducible NOS, which is found in various cell types stimulated upon inflammatory 
response and (iii) eNOS found in endothelium [111]. Mitochondrial NOS (mtNOS) is 
another isoform, which facilitates the formation of NO● inside the mitochondria. This 
NO formation plays an important role in regulating mitochondrial respiration and has 
the potential to reversibly inhibit cytochrome oxidase activity, which is responsible for 
superoxide production [112]. Reaction of superoxide with nitric oxide under 
physiological conditions to produce peroxynitrite is found to be 3 times faster than 
hydrogen peroxide production and again is also a highly reactive RNS [113].  Hydrogen 
peroxide also contributes to the production of hypochlorite radical upon reaction with 
chloride ion (Cl-) in activated leukocytes by the action of myeloperoxidase (neutrophils 
and monocytes) and eosinophil peroxidase (eosinophils) [114, 115]. Their ideal 
function is to act as antimicrobial agents, but excess or unregulated production can 
result in fragmentation and aggregation of proteins [115, 116]. As for the production of 
singlet oxygen, it is known to be generated at the catalytic sites of multiple enzymes in 
the cellular matrix or via dismutation of unstable oxidation products like superoxide 
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both spontaneous and enzyme catalyzed. It is also known to be produced as a byproduct 
of peroxyl radical reaction between hydrogen peroxide and hypochlorite via the Russell 
Mechanism, found to occur in stimulated neutrophils mostly during the respiratory 
burst phenomena (anti-microbial cell lyses process) [117, 118].  
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Table 2.3 Role of enzymes in carrying out various redox reaction and maintaining 
cell homeostasis 
 
Enzyme Function Ref 
SOD (CuZn-SOD, Mn-
SOD, Fe-SOD) 
Catalyzes dismutation of superoxide to 
hydrogen peroxide 
[119, 
120] 
NOS (eNOS, iNOS, 
NOSI) 
Oxidation of L-arginine with production 
of nitric oxide (NO) 
[75, 
121] 
NADPH oxidase 
Superoxide production from dioxygen 
molecule 
[75, 
122] 
GPx 
Reduction of GSH to GSSG with 
simultaneous conversion of hydrogen 
peroxide to water 
[123, 
124] 
Myeloperoxidase 
(abundant in neutrophils) 
Produces HOCl from H2O2 and Cl- ion, 
oxidation of tyrosine to tyrosyl radical 
in presence of H2O2 
[125] 
Catalase (in peroxisomes) 
Decomposition of hydrogen peroxide to 
water and oxygen 
[126, 
127] 
5-lipoxygenase 
Inducible source of ROS production in 
lymphocytes 
[128, 
129] 
Cyclooxygenease 
ROS generation in TNF-α stimulated 
cells 
[130, 
131] 
Xanthine oxidase 
Source of ROS in diabetes mellitus, 
catalyzes oxidation of hypoxanthine to 
xanthine with simultaneous production 
of  H2O2, xanthine further catalyzes to 
uric acid and H2O2, sometimes can also 
produce superoxide radical 
[33] 
monoamine oxidase 
(outer mitochondrial 
membrane) 
Catalyzes oxidative deamination of 
biogenic amines, large source of H2O2 
and OH● radical as well. 
[132] 
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Figure 2.8 Examples of various routes of metabolic free radical production and 
detoxification pathways [113, 133] 
 
 
Figure 2.9 Concept of redox cycle in maintaining the healthy redox state of a cell. 
2.4 Known targets and elements of concern 
Proteins, polyunsaturated fatty acids (PUFAs) and carbohydrates are very common 
targets to ROS. These molecules constitute very important cell organelles including 
lipid membranes, mitochondria, DNA and other nucleic acids. Reaction with these 
biological components starts with the excess production of ROS and insufficient 
endogenous antioxidants available to stabilize them, resulting in disruption of the 
cellular redox balance. Extent or affinity of ROS/RNS to react with the cellular 
components varies with the type of ROS depending on its reduction potential. For 
instance, hydroxyl and peroxynitrite radicals discussed in section 2.3.1 have relatively 
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higher reduction potential amongst other oxidants (Table 2.2) and are considered to be 
the most reactive towards lipids, DNA etc. It is difficult to detect or measure their 
quantity in vivo as their rate constants are in the range of 107 to 1010 M-1s-1,  which 
almost matches their diffusion rates [133, 134]. In theory, oxidation of proteins, 
peptides, and amino acids by these free radicals can take place via several routes 
including hydrogen abstraction (favorable with aliphatic amino acids), electron 
transfer, dimerization, disproportionation, rearrangement and many more [135, 136]. 
Protein and amino acids have multiple sites of attack on their backbone and their 
reactivity depends on the stability of the resulting radical and degree of carbon 
hydrogenation  [37].  Aromatic amino acids have a tendency to undergo an addition 
reaction with free radicals rather than hydrogen abstraction due to their stabilizing 
resonance property forming hydroxylated/ quinone molecules after reaction with 
hydroxyl radical [137, 138].   
One of the most prone target sites to free radicals are mitochondria and their DNA 
components (mtDNA) [139, 140]. This is because, mitochondrion is the key production 
site of ROS/RNS where superoxide anion concentration is found to be 5-10 times higher 
than in the cytosol, with mtDNA to the closest proximity in comparison to nuclear DNA 
to the cytosolic ROS [141, 142]. There are numerous studies demonstrating that 
mitochondrial dysfunction due to excess ROS/RNS production is a kick-off event 
towards the final stage of cell apoptosis or necrosis [133]. The mitochondrial 
dysfunction is thought to start via mtDNA damage and protein deactivation. This leads 
to the incapability of the mitochondrion to maintain its membrane potential, resulting 
in the net loss of ATP production, de-structuring of the mito-membrane (inner and outer 
both), resulting in release of excess calcium ion (Ca+2), cytochrome c and lysosomes. 
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These apoptogenic proteins/enzymes finally activate the apoptotic pathway leading to 
cell death [143]. 
 Another potential target of ROS like singlet oxygen, peroxynitrite or hydroxyl radical 
is the cellular lipid membrane, which is made of unsaturated fatty acids. It is thought 
that the central carbon of the unsaturated fatty acids (L) is attacked by ROS/RNS to 
produce lipid free radical (L●), which oxidizes further to its alkoxyl (LO●) and peroxyl 
(LOO●) radical form  [144]. These radicals, considered to be important intermediates 
in the lipid oxidation process, again reacts with another fatty acid chain (L) to produce 
more L● radical and the chain reaction continues. In this propagation event, radicals 
like NO● can act as an antioxidant towards termination of the chain by forming stable 
alkyl nitrites (LONO2) or as pro-oxidant to form more LO● and NO2 through the 
peroxynitrite pathway (eq 54, 55 and 56) [145].  Due to this process, lipid fatty acid 
chains are often considered as secondary free radicals as they form reactive 
intermediates that propagate the lipid peroxidation chain reaction resulting in 
membrane degeneration and membrane protein dysfunction [113]. This degeneration 
leads to loss of membrane integrity making membrane bound protein even more 
susceptible to free radical attack. Alkyl peroxyl radicals (another form of secondary 
radicals) generated by decomposition of alkyl hydroperoxide in the presence of 
transition metal ion also contributes in the propagation of lipid peroxidation [146-149].  
 𝐿𝐿𝑂𝑂𝑂𝑂● + 𝑁𝑁𝑂𝑂● → 𝐿𝐿𝑂𝑂𝑂𝑂𝑁𝑁𝑂𝑂 (54) 
 𝐿𝐿𝑂𝑂𝑂𝑂𝑁𝑁𝑂𝑂 → 𝐿𝐿𝑂𝑂● + 𝑁𝑁𝑂𝑂2….. Chain propagation (14%) (55) 
 Or  𝐿𝐿𝑂𝑂𝑂𝑂𝑁𝑁𝑂𝑂 → 𝐿𝐿𝑂𝑂𝑁𝑁𝑂𝑂2…...chain termination (86%) (56) 
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3 RESEARCH OUTLINE 
3.1 Overall hypothesis: 
Antioxidant conjugated PβAE crosslinked micro/nanoparticles can be synthesized 
using the Michael addition chemistry of acrylates with amines, which exhibit tunable 
degradation properties, capable of releasing active polyphenolic antioxidants as well as 
increase the apparent solubility of these antioxidants. With controlled drug release 
through these systems, the apparent safe concentrations of the antioxidants can be 
increased, thereby opening the routes for prolonged suppression of cellular oxidative 
stress (OS) at therapeutic levels.  
3.1 Specific aim 1. Synthesis and characterization of quercetin conjugated 
PβAE nanogels (Chapter 4) 
a. Formulate quercetin-PβAE nanogels via single step reaction-precipitation 
Michael addition under dilute conditions.  
b. Evaluate the impact of synthesis parameters (e.g. feed reactant concentrations, 
acrylate to amine ratio) on nanogel diameter and effect of PEG conjugation as 
a second step towards their aqueous stability and protein binding properties.  
c. Study quercetin release profile during hydrolytic degradation of nanogels and 
the antioxidant activity of the degradation products. 
d. Evaluate dose dependent cytotoxicity of nanogels and their ability to suppress 
externally induced OS. 
Hypothesis:  
a. The hydrodynamic diameter of Quercetin-PβAE nanogels increases with 
increasing feed reactant concentration and PEG conjugation helps in the 
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aqueous stabilization of these hydrophobic systems as well as decreases 
opsonization effects.  
b. Hydrolytic degradation of quercetin-PβAE nanogels at the ester linkage 
releases active quercetin in a steady state manner with bulk erosion kinetics.  
Extended release kinetics allows the system to suppress induced cellular OS for 
a prolonged period of time.  
3.2 Specific aim 2. Synthesis and characterization of curcumin conjugated 
PβAE nanogels (Chapter 5) 
a. Formulate curcumin-PβAE nanogels using a reaction-precipitation method 
under dilute conditions and study the curcumin release kinetics via hydrolytic 
degradation. 
b. Evaluate dose dependent cytotoxicity of curcumin-PβAE nanogels and compare 
them with free curcumin at similar equivalent concentrations with endothelial 
cells. 
c. Evaluate their ability to prevent cellular oxidative stress and protection against 
mitochondrial OS using a H2O2 injury model by monitoring real-time 
mitochondrial bioenergetics. 
Hypothesis:  
a. Uniform and steady release kinetics of curcumin with no burst release effect 
increases the in vitro viable concentration and hence widens the safety window 
of  curcumin towards endothelial cells  
b.  Non-toxic nature at higher concentrations via administration of curcumin via 
curcumin-PβAE nanogels allows the OS injury to be treated at therapeutic 
levels and suppresses the mitochondrial oxidative damage for at least 24 hours. 
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3.3 Specific aim 3. Curcumin PβAE nanogels for the protection against 
polychlorinated biphenyls (PCBs) induced toxicity (Chapter 6) 
a. Study the dose dependent effect post PCB 126 and 153 treatment on overall cell 
toxicity and mitochondrial bioenergetics. 
b. Analyze the protection against PCB-induced mitochondrial OS with the help of 
curcumin-PβAE nanogels by analyzing both overall cell viability and mitochondrial 
bioenergetics at variable nanogels pretreatment conditions. 
Hypothesis: 
a. Mitochondrial bioenergetics are more sensitive towards PCB exposure 
compared to overall cell viability and immediate toxic effects can be better 
analyzed at mitochondrial level than overall cellular response.  
b. Curcumin-PβAE nanogel pre-treatment helps prevent mitochondrial 
dysfunction of PCB-exposed endothelial cells. Longer the nanogel 
pretreatment, better the suppression of OS during PCB exposure. 
3.4 Specific aim 4. Synthesis and characterization of curcumin-PβAE gel 
microparticles to treat oral mucositis (Chapter 7) 
a. Formulate curcumin-PβAE gel microparticles of different compositions using 
PEGDA as co-monomer to formulate tunable degradation systems. 
b. Study the degradation kinetics of the curcumin-PβAE microparticles as a 
function of co-monomer compositions and antioxidant activity of the 
degradation products containing released curcumin. 
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c. Evaluate dose dependent cytotoxicity of the released products in vitro and the 
extent of protection against induced oxidative stress using Normal Human 
Dermal Fibroblasts as the model cell line. 
d. Test the treatment/protection efficacy of microparticles in vivo on hamsters with 
induced oral mucositis injury using 5FU/scratch experimental model. 
Hypothesis:  
a. Increasing the content of PEGDA in curcumin-PβAE gel microparticles 
accelerates the degradation rate due to increased hydrophilic content in the 
gels.  
b. Released products are active as free radical scavengers and microparticles with 
similar curcumin loading show relatively less cellular toxicity when compared 
with free curcumin. 
c. Microparticles with high yet safe curcumin loading shows prolonged protection 
against induced OS in vitro and reduces the extent of oral mucositis injury in 
vivo with lesser dosage frequency. 
3.5 Specific aim 5. Synthesis and characterization of resveratrol conjugated 
PβAE gel microparticles (Chapter 8) 
a. Synthesize resveratrol conjugated PβAE gel films with PEGDA as a co-
monomer (R-PβAE microparticles) and optimize antioxidant release kinetics 
based on polymer composition. 
b. Analyze dose dependent toxicity of the microparticles and anti-inflammatory 
capacity to suppress H2O2 induced oxidative stress with normal human dermal 
fibroblasts. 
Hypothesis: 
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a. Increasing resveratrol content intensifies the hydrophobic nature of the 
crosslinked system leading to slower degradation kinetic and hence slow 
resveratrol release. 
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4 SYNTHESIS AND CHARACTERIZATION OF QUERCETIN 
CONJUGATED POLY (β-AMINO ESTERS) NANOGELS 
Based on the research articles published in: 
Prachi Gupta, J. Zach Hilt, Thomas D. Dziubla, ‘Quercetin conjugated Poly (β-
Amino Esters) Nanogels for the Treatment of Cellular Oxidative Stress’, (Acta 
Biomaterialia), 2015, 27, 194-204  
Abstract 
PβAE polymers have emerged as highly promising candidates for biomedical and 
drug delivery applications owing to their tunable, degradable and pH sensitive 
properties. These polymeric systems can serve as prodrug carriers for the delivery 
of bioactive compounds, which suffer from poor aqueous solubility, low 
bioavailability and are biologically unstable, such as the antioxidant, quercetin. 
Using acrylate functionalized quercetin, it is possible to incorporate the 
polyphenol into the backbone of the polymer matrix, permitting slow release of 
the intact molecule which is perfectly timed with the polymer degradation. While 
formulating the quercetin conjugated PβAE matrix into nanocarriers would allow 
for multiple delivery routes (oral, intravenous, inhalation etc.), well- known oil-
water nano-emulsion formulation methods are not amenable to crosslinked 
hydrolytically sensitive nanoparticles/nanogels. In this work, a single-phase 
reaction–precipitation method was developed to formulate quercetin conjugated 
PβAE nanogels (QNG) via reaction of acrylated quercetin (4–5 acrylate groups) 
with a secondary diamine under dilute conditions using acetonitrile as the reaction 
medium, resulting in a self-stabilized suspension. The proposed approach permits 
the post synthesis modification of the spherical nanogels with a PEGylated 
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coating, enhancing their aqueous stability and stealth characteristics. Nanogel 
size was controlled by varying feed reactant concentrations, achieving drug 
loadings of 25–38 wt%. Uniform release of quercetin over 45–48 hours was 
observed upon PβAE ester hydrolysis under physiological conditions with its 
retained antioxidant activity over the extended times. 
4.1 Introduction 
Oxidative stress is a pathophysiological condition when endogenous antioxidants are 
unable to counteract the production of oxidants, leading to cellular dysfunction. The 
origins for this overproduction of the reactive oxygen and nitrogen species (ROS/RNS) 
(e.g., hydroxyl radicals, singlet oxygen, hydrogen peroxide, peroxyl radicals) can be 
caused by both endogenous sources and exogenous sources. Examples of endogenous 
routes include ROS-generating enzymes such as nitric oxide synthase, xanthine 
oxidase, amplified mitochondrial metabolism especially in aging cells resulting in 
mitochondrial dysfunction, damaged membrane and hence leakage of ROS into the 
intracellular environment [150-153]. Some of the exogenous sources include exposure 
to ozone, UV, ϒ-irradiation, air pollutants penetrating through the skin or via 
inhalation, intake of various drugs, xenobiotic and many more [153-158]. At a systemic 
level, oxidative stress has been shown to play a role in the development and acceleration 
of many diseases, including diabetes, cardiovascular diseases, Alzheimer’s and 
Parkinson’s disease, acute renal failure, acute lung injury, radiation injury, etc. [159, 
160].  
Rationally, one would expect that the supplementation of dietary antioxidants would be 
sufficient to reduce the excess ROS into non-reactive stable molecules, resolving the 
oxidative stress and thereby mitigating many diseases. In fact, this beneficial property 
of antioxidants, including polyphenol flavonoids, has been successfully demonstrated 
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in vitro several times using different assays [161, 162]. But despite these in vitro 
demonstrations, nearly all clinical trials with antioxidants have failed to demonstrate 
substantial benefit [3, 163].  As a result of these outcomes, it was inferred that the major 
limitation of dietary antioxidants was their inability to impact the oxidative stress levels 
in the patients.  Given the highly unstable nature of these antioxidants, their typically 
poor aqueous solubility and lack of natural accumulation in tissues of interest, it is 
unsurprising that these molecules were unable to perform their intended function. For 
instance, quercetin has been shown in multiple in vitro and in vivo studies to possess 
anti-inflammatory [34], anti-hypertensive [164], anti-allergic [165] properties and an 
ability to control metabolic syndrome [166]. Yet, it has not been used therapeutically 
for pharmaceutical applications due to its low bioavailability, which is likely due to its 
poor aqueous solubility, structural instability and extensive first pass metabolism [167, 
168]. It has been reported that the oral bioavailability of quercetin is 17% in rats and 
merely 1% in humans [168, 169]. Moreover, upon intravenous injection, a 100 mg of 
dose resulted in 12 µM plasma concentration after 5 minutes and 1 µM after 3 hours, 
demonstrating the relatively short half-life of the compound [170]. 
In order to overcome this difficulty of low systemic bioavailability, one potential 
solution is to deliver quercetin through encapsulation into nanoparticles, which can be 
administered via a number of routes (e.g., intravenous, subcutaneous, inhalation, etc.) 
with an objective of extended drug release and control the rate of first-pass metabolism 
[171]. Several studies have demonstrated the ability to encapsulate quercetin into 
nanoparticles composed of poly (lactic acid) (PLA), poly (lactic-co-glycolic acid) 
PLGA, solid lipid nanoparticles (SLN). However, these approaches, while potentially 
useful, possessed significant burst drug release and low overall drug loading, ranging 
from only 0.05 to 2 wt% of the total particle weight [172, 173]. Incorporating 
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antioxidants into the backbone of a polymer system could be an alternative towards the 
effective antioxidant delivery as demonstrated by Wattamwar et. al. in his work on 
enzymatically biodegradable poly(trolox) nanoparticle system to deliver trolox, a water 
soluble analog of vitamin E [174].  
Building upon this prior work, it may be possible to overcome drug stability, solubility 
and drug release limitations by conjugating the drug into the backbone of a 
hydrolytically biodegradable polymer, such as poly(β-amino esters) (PβAEs), to form 
prodrug nanoparticles/nanogels [175, 176]. Our lab has shown previously that 
antioxidants like curcumin and quercetin can be loaded into crosslinked PβAEs and 
subsequently released into their original structural form upon hydrolysis [177].  But due 
to the fast reaction kinetics and hydrolyzing property of PβAE, the bulk crosslinking 
approach is not amendable towards typical nanoparticles synthesis approaches (e.g., 
o/w emulsion polymerization). To overcome this problem, we have synthesized 
quercetin conjugated PβAE gel nanoparticles/nanogels using a novel approach of single 
phase reaction-precipitation method in an organic solvent under dilute conditions 
giving a stable suspension of uniformly sized particles. Covalently reacting terminal 
amine groups with poly (ethylene glycol) monomethacrylate resulted in a coating that 
minimizes post purification instability, is expected to reduce the rate of first-pass 
metabolism and serves as an alternative to conventional surfactant based stabilization 
of nanoparticles. Uniform degradation of these nanogels over 48 hours successfully 
demonstrated release of active quercetin with negligible burst release. Particle sizes 
were easy to control with resulting quercetin loading capacities of 25-38 wt%, which 
possessed biocompatibility equivalent to pure quercetin and were able to suppress 
cellular oxidative stress over 48 hours. 
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4.2 Materials and methods 
4.2.1 Reagents  
Quercetin was purchased from Cayman Chemicals, Michigan, USA. Acryloyl chloride, 
potassium carbonate, N, N’-dimethyl 1-3-propanediamine, polyethylene glycol methyl 
ether methacrylate (Mn=4000) (PEGMEMA4000), potassium persulfate, 2, 2’-azo-bis 
(3-ethylbenzothiazoline-6-sulphonic acid), and hydrogen peroxide were purchased 
from Sigma-Aldrich. IgG antibody was purchased from Jackson Immuno Research 
Laboratory Inc. For cell culture studies, EBM basal medium (phenol red free), EGM-2 
growth factors, and Human Umbilical Vein Endothelial Cells were purchased from 
Lonza. Calcein-AM red-orange and 2', 7 dichlorodihydrofluorescein diacetate 
(H2DCFDA) were purchased from Life Technologies. Iodogen® iodination reagent (1, 
3, 4, 6-tetrachloro-3α-6α-diphenylglycouril) was bought from Thermo Scientific, 
Rockford, IL. 
4.2.2 Quercetin functionalization to quercetin multiacrylate monomer 
Quercetin multiacrylate (4-5 acrylate groups per molecule) (QMA) was prepared in 
accordance with the protocol described by Wattamwar et. al. [178] with a slight change 
of using potassium carbonates as the acid capturing agent instead of triethylamine. 
Briefly, the reaction between quercetin (20 gms in 200 ml of Tetrahydrofuran (THF)) 
and acryloyl chloride was carried out in anhydrous THF. Potassium carbonate was 
added to the reaction system to capture the hydrogen chloride forming its salt as the 
reaction byproduct. The system was purged with nitrogen for 30 minutes initially and 
then was further allowed to react overnight at room temperature to functionalize 
quercetin phenolic groups into acrylate. Acryloyl chloride and potassium carbonate, 
were added in the molar ratio of 1:1.2 with respect to the phenolic groups present in 
quercetin. Quercetin has four phenolic groups, which can be actively functionalized. 
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Therefore, for every mole of quercetin, five moles of acryloyl chloride and potassium 
carbonate were added to the reaction medium. Acrylated quercetin solubilizes in THF 
as the reaction proceeds. After the reaction, solubilized product was separated from the 
precipitated salts via filtration. Subsequently, filtrated was vacuum dried to remove all 
the THF and was re-dissolved in dichloromethane (DCM) in order to carry out an 
aqueous-organic solvent extraction process to remove any unreacted acryloyl 
chloride/acrylic acid and quercetin. A basic solution of 0.1 M potassium carbonate in 
DI water was used as the extraction medium for acrylic acid and quercetin both. After 
extraction, magnesium sulfate was added to the product solubilized in DCM to remove 
any remains of water. Finally, the pure QMA was obtained as a dry product after 
evaporation of DCM overnight. Characterization of the functionalized quercetin was 
completed using 1H-NMR and mass spectroscopy to identify the number of acrylate 
groups per molecule of quercetin. 
4.2.3 Quercetin PβAE nanogel (QNG) synthesis 
Quercetin PβAE nanogels were prepared using a single-pot dilute synthesis approach. 
QMA was dissolved in anhydrous acetonitrile to specified concentrations of 0.75, 1.25, 
2.5, 5 and 10 mg/ml. A stock solution of N, N’dimethyl-1-3 propane diamine (NNDA, 
a secondary diamine) (100 mg/ml) was prepared in acetonitrile. Calculated volume of 
NNDA stock: 3.67, 6.12, 12.25, 24.5, and 49 µl was added to the reaction solutions 
with QMA concentrations: 0.75, 1.25, 2.5, 5 and 10 mg/ml respectively to achieve the 
required reaction concentration, maintaining a stoichiometric ratio of acrylate to 
reactive amine at 1:1.1. QMA-NNDA reaction in these diluted conditions resulted in 
precipitation into nanogel form. These quercetin-PβAE nanogels will be further 
referred as QNG (0.75), QNG (1.25), QNG (2.5), QNG (5), and QNG (10) for different 
systems with feed QMA concentrations of 0.75, 1.25, 2.5, 5 and 10 mg/ml respectively. 
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The reaction time of the nanogel synthesis was determined by analyzing the reaction 
supernatant at different time point to observe the decrease in QMA absorbance peak. 
After about 45 minutes of reaction, peak intensity does not change. Therefore with a 
buffer of 15 minutes, the reaction was carried out for one hour, resulting in precipitated 
nanogels. The hydrodynamic radius of the synthesized nanogels in acetonitrile was 
determined using dynamic light scattering (DLS) (Malvern Zetasizer (ZS 90)). 
Appropriate dilution using fresh acetonitrile were used in order to get the count rate 
between 200 to 300 cps. Hydrodynamic diameter was reported as z-average. All the 
parameters were set for acetonitrile medium at 25o C.  
After completion of the reaction, 63 µl (32 mg) of a concentrated solution (500 mg/ml) 
of polyethylene glycol methyl ether methacrylate 4000 (PEGMEMA4000) in 
acetonitrile was added to 1 ml of the nanogel suspension along with gentle mixing for 
few seconds to get 3% wt/vol PEGMEMA4000 in suspension. This system was allowed 
to react for one hour, followed by centrifugation at 6700 rpm for 10 minutes (Figure 
4.1). The pellets were re-suspended in fresh acetonitrile by sonication for 3-5 minutes. 
Particles were then centrifuged and nanogels pellets were freeze-dried and stored at -
80o C for further analysis. 
Nanogels were also synthesized at variable acrylate to reactive amine hydrogen 
stoichiometric ratios ranging from 0 to 10, in order to study the effect of reactant molar 
ratio. For this system, QMA feed concentration was kept constant at 2.5mg/ml and 
amine content was varied. Nanogel suspension obtained from each ratio was diluted 
with DMSO, in order to dissolve any precipitated quercetin due to the excess amine. 
The size of the nanogels in suspension was measured using DLS after adjusting the 
instrument parameters according to the suspension medium. 
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Figure 4.1 Schematic of Q-PΒAE nanogel synthesis 
4.2.4 Size and yield of nanogel synthesis reaction 
In order to determine reaction yield, concentration of unreacted QMA in the supernatant 
obtained after first centrifugation was measured, via UV-VIS spectroscopy. The sample 
was prepared by diluting 100 µl of supernatant with 1 ml of acetonitrile. The absorbance 
of the diluted solution was measured at 350 nm using UV-VIS spectrophotometer 
(Varian Cary 50 Bio UV-Vis spectrophotometer). The amount of unreacted QMA was 
calculated using standard calibration curve of pure QMA dissolved in acetonitrile and 
percent QMA reacted or yield was back calculated subsequently. The size of the 
nanogels was measured using DLS at different stages of synthesis. 
4.2.5 SEM imaging 
In order to determine particle morphology, scanning electron microscopy was 
performed on the synthesized nanogels. 50 μL of PEG coated nanogel suspension in 
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acetonitrile (synthesized using 2.5 mg/ml feed QMA concentration) was diluted to 1 ml 
with acetonitrile and probe sonicated 8-10 times at 2-6 watts. A drop of the solution 
was dried on gold plated surface overnight in the bio-hood and covered with Kim wipes 
as an added precaution to prevent dust settling. Next day the dried sample on a gold 
surface was sputter coated with gold-palladium alloy and images were taken at various 
magnifications using S-4300 Hitachi Scanning Electron Microscope. 
4.2.6 Analysis of enhanced stability of nanogels after the reaction with 
PEGMEMA4000 
To determine the impact of PEGMEMA4000 treatment on nanogel stability, particle 
size was analyzed at two stages, first before the PEGMEMA4000 reaction and second 
after the PEGMEMA4000 reaction. To prepare the samples, 50 μL of nanogel 
suspension was added to 1 ml of PBS (pH=7.4) to form a suspension. Size measurement 
of the suspended nanogels in PBS was carried out using DLS without any further 
agitation at an interval of 10 minutes for a total time of 50 minutes and recorded to 
analyze the effect of PEGylation. The size measurement was done for nanogels 
obtained at both the stages described above. Nanogels were also treated with only 
polyethylene glycol methyl ether Mn=5000 (PEGME5000) for 1 hour and analyzed for 
the size afterwards in order to determine the kind of linkage of PEG to nanogel surface. 
4.2.7 PEG content analysis after nanogel formulation 
Analysis of PEG content in nanogels was performed using the barium-iodide assay 
[179]. To carry out the assay, two solutions were prepared. A) 60 mg/ml barium 
chloride in 1.2 N HCl (HCl stock diluted in DI water), B) potassium iodide and iodine 
in DI water with a final concentration of 20 and 12.5 mg/ml respectively. Separately, 1 
mg of nanogels was rapidly hydrolyzed in 500 µL of 5 N NaOH for 4 hours at 80o C. 
Hydrolyzed nanogels were neutralized by addition of 500 µL of 5 N HCL. 
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PEGMEMA4000 dissolved in DI water was used for standard calibration within the 
range of 0-10 µg per well in a 96 well plate. 20 µL of the hydrolyzed nanogel solution 
was added to the wells. Sample and the calibration volumes were diluted to 170 µL 
with DI water. 40 µL of solution A was then added to each well followed by mixing. 
40 µL of solution B after doing 1/5th dilution was added subsequently to all the wells 
and mixed. The reaction was allowed to develop for 10 minutes after which absorbance 
was recorded at 550 nm using Varian Cary 50 Bio UV-Vis spectrophotometer. 
Calibration curve of pure PEG was used to calculate the PEG content in the nanogels. 
4.2.8 Antibody Binding studies of Q-PΒAE nanogels using IgG using 
radiolabeling 
125I-IgG stock preparation: IgG was radiolabeled with 125I to serve as a tracer to protein 
bound to the nanogels. Briefly, 200 µL of 2 mg/ml Iodogen® iodination reagent (1, 3, 
4, 6-tetrachloro-3α-6α-diphenylglycouril) in chloroform was dried in a glass tube using 
dry nitrogen gas to form a thin layer on the glass wall. 100 µL of 1 mg/ml Mouse IgG 
was added to iodogen coated tube and radioactive iodine (Na125I) was added and 
incubated for 5 minutes. Free iodide was removed from the protein using a Thermo 
Scientific protein desalting spin column according to manufacturing instructions. Any 
free iodine remaining in the spun down solution was determined using trichloroacetic 
acid (TCA) precipitation. Gamma counts of both the precipitate and supernatant were 
analyzed using a Perkin Elmer 2470 automatic gamma counter. The amount of free 
iodine in hot IgG was found to be 5.6%.  
IgG binding to quercetin nanogels: Three different formulations of QNG were used: 
QNG (0.75), QNG (1.25), and QNG (2.5). IgG having 2 wt% 125I-IgG was added to the 
nanogels (with and without PEG coating) suspended in PBS. Final concentrations of 
IgG and nanogels in the buffer were maintained at 1.17 and 0.4 mg/ml respectively. 
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After 3 hours of incubation, the suspension was then centrifuged at 6700 g for 20 
minutes to collect the pellet at the bottom and supernatant from the top. Both pellet and 
the supernatants of all the nanogel formulation were analyzed for the total gamma 
counts using gamma counter.  
4.2.9 Quercetin release profile of Q-PΒAE nanogels in PBS 
QNGs were suspended in PBS buffer (pH=7.4) using probe sonication to a 
concentration of 1 mg/ml. As quercetin has very limited aqueous solubility, degradation 
buffer was prepared using 2 vol% DMSO in order to solubilize any released quercetin 
during hydrolytic degradation. This suspension was incubated at 37º C in a shaker bath 
at 70 RPM. Every 2 hours, nanogel suspensions were centrifuged at 6700 RCF for 10 
minutes and the supernatant was collected and stored at -20º C for further analysis. The 
centrifuged pellet was re-suspended in the fresh buffer to continue degradation. 
Absorbance of the supernatant was measured at 370 nm using Varian Cary 50 Bio UV-
Vis spectrophotometer to determine the amount of quercetin released. Degradation was 
carried out for 50 hours and quercetin concentration in supernatants were analyzed after 
each collection.  
4.2.10 In vitro antioxidant activity capacity of the degradation products of 
nanogels 
Antioxidant activity of released quercetin and degradation products was evaluated 
using the Trolox Equivalent Antioxidant Capacity (TEAC) assay, which is based on 
scavenging of 2, 2’-azinobis-(3- ethylbenzothiazoline-6-sulfonate) radical anions 
(ABTS.-). Briefly, 7 mM ABTS radical cation stock solution was prepared by mixing 
1 ml of 8 mg/ml of ABTS solution with 1 ml of 1.32 mg/ml of potassium persulfate 
solution, both prepared in DI water. This solution was allowed to react overnight to 
form ABTS radical cation stock solution. After 24 hours, ABTS radical cation working 
56 
 
  
solution was prepared by diluting the stock solution in PBS to an absorbance of 0.4 at 
734 nm. For calibration purposes, a standard solution of trolox of known concentrations 
(0 to 0.27 mM) in PBS were prepared and used for the assay. To carry out the TEAC 
assay, 10 μL of the test sample (degradation supernatants/trolox standards) was added 
in a 96-well plate. Subsequently, 200 μL of the ABTS radical cation working solution 
was added to all the wells. After 5 minutes absorbance of all the samples was measured 
at 734 nm. Trolox standard curve with respect to the obtained absorbance was prepared 
and equivalent trolox concentration in the samples was calculated using the trolox 
calibration curve. The equivalent quercetin concentrations were calculated by obtaining 
the TEAC value of pure quercetin using the same assay. 
4.2.11 Cell toxicity study of QNGs on Human Umbilical Vein Endothelial Cells 
(HUVECs) 
HUVECs were cultured in EBM basal medium (phenol red free) with EBM-2 growth 
factors to an 80% confluence in a 48-well plate overnight. A range of concentrations 
(from 1 to 70 µg/ml of equivalent quercetin content) of nanogels in media were 
prepared and added to the well plate (n=4). After 24 hours, treated and non-treated 
control cells were washed with fresh media followed by incubation in 1 mM Calcein 
AM red-orange live cell tracer. After 1 hour, cells were washed again with fresh media 
once, followed by addition of fresh media. Fluorescence was recorded at 
excitation/emission of 540/590 nm using BioTek Synergy Mx, Gen5 2.0, Winooski, 
VT to analyze the cell viability. 
4.2.12 Cellular oxidative stress suppression 
HUVECs were cultured in 48 well plate in EBM basal medium with EBM-2 growth 
factors. In order to determine the ability of Q-PΒAE nanogels to block oxidative stress 
injury, HUVECs exposed to hydrogen peroxide (0.5 mM) were treated with free 
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quercetin and nanogels (QNG (1.25)) with equivalent quercetin concentrations of 5 and 
10 µg/ml. DCF-DA to a final concentration of 10 µM was added at the time of treatment 
and DCF fluorescence was used as a measure of oxidative stress levels in the cells. 
Three similar 48 well plates were prepared. DCF fluorescence at 490/525 nm and cell 
viability was measured at 24 and 48 hours using BioTek Synergy Mx, Gen5 2.0, 
Winooski, VT. 
4.3 Results 
4.3.1 Hydrodynamic radius and yield of reaction of Q-PΒAE nanogels 
The hydrodynamic diameter of the nanogels was determined using DLS before and 
after PEGylation. The extent of reaction was evaluated by UV-Vis spectrophotometer. 
As the concentration of reactants increased, nanogels size increased from 273 ± 6 to 
642 ±21 nm, and reaction yields increased from 81.4 ± 2.6 % to 97.8 ± 0.54 % (Figure 
4.2). A slight increase in nanogel diameter (approximately 50 nm), for smaller diameter 
particles was observed after the reaction with 3 wt/vol% of PEGMEMA4000 (Figure 
4.3). This increase can be likely be attributed to the attachment of PEG chains at the 
surface of nanogels as shown in figure 4.1.  
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Figure 4.2 Percent reaction yields and size variation of QNGs with respect to variable 
reactant QMA concentration. All samples were analyzed with n=3. 
 
Figure 4.3 QNGs size variation before and after PEGylatio with PEGMEMA4000.  
Black circles:  Nanogel diameter before reaction with PEGMEMA4000. Grey squares: 
Nanogel diameter after reaction with PEGMEMA4000 followed by centrifugation and 
re-suspension in fresh acetonitrile. N=3, error bars: std. dev. 
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4.3.2 Analysis of shape and size of nanogels 
Nanogels prepared using 2.5 mg/ml feed QMA concentration were imaged in SEM to 
examine shape and size. Nanogels with diameter ranging from 100-250 nm with an 
average of 197 ± 57 nm as analyzed using Image J software were observed (Figure 4.4 
a, b). The nanogels’ spherical morphology was confirmed by imaging at an angled view 
at 38o (Figure 4.4, c and d). There was an observed phenomenon of fusion at nanogel 
surface as they are soft polymeric particles, which might be undergoing interfacial 
attraction forces during solvent evaporation on the gold substrate.  
 
 
 
Figure 4.4 Scanning electron microscopy of the QNGs synthesized with reactant 
QMA concentration of 2.5 mg/ml. a, b: plain view (Top view); c, d: angled view, 
38o. 
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4.3.3 Effect of the acrylate to amine ratio on nanogel size (stoichiometric feed 
ratio) 
Different acrylate to amine ratios during the synthesis were investigated to study the 
effect of stoichiometric ratios on nanogel diameter and reaction yield. Because of the 
possibility that a higher amount of amine can result in hydrolysis of QMA and 
precipitation of quercetin, 200 μL of DMSO was added to each 1 ml suspension of 
nanogels to dissolve any precipitated quercetin but not crosslinked nanogels. The 
dissolution of precipitated quercetin was verified by conducting a control experiment. 
In the control experiment, highest possible amount of quercetin that could get 
precipitated for the QNG (2.5) was suspended in acetonitrile, followed by addition of 
200 μL of DMSO resulting in dissolution of suspended quercetin. It was observed (as 
shown in figure 4.5), the highest hydrodynamic diameter (311 nm) was obtained with 
an acrylate to reactive amine hydrogen ratio of 1:1.1 while higher or lower ratio resulted 
in smaller sizes with either incomplete reaction of QMA or precipitation of nascent 
quercetin. This ratio also gave highest yield of the reaction (89%) not shown in the 
figure. For all further studies, QNGs were synthesized with feed ratio of 1:1.1, which 
results in slightly excess of amine, which permits conjugation of the PEGMEMA4000 
system  
61 
 
  
 
Figure 4.5 Effect of total acrylate to total reactive amine hydrogen on QNGs size. 
Variable acrylate to amine ratio ranging from 0.1 to 10 was taken and size was 
measured after 1 hour of reaction with 2.5 mg/ml of reactant QMA concentration 
constant for all formulation changing the amount of amine added. (n=3). Nanogel 
diameter at acrylate to amine ratio of 1.1 was found to be the highest with respect to 
other stoichiometric ratios mostly due to the maximum extent of reaction. Hence, this 
ratio was used for all the formulations with variable feed reactant concentrations. N=3, 
error bars: std. dev. 
 
4.3.4 Analysis of enhanced stability of nanogels after the reaction with 
PEGMEMA4000 
PEGylation of nanogels with PEGMEMA4000 resulted in the physical stability of 
nanogel suspension in aqueous media (PBS. pH=7.4). As shown in figure 4.6, 
PEGMEMA4000 treated retained their size from 373 ± 5.8 at t=0 to 364 ± 68 after 50 
minutes of suspension. This could be due to the stearic hindrance of the PEG groups 
that leads to the formation of stable suspensions in contrast to non-PEGylated nanogels 
that aggregated with time in PBS giving the size of over 1 micron within 20 minutes. 
Incubation of nanogels with PEGME5000 did not result in their stability in PBS either 
but in aggregation of nanogels over time with an observed diameter of 2.5 µM within 
50 minutes of suspension, confirming that the stability of nanogels after PEGylation is 
due to the covalent bonding of PEG to its surface due to the reaction of mono acrylate 
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from PEG with unreacted terminal amine hydrogen of the nanogels. The size of the 
nanogels treated with PEGMEMA4000 after 30, 40 and 50 minutes of suspension was 
significantly lower than the other two groups with p< 0.005, while did not show any 
significant increase in size when compared at different time points of suspension. 
 
Figure 4.6 Stability analysis of QNGs before and after reaction with 
PEGMEMA4000 and PEGME5000 in PBS.  
Size measurements were taken at various time intervals after suspension of nanogels in 
PBS. Nanogels after PEGMEMA4000 coating were more stable than non-coated 
nanogels. Nanogels were prepared with 2.5 mg/ml reactant QMA concentration and 
reacted with 3 wt/vol% PEGMEMA4000. N=3, error bars: std. dev. Nanogel 
PEGylation and protein binding 
 
4.3.5 PEG content analysis after nanogel formulation 
PEG content in the nanogels has been represented as PEG weight percent in the total 
nanogel mass shown in figure 4.7. It was observed that nanogels synthesized from lower 
QMA feed concentrations of 0.75 and 1.25 mg/ml had 40.7 and 30.4 wt% PEG 
respectively, while the higher concentration systems, 2.5, 5, and 10 mg/ml, had lower 
63 
 
  
PEG content at 7.6, 1.23 and 3.1 wt% respectively. The influence of this variable PEG 
content was seen in the IgG binding capacity as discussed below. 
 
Figure 4.7 PEG weight percent in QNGs after reaction with 3 wt/vol %. 
Barium Iodide assay for PEG content determination was used with n=3 for each 
formulation. 
 
4.3.6 Decrease in QNG-antibody binding by using radiolabeled IgG 
Nanogels without PEG coated system showed high IgG binding, 59.8 ± 1.6, 73.84 ± 
2.1 and 71.25 ± 1.2 % surface coverage for QNG (0.75), QNG (1.25) and QNG (2.5), 
respectively. PEG coated nanogels with the same formulations showed a substantial 
decrease in IgG binding, 18.4 ± 4.8, 37.3 ± 7.4 and 50.6 ± 5.4 % surface coverage for 
QNG (0.75), QNG (1.25) and QNG (2.5), respectively (Figure 4.8, bar chart). 
Additionally, as the PEG weight percent decreased, the percent IgG bound increased, 
indicating the presence of a PEG coating of the nanogels (Figure 4.8, line graph).  
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Figure 4.8 Extent of IgG binding to non-PEG coated and PEG coated QNGs 
compared in three different nanogel systems having different PEG wt% in them. 
4.3.7 Quercetin release profile and antioxidant activity 
Figure 4.9 a,b shows the released products and degradation profile of the nanogels in 
PBS at 37° C. Supernatants containing the degradation products were analyzed using 
UV-Vis spectroscopy. Quercetin release was linear for the first 36 hours, followed by 
a plateauing profile, with approximately 95% total release in 35-40 hours. These 
nanogels had initial burst release of 11.93 ± 1.5, 4.43 ± 0.4, 6.8 ± 0.27, 9.3 ± 1.6, 9.9 ± 
0.97 % for QNG (10), QNG (5), QNG (2.5), QNG (1.25) and QNG (0.75), respectively. 
This low level is likely due to unconjugated quercetin in the gel matrix. Taking into 
account the first 60% of the total release, profiles were fit to the Korsmeyer-Peppas 
model (Mt/Minf = Ktn) for the in vitro release model fit [180, 181]. To identify between 
the diffusion, anomalous and erosion controlled release regimes, exponent ‘n’ values 
were identified. For a spherical system, n=0.43 implies pure diffusion, n=0.85 suggests 
erosion and 0.43<n<0.85 implies anomalous transport or a combination of diffusion 
and erosion. The ‘n’ values of 0.55, 0.85, 0.69, 0.58 and 0.58 for QNG (10), QNG (5), 
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QNG (2.5), QNG (1.25) and QNG (0.75) respectively, indicate the anomalous diffusion 
release mechanism of nanogel degradation according to the model definition. R2-values 
were within the range of 0.97-0.99. Since similar release profiles were seen for all 
formulations irrespective of the different nanogels formulations, which gave varied 
nanogel diameter and given the swellable nature of PβAE polymer, bulk erosion 
phenomenon is likely to happen via hydrolysis instead of surface erosion for these 
systems. This study was conducted in three different batches and was found to be 
reproducible, although figure 4.9 shows data from only one batch. Figure 4.9 
(a) represents the HPLC chromatograms of quercetin, quercetin multiacrylate and 
degradation products of Q-PβAE bulk gel system and nanogel systems. HPLC Analysis 
of degradation products of Q-PβAE bulk gels (#3) in the Figure 4.9 (a) identified release 
of both quercetin and the monoacrylate form. However, degradation products of the 
synthesized Q-PβAE nanogels (#4)) resulted in the release of pure quercetin, with no 
detectable trace of mono or higher acrylate products, confirming the retrieval of the 
original drug. Meanwhile, TEAC studies of the degraded product indicated that the 
released compounds possessed antioxidant activity against free radicals for 36-40 hours 
(Figure 4.9 (c)) and possessed a similar release profile as obtained from degradation 
product UV-Vis analysis. Equivalent active quercetin was also calculated for each time 
point taking 4.2 as the TEAC value of quercetin. It was observed that equivalent active 
quercetin either complied with the released quercetin or was higher than that implying 
no loss of quercetin activity during degradation and release. Higher values of equivalent 
active quercetin is likely from oligomers released during hydrolysis and degradation 
products of quercetin, which also have some inherent antioxidant activity. Taken 
together, quercetin was successfully kept intact within the polymer matrix for an 
extended period of time without loss of activity. This result is in contrast to the usual 
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behavior of quercetin, where structural stability and antioxidant activity is lost within 2 
hours of incubation in aqueous media. 
 
Figure 4.9 Degradation of QNGs at physiological conditions and subsequent 
analysis.  
(a) HPLC analysis of QNG degradation products to confirm the recovery of pure 
quercetin and not any other mono or higher quercetin acrylates. This was confirmed 
by comparing the nanogel degradation products with quercetin, QMA (monomer) and 
degradation products of bulk Q-PΒAE gels, which results in quercetin and quercetin 
monoacrylate release, (b) Degradation/quercetin release profile from QNGs in PBS 
(pH 7.4 with 2vol% DMSO).  90% of the quercetin was released within 35 hours of 
incubation. N=3 and the profile fits Korsmeyer-Peppas release kinetic model Mt/Minf 
= Ktn with n values within 0.45-0.85 showing anomalous release. R-square ranged from 
0.9737 to 0.9923, (c) Antioxidant activity profile of the degraded products of QNGs. 
The study was done using the trolox equivalent antioxidant capacity assay (TEAC), and 
the activity is expressed in terms of equivalent amount of trolox. n=3, (d) Instantaneous 
active quercetin values calculated from TEAC values compared with instantaneous 
quercetin released values obtained after each degradation time interval. 
 
4.3.8 Effect of QNGs on human umbilical vein endothelial cells  
4.2.1.1 Dose dependent cell toxicity 
 
Cytotoxicity of quercetin-based nanogels in the biological environment was analyzed 
by exposing HUVEC monolayers to quercetin nanogels. The cells were exposed to 
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equivalent quercetin concentrations ranging from 1 to 70 µg/ml of nanogels for 24 
hours followed by treatment with Calcein AM red-orange (fluorescent cell tracer), as a 
measure of cell viability. Calcein AM red-orange was used as it does not interfere with 
the fluorescence of quercetin itself, being in the different fluorescence wavelength 
region. As shown in figure 4.10, cell viability starts to decrease to about 50% at 70 
µg/ml of equivalent quercetin concentrations. All nanogel formulations showed similar 
viability trends when compared within themselves as well as when compared with pure 
quercetin for both 24-hour exposure time. This was confirmed after conducting two-
way ANOVA test considering nanogel composition and treatment concentrations as 
two groups. The two-factor analysis of variance showed no significant effect of 
composition towards cell viability but dose dependent cytotoxic effect was statistically 
different after 24-hour treatment. This demonstrates that presence of PβAE nanogels or 
its degradation products apart from quercetin did not contribute to cell cytotoxicity. 
 
Figure 4.10 Dose dependent toxicity of QNGs on HUVECS  
(a) Cell viability after exposure of HUVECs with QNGs and pure quercetin for 24 
hours. Calcein AM red-orange was used as a live cell tracer. (n=4), (b) Specific 
viability of QNGs with respect to quercetin. A two-way ANOVA test was conducted 
taking nanogel compositions and treatment concentrations as two variables. No 
significant difference in viability was observed due to different compositions and pure 
quercetin while treatment concentrations showed statistically significant difference in 
cell viability. 
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4.2.1.1 Effect of nanogels on H2O2 treated HUVECs for 24 hours 
 
HUVECs at 80% confluence were treated with two different concentrations of QNG-
1.25 (5 and 10 µg/ml equivalent quercetin concentration) and 0.5 mM H2O2 as an 
inducer of cellular injury and oxidative stress. 10 µM DCFDA was added to each well. 
Cell viability and DCF fluorescence were measured at 24 and 48 hours and compared 
with the no particle treatment and no H2O2 controls. Cell viability was maintained on a 
concentration basis for only quercetin/QNG treatment after 48 hours. A slight increase 
in viability was seen after 48 hours with the antioxidant treatments (Figure 4.11 (a) and 
4.11 (b)). When looking at DCF fluorescence for the same treatment system, 
antioxidant treatment suppressed the background oxidative stress to a significant level 
at both 24 and 48 hours when compared with no treatment controls (Figure 4.12 (a)). 
External oxidative stress induced using H2O2, as shown in figure 4.12(b), resulted in 
cell viability dropping down to 10% after 24-hour exposure and 20% after 48-hour 
exposure. H2O2 exposed groups treated with free quercetin or QNG showed different 
responses after 24 and 48-hour exposure. For 24 -hour, all the treatments with either 
free quercetin or QNGs, showed same protection from H2O2 with cell a viability of 
approximately 50%. With 48-hour exposure study, though we saw equivalent 
protection from both free quercetin and QNG with 5 µg/ml, QNGs at 10 µg/ml showed 
improved performance than just quercetin despite having same inherent toxicity at that 
concentration. Suppression of DCF fluorescence at both 24 and 48 hours for 10 μg/ml 
QNG system was superior to pure quercetin. 
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Figure 4.11 Cell viability of HUVECs treated with two different concentrations of 
QNG (1.25): 5 and 10 µg/ml and/or 0.5mM H2O2.  
Cell death analyzed after 24 and 48 hours of treatment. (a) Treatment with only 
QNG/quercetin. (b) Treatment with QNG/quercetin and H2O2. * p<0.05 
 
 
 
 
Figure 4.12 Oxidative stress suppression analysis using 10 µM DCF-DA as an 
oxidative stress marker. 
Two different of QNG/quercetin, 5 and 10 µg/ml were used. Fluorescence was 
measured after 24 and 48 hours of treatment. (a) Treatment with QNG/quercetin. (b) 
Treatment with QNG/quercetin and 0.5 mM H2O2. * p<0.05 
 
4.4 Discussion 
Numerous trials have been conducted over the years evaluating the continuous 
administration of antioxidants and their effect on chronic diseases like atherosclerosis 
or diabetes. Yet, results have been inconclusive and debatable towards their beneficial 
effects [182].  However, as the use of antioxidants in sub-acute inflammatory diseases 
(e.g., N-acetyl cysteine in acetaminophen toxicity) have shown clinical acceptance, 
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there must be something more to this observed discrepancy [183]. One explanation for 
the better in vivo performance of N-acetyl cysteine in this setting is the improved 
natural accumulation in the intended site of action (e.g., the liver) and more favorable 
circulation times over that of other antioxidants, which has a half-life of 6 hours 
compared to minutes for many polyphenolic antioxidants [184, 185].  However the use 
of N-acetyl cysteine is also complicated with side effects common of sulfur containing 
compounds, including nausea, vomiting and risk factors of asthma, drug allergy etc. 
[186]. As such, it may be possible to rescue small antioxidant therapy for short-term 
oxidative stress disorders through changing their inherent pharmacokinetics.   
The objective of this work was to design a biocompatible polymeric nanocarrier capable 
of systemically delivering highly active though labile antioxidant, quercetin, over an 
extended period of time to fight acute oxidative stress conditions. We have incorporated 
PβAE gel synthesis chemistry in making quercetin conjugated PβAEs nanogels. Our 
lab group and other researchers have previously reported successful synthesis of PβAE 
bulk hydrogels using different co-monomers including polyphenolic antioxidants along 
with PEGDA and DEGDA [178, 187, 188]. By taking advantage of its polyphenolic 
structure, quercetin can be acrylated, which when reacted with an amine can form a 
crosslinked gel via a Michael addition mechanism. However, due to rapid kinetics and 
multifunctional nature of the monomer, translation from bulk gel to nanogel is a 
technically challenging hurdle. Owing to the hydrolytically degradable property of 
PβAEs, standard two-phase (oil-water or oil-oil) emulsion techniques are not feasible. 
However, formulating quercetin-PβAE nanogels (QNG) via a single-phase reaction-
precipitation method in acetonitrile under dilute conditions resulted in a nanogel 
suspension as the reaction proceeded to completion, the spherical nature of which was 
confirmed by SEM imaging (Figure 4.4). The presence of excess available terminal 
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amines permitted the covalent linkage of PEG monoacrylate grafts to the nanogel 
resulting in a stable coating. As PEG grafts are able to stearically stabilize 
nanoparticles, PEGylation of the nanogels enhanced their post-purification stability and 
improved their stealth characteristics. The single-phase reaction systems/ one-pot 
synthesis simplified the synthesis process, eliminating the requirement of any stabilizer 
and removal of the excess stabilizer added during purification. A very simple 
purification step of centrifugation was used, after which nanogels restored their original 
size without any aggregation (figure 4.1 and 4.3). PEGylation improved the stability in 
organic-aqueous solutions. This is in contrast to QNGs incubated with PEGME5000 
(MW in the range similar to PEGMEMA4000).  The lack of the acrylate group 
prevented covalent addition to the particles and was, therefore, unable to prevent 
particle aggregation (Figure 4.6). This confirms the presence of covalent linkage 
between PEG acrylate group and NNDA unreacted terminal hydrogen amines, which 
eventually results in QNG physical stability. 
Precise control of nanogel size was made possible by varying the feed reactant 
concentration while keeping the stoichiometric ratio constant, with increasing 
concentration increasing particle size (Figure 4.3). Interestingly, as the ratio of acrylate 
to amine decreased, the excess amine catalyzes the hydrolysis of the acrylate groups.  
To minimize the occurrence, the stoichiometric ratio of acrylate to reactive hydrogen 
amine was limited to 1:1.1 which still offered maximum reaction yield, diameter and 
provides the opportunity to covalently bind PEGMEMA4000 to terminal amines 
(Figure 4.4). It was observed that after using the same concentration of 
PEGMEMA4000 for all formulations, the smaller nanogels had a higher amount of 
PEG attached (30-40% wt/wt) while the larger diameter nanogels had PEGylation of 
only 3-5 wt% (Figure 4.7). This could be due to the presence of more amine reactive 
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sites on smaller particles due to the overall higher surface area for the same quantity. 
The PEG presence was further substantiated by performing a radiolabeled-IgG binding 
studies where reduced amount of IgG binding was observed for PEGylated nanogels as 
opposed to non-PEGylated nanogels (Figure 4.8). Also, as wt% of PEG decreased with 
different nanogel formulations, percent IgG bound increased clearly implying that 
presence of PEG was altering the antibody binding effect in a positive fashion.  
These hydrophobic polymeric quercetin-PΒAE systems are hypothesized to degrade in 
PBS via hydrolysis of ester bond to release quercetin. This was confirmed by injecting 
degradation products through HPLC where we saw the most significant elution peak 
coinciding with pure quercetin peak with no oligomer or other forms of quercetin 
acrylate present (Figure 4.9 (a)) confirming the presence of original quercetin molecule 
in the degradation product. Nanogels showed uniform degradation over 48 hours with 
about 5-10% of the total quercetin released in first 30 minutes as analyzed by UV-Vis 
(Figure 4.9 (b)). While the Korsmeyer-Peppas (K-P) release profile model for spherical 
systems with 0.43<n<0.85 suggests the contribution of diffusion, as well as erosion 
based degradation, similar release profile of all the formulations (QNG (0.75)-QNG 
(10)) with variable diameter, confirms the bulk erosion instead of surface erosion 
degradation mechanism, (Figure 4.9 (b)). An important fact to notice in the release 
profile is that the value of ‘n’ obtained using the K-P model closely correlates with the 
percent burst release considering it to occur at 1st sampling time point of 30 minutes. 
The system with highest burst release of 11.93% (QNG (10)) fits with the ‘n’ value of 
0.55 (near diffusion boundary) while QNG (5) with lowest burst release of 4.43% 
amongst all the systems gives the ‘n’ value of 0.85 (pure erosion mechanism). This 
trend of higher burst release with lower ‘n’ value clearly implies that the diffusion 
contribution in the release model is largely coming due to the unconjugated quercetin 
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being diffused through the spherical gel matrix at early time points while the quercetin 
released due to the ester hydrolysis is derived by erosion based mechanism. Analyzing 
the antioxidant activity of the released products using TEAC assay confirmed that the 
products released at 24 hours or 48 hours still possess antioxidant activity and quercetin 
conjugated to PΒAE backbone was structurally intact even after being incubated in 
aqueous media for several hours (Figure 4.9 (c)). Comparing the equivalent quercetin 
amount obtained from TEAC assay and actual quercetin release in figure 4.9 (c), it is 
clear that the nanogel degradation products are showing higher activity than would be 
estimated through pure quercetin release (Figure 4.9 (d)). One possible explanation for 
the persistent excess activity throughout the degradation process could be due to the 
auto-oxidation or molecular degradation of the released quercetin in the aqueous 
environment resulting in metabolized fragments such as phloroglucinol, protocatechuic 
acid etc [189]. These small fragmented molecules though not quantifiable at the same 
wavelength as quercetin have some potential towards free radical scavenging which 
could be contributing towards ABTS radical consumption in the TEAC assay [190]. 
Hence, even the fragmented degradation products contributed to the total antioxidant 
potential of the system over time. 
As a pharmaceutically active compound, quercetin like any other therapeutic compound 
has a window of safety with TC50 value of 0.23 mM or ~ 70 μg/ml (Fig 4.10 (a)). When 
loaded into a drug carrier system, it is important to investigate the potential toxicity of 
the carrier system along with the loaded drug. As literature for PβAE systems indicates 
low relative toxicity in vitro and in vivo, it is expected that quercetin PβAE nanogels 
would have a similar safety window as for pure quercetin with no added effect due to 
the polymer backbone. This was confirmed with the dose dependent cytotoxicity study 
of all the QNG systems and when compared with quercetin, QNGs toxicity patterns the 
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cytotoxic profile of quercetin directly confirming once again the viable nature of PβAE 
nanogel by itself (Figure 4.10 (a) and (b)). These nanogels were further evaluated for 
their ability to suppress oxidative stress due to external injury induced using 0.5 mM 
H2O2 exposure. They not only showed ROS scavenging capacity against H2O2 induced 
injury as good as pure quercetin at equivalent quercetin loading of 5 µg/ml, but the 
treatments done with QNGs having 10 µg/ml of equivalent quercetin loading showed 
enhanced protection against oxidative stress as compared to nascent quercetin after 48 
hours probably due to prolonged supply of active quercetin during nanogel degradation. 
This was verified by both viability and DCF fluorescence studies showing superior 
properties of QNGs than pure quercetin even though present in same quantities (Figure 
4.11 and 4.12). Therefore, with the ability to suppress oxidative stress in vitro, slow 
uniform release, and longer circulation efficacy; these nanogels can serve as an 
effective delivery system a therapeutically potential yet fragile antioxidant, quercetin, 
which shows very low bioavailability in vivo otherwise.  
4.5 Conclusions 
Nanogels were synthesized using a novel but simple single-phase reaction-precipitation 
system with control over the size through varying feed reactant concentrations. These 
nanogels were able to be PEGylated post-synthesis through a secondary Michael 
addition reaction with available amines on the nanogel surface, resulting in decreased 
opsonization. The PΒAE chemistry to chemically conjugate quercetin protects 
quercetin from losing antioxidant activity until the polymer degrades and releases the 
quercetin.  To the best of our knowledge, these nanogel systems when compared with 
other nanocarriers have the highest reported quercetin drug loading. The uniform, 
prolonged release of quercetin from QNGs due to hydrolytic cleavage showing 
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equivalent antioxidant activity as pure quercetin potentially shows protection against 
induced oxidative stress for as long as 48 hours.   
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5 CURCUMIN CONJUGATED POLY (Β- AMINO ESTERS) 
NANOGELS AND SUSTAINED SUPPRESSION OF 
MITOCHONDRIAL OXIDATIVE STRESS 
Based on the research to be published in: 
 Prachi Gupta, Mihail Mitov, J. Zach Hilt, Thomas D. Dziubla. Sustained 
Suppression of Mitochondrial Oxidative Stress using Curcumin conjugated Poly (β- 
Amino Esters) Nanogels (submitted) 
Abstract 
Mitochondria are considered to be the “power plant” of the cell, but can also initiate 
and execute cell death, stimulated by oxidative stress (OS). OS induced mitochondrial 
dysfunction is characterized by a loss in oxygen consumption and reduced ATP 
production. Curcumin, with potential therapeutics and interventions, has been explored 
as a potential candidate for mitochondrial OS suppression, but rapid metabolism and 
aqueous insolubility prevent it from being an effective therapeutic. Further, effective 
delivery of curcumin via incorporation into nanocarrier formulation has again been 
limited due to low drug loading capacities and/or significant burst release effects 
resulting in cytotoxicity. Hence, to increase therapeutic opportunities and ease toxic 
effects of curcumin, self-precipitated curcumin conjugated poly(β-amino ester) 
nanogels (CNGs) were synthesized using the Michael addition chemistry. With easy 
control over the nanogel size, CNGs showed a uniform release of active curcumin over 
48 hours with no burst release. This uniformly releasing system significantly increased 
the safety limit for curcumin as a treatment drug (10xfree curcumin). Further, real-time 
mitochondrial response analysis with Seahorse XF96 showed effective and prolonged 
suppression of H2O2 induced mitochondrial oxidative stress upon pre-treating 
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endothelial cells with CNGs and this potential of nanogels was studied at different pre-
treatment times prior to H2O2 exposure. 
5.1 Introduction 
Given its ubiquity in a number of disease states, oxidative stress (OS) and its consequent 
effects are extensively researched topics in biological and pharmaceutical disciplines. 
Its cascading effects are seen in diabetes, cancers, neurological disorders, cardiac 
disorders and many more [191-193]. OS occurs when the natural balance of oxidants 
and antioxidants is disturbed, leading to excess production of free radicals such as 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). Higher levels of 
ROS and RNS lead to cellular damage by lipid peroxidation, protein carbonylation, 
DNA damage, etc. [194, 195]. Mitochondrion, the central system for energy production 
pathways and metabolism in most cells, is also a key organelle for ROS generation 
[196, 197]. Interestingly, mitochondria are not just a key generating source of free 
radicals but also a sensitive target to ROS and RNS damage [198]. Mitochondrion is 
believed to be specifically affected by lipid peroxidation, leading to the generation of 
hydrogen peroxide and superoxide radicals and hence resulting in additional ROS 
production [199]. This cycle cascades in a feed forward fashion leading to cell necrosis 
and apoptosis [199, 200]. Therefore, it is believed that when a cell is exposed to any 
free radical or ROS, the mitochondria are the first one of the cellular organelles to be 
targeted by ROS. This leads to mitochondrial dysfunction, disturbing the normal 
respiration mechanism and loss in ATP production before finally losing a major energy 
pathway of the cells. Mitochondrial protein, lipids and DNA (mtDNA) are considered 
the primary target of ROS. As a result, mitochondrial oxidative stress (Mito OS) 
becomes the indirect cause of many diseases, primarily neurogenerative disorders such 
as Alzheimer’s and Parkinson’s disease, numerous metabolic disturbances, 
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cardiomyopathies and metabolic complexities in patients suffering from diabetes 
mellitus [1, 201-205]. 
Because mitochondrion becomes the generation source of more ROS, it is 
important to control the damage to mitochondrial structure and function when the cells 
encounter increased ROS/RNS. One potential solution to prevent mito OS is to reduce 
excess ROS production in mitochondria by effectively supplementing with 
antioxidants. Most attempts to accomplish this have failed in vivo due to the non-
specific delivery of antioxidants to mitochondria below therapeutic limits as well as in 
vivo molecular instability issues with most of the antioxidants. Among the 
molecules/compounds studied, curcumin has shown protective effects, including a 
cytoprotective effect against aluminum induced neurogenerative disorders [206], 
maleate induced oxidative stress [207], and preventing mitochondrial OS in high fat 
diet induced obese mice [208]. Despite these promising findings in animal models, most 
clinical studies performed with high and frequent oral doses up to 4 g/day for 48 weeks, 
specifically for Alzheimer’s, have failed to show clinically significant improvement in 
reducing symptoms for the disease [209]. Among limitations for curcumin, poor 
aqueous solubility, and extremely low bioavailability are most significant because pure 
curcumin has shown to be below detectable serum concentrations within a few minutes 
of administration [210]. Attempts have been made to incorporate curcumin into any 
viable polymeric or similar nanocarriers with the aim for higher curcumin loading, 
sustained release characteristics and ability to perform its antioxidant function with no 
cytotoxic effect. Unfortunately, curcumin drug loading capacities of most nanocarriers 
have not exceeded more than 4 wt%, resulting in the higher amount of carrier material 
but minimal doses of the functional drug [211]. Furthermore, little work has been 
pursued using curcumin as a treatment targeted towards stressed endothelial cells for 
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cancer and tumor treatment. In our approach to fight OS (specifically mito OS) with C- 
PβAE nanogels, curcumin is chemically conjugated to the polymer backbone, which 
upon hydrolytic degradation of the ester bonds releases pure curcumin. Theoretically, 
chemical conjugation into the PβAE matrix gives curcumin a structural stability and 
prevents deactivation prior to hydrolysis. Uniform drug release over 36-40 hours 
resulted in protected functionality of curcumin for a longer period. A higher IC50 value 
of more than 100 µg/ml of loaded curcumin in contrast to free curcumin (IC50=5.3 
µg/ml) increased the safety window of this potential drug. An increased safety window 
gives higher flexibility to work in therapeutic dosage amounts and reach adequate 
curcumin levels to treat and or prevent OS. In contrast, free curcumin administered at 
therapeutic levels will kill endothelial cells. A mitochondrial stress assay using 
Seahorse XF96 analyzer with the ability to monitor real-time mitochondrial 
bioenergetics was employed to analyze mitochondrial bioenergetics post induced 
oxidative stress and protective effect of C- PβAE nanogels (CNGs) versus free 
curcumin. CNGs with higher, yet viable, treatment concentrations (5 µg/ml) were able 
to shield against dropping ATP production or basal respiration rates due to hydrogen 
peroxide induced mito OS. On the other hand, free curcumin proved to be fatal at these 
high treatment concentrations and showed no protection at safe concentrations of 1 
µg/ml against mito OS. 
5.2 Methods and materials 
5.2.1 Reagents 
Curcumin was purchased from Chem-impex Int’l ‘Inc, (Wood Dale, IL). 4,7,10 
Trioxatridecane-1,13-diamine (TTD), acryloyl chloride, 2,2′-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS), triethylamine (TEA) and potassium 
carbonate were bought from Sigma-Aldrich (St. Louis, MO). Sodium chloride, 
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potassium phosphate, sodium phosphate and sodium dodecyl sulfate (SDS) were 
purchased from Fisher Scientific (Fair Lawn, NJ). Human Umbilical Vein Endothelial 
Cell line (HUVECs), EBM-2 basal medium and its growth factors were purchased from 
Lonza, (Walkersville, MD). All solvents were purchased from Pharmco-aaper 
(Shelbyville, KY). All media kit and cell culture plates for XF96 Seahorse experiments 
were purchased from Seahorse Bioscience (Massachusetts, USA). Calcein AM red-
orange tracer was bought from Invitrogen (Grand Island, NY). 
5.2.2 Curcumin acrylate (CA) synthesis 
Acrylation of the curcumin phenolic group was carried out via reaction of curcumin 
with acryloyl chloride in the molar ratio of 1:3 with anhydrous THF as the reaction 
medium. Triethylamine (TEA) was added in the same molar ratio as acryloyl chloride 
to capture byproduct hydrogen chloride by forming a chloride salt with the progression 
of the reaction. The reaction was carried out for 15 hours at room temperature in dark 
(aluminum foiled). The acrylated product was filtered from the salts formed during the 
reaction. The product was further purified via a solvent extraction process to remove 
any unreacted monomers then vacuum dried to obtain dry curcumin acrylate product. 
Obtained curcumin acrylate was analyzed using HPLC to verify product quality. 
5.2.3 Synthesis of curcumin PβAE nanogels (CNGs) 
CA solubilized in acetonitrile at known concentrations was reacted with TTD keeping 
acrylate to reactive hydrogen amine ratio of 1:1. Curcumin has two phenolic groups 
and upon acrylate functionalization should react to form curcumin diacrylate. TTD has 
four reactive hydrogen amines. Therefore, for each mole of TTD (molecular weight 
220.31 g/mol), two moles of CA (molecular weight~ 476 g/mol) are reacted to get the 
required acrylate to reactive hydrogen amine ratio of 1:1. To formulate 1 ml of 
curcumin conjugated PβAE nanogels with the starting CA feed concentration of 10 
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mg/ml, 2.3 mg of TTD was added and allowed to react for 24 hours. Feed reaction 
concentrations of CA were varied from 0.75 to 10 mg/ml, hence the amount of TTD 
added to the reaction system was changed accordingly to keep the stoichiometric ratio 
constant. After 24 hours and self-precipitation of CA and TTD into C- PβAE nanogels 
(CNGs), the suspension was diluted in anhydrous THF with BHT as inhibitor, in a 1:4 
ratio v/v (1 ml CNG suspension with 4 ml THF) as a purification step. An hour later, 
the system was centrifuged at 6.7 RCF for 20 minutes. The supernatant was removed 
and another wash with THF was given to remove any remaining unreacted monomers. 
After the second purification step, the centrifuged pellet was re-suspended in 1 ml 
acetonitrile via sonication and then freeze-dried overnight to get dry C- PβAE nanogels 
(CNGs).  
5.2.4 Yield of reaction, nanogel size and morphology characterization 
Yield: Yield of the C-PβAE nanoparticle reaction synthesis was determined by 
calculating the unreacted CA concentration in the supernatant after nanoparticle 
centrifugation. The unreacted CA concentration was determined by analyzing the 
degradation supernatants using a Varian Cary 50 UV-Vis spectrophotometer and 
quantifying the absorbance at the curcumin characteristic wavelength of 420 nm. The 
yield was determined by subtracting the amount of unreacted CA from the starting 
amount added. An assumption that CA and TTD reacted in the same ratio was taken 
into account while calculating the yield.  
Size and morphology: Hydrodynamic radii of the different CNGs formulations were 
measured using dynamic light scattering (DLS) after suspending dried nanoparticles in 
acetonitrile and setting the measurement parameters according to the solvent used. 
CNGs were scanned with electron microscopy to determine their shape and 
morphology. To prepare the samples, synthesized nanoparticles were first suspended in 
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acetonitrile at a concentration of 100 µg/ml using probe sonication. A drop of 10 µl of 
this suspension was put on ODT treated gold substrate and allowed to dry for 2 hours. 
The sample was then sputter coated using gold-palladium alloy and images were taken 
at various magnifications using S-4300 Hitachi Scanning Electron Microscope. 
 
5.2.5 Hydrolytic degradation of C-PβAE nanogels and the subsequent 
curcumin release profile 
In order to test the degradation of these nanogels with subsequent release of pure 
curcumin upon ester hydrolysis, nanoparticles synthesized with 5 mg/ml as the CA feed 
concentration were suspended in PBS buffer containing 0.1% SDS wt/vol (pH 7.4).  
SDS was added to the buffer to enhance the solubility of released curcumin or its 
oligomeric products for further quantification. The nanogels were suspended in the 
buffer at a concentration of 100 µg/ml. At time points 0, 2, 4, 6, 8, 12, 24, 30, 36, 52 
and 71 hours, the suspension was centrifuged at 6.7 RCF for 20 minutes and the 
supernatant was collected and stored at -20o C for further analysis. The centrifuged 
pellet was re-suspended in fresh buffer maintaining appropriate sink condition. A 
degradation study was carried out over 72 hours under sink conditions at 37°C. To 
determine the release rate of curcumin during hydrolytic degradation of CNGs, UV-Vis 
spectrophotometry was used to analyze the curcumin concentration in the collected 
supernatants. The absorbance of the supernatants was measured at 420 nm using Varian 
Cary 50 Bio UV-Vis spectrophotometer followed by quantification of the amount of 
curcumin released using a standard calibration curve. 
5.2.6 Antioxidant activity of released curcumin  
It was important to assess that the released curcumin from CNGs was still active with 
its antioxidant potential intact as its phenolic groups were chemically altered during the 
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nanoparticle synthesis. Therefore, a trolox equivalent antioxidant capacity (TEAC) 
assay was performed in order to verify the antioxidant potential or radical scavenging 
property of released degradation products. TEAC is a colorimetric assay based on 
scavenging of 2, 2’-azinobis-(3- ethylbenzothiazoline-6-sulfonate) radical anions 
(ABTS.-) in the presence of an antioxidant. Briefly, 7 mM ABTS radical cation stock 
solution was prepared by mixing 1 ml of 8 mg/ml of ABTS solution with 1 ml of 1.32 
mg/ml of potassium persulfate solution in DI water overnight. This concentrated ABTS 
radical stock solution was diluted in PBS to an absorbance of 0.4 AU at 734 nm to 
prepare a working solution after baseline correction. Trolox, with known concentrations 
ranging from 0 to 0.27 mM, was used for calibration. The assay was carried out in a 96-
well plate and 10 µl of the sample was added to each well, followed by 200 µl of ABTS 
radical working solution. Five minutes later, absorbance was read at 734 nm using a 
Varian Cary 50 Bio UV-Vis spectrophotometer. A trolox calibration curve was used to 
determine equivalent trolox concentrations in the supernatant degradation products. 
5.2.7 Dose dependent cytotoxicity of C-PβAE nanogels (CNGs) towards 
HUVECs 
HUVECs were cultured in EBM basal medium (phenol red free) with EBM-2 growth 
factors to an 80% confluence in a 96-well plate overnight. Curcumin and CNGs (CA 
feed concentration = 5 mg/ml) suspension in media with equivalent curcumin 
concentrations ranging from 0 to 70 µg/ml were prepared. Wells containing HUVECs 
received and were treated with antioxidant/CNG solution for 24 hours (n=5). After 24 
hours, media with antioxidant was removed from the wells, then incubated in 1 mM 
calcein AM red-orange live cell tracer. After 1 hour, cells were washed and fresh media 
was added to each well. The well-plate was subjected to fluorescence measurement 
with 540/590 nm as excitation and emission wavelength, respectively, using BioTek 
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Synergy Mx, Gen5 2.0, Winooski, VT to measure dose dependent toxicity of C-PBAE 
nanoparticles. 
5.2.8 Effect of CNGs exposure on H2O2 induced cellular OS: cell viability 
analysis 
HUVECs cultured in EBM-2 basal medium were seeded in a 96-well plate and 
incubated overnight to achieve 80% confluency with respect to well area. CNGs (CA 
feed concentration = 5 mg/ml) at a concentration of 7.5 μg/ml (5 μg/ml equivalent 
curcumin loading) were suspended uniformly in EBM-2 basal medium with the aid of 
bath sonication. The media from the cells was removed and 200 μl of the CNG 
suspension was added to the well of interest. 10 μl of 10 mM H2O2 stock solution 
prepared in EBM media was added simultaneously to the CNGs containing to get final 
exposure concentration of 0.5mM. A control group of only CNGs and only H2O2 
exposed cells was also prepared. To all the wells, 10 μl of DCF-DA prepared in EBM-
2 media was added to get a final cell exposure concentration of 10 μM.  24 hours later, 
DCF fluorescence was read at 490/525 nm as excitation/emission wavelength using 
BioTek Synergy Mx, Gen5 2.0, Winooski, VT spectrophotometer. Post fluorescence 
measurement, CNGs ± H2O2 solutions were removed and wells were washed with fresh 
media, followed by addition of 1 mM Calcein AM red-orange live cell tracer. Cell 
viability was measured by following the similar protocol as given in section 2.7 
 
5.2.9 Measurement of mitochondrial OS changes after treatment with C-PβAE 
nanogels (CNGs) using XF-96 extracellular flux analyzer. 
A Seahorse XF-96 Flux Analyzer (Seahorse Bioscience, North Billerica, MA) was used 
to analyze the effect of CNGs on cellular bioenergetics. HUVECs were seeded in a 
Seahorse 96-well tissue culture plate at a seeding density of approximately 35,000 
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cells/well. Cells were then allowed to adhere and grow for 24 hours. Prior to assay, the 
cell growth media was replaced with 175 µL of FX media (FX Assay Modified DMEM 
from Seahorse Bioscience with 5.5 mM glucose, 1 mM pyruvate, and 2 mM glutamix). 
Wells and cells were washed once, media exchange was completed and then cells were 
equilibrated for 60 minutes at 37° C in a non-CO2 incubator. The 96-well plate was then 
subjected to Mitochondrial stress assay to analyze mitochondrial energetics and cellular 
metabolic profile. The mitochondrial stress assay consisted of subsequent injections of 
three mitochondrial inhibitor drugs: oligomycin A (1 µM), which act as ATP synthase 
inhibitor; FCCP (1 µM), an uncoupling agent; and a mixture of 1 µM rotenone and 1 
µM antimycin A, each used as inhibitors for mitochondrial respiratory chain complex I 
and III to shut down the mitochondrial oxygen consumption. Oxygen consumption rates 
(OCR) and extracellular acidification rates (ECAR) were measured using measurement 
periods of 3 minutes minimum and 3 minutes maximum with drug injection series. 
Once OCR/ECAR measurements were completed, the FX media was carefully 
removed from all individual wells and replaced with 25uL of cell lysis buffer containing 
0.32 mM Sucrose, 2 mM EDTA, 2 mM EGTA, 20 mM HEPES, pH 7.4, containing 
protease inhibitors 4 μg/mL leupeptin, 4 μg/mL pepstatin, 5 μg/mL aprotinin, and 0.2 
mM PMSF. The plates then put in -20° C freezer overnight to disrupt cells membranes. 
The next day, plates were taken out to room temperature and put on an orbital shaker 
for an hour. Unknown protein levels (samples) of the wells were measured using the 
modified BCA protein assay (Thermo Scientific, Rockford IL). Known amounts of 
protein standards (2.5 μg, 5.0 μg, 10 μg etc.) were added in the background wells of the 
plate to construct an optical density standard curve. Protein levels were determined after 
the optical densities were measured on iMark plate reader (Bio-Rad, Hercules, CA). 
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The OCR pmol/min were normalized to protein levels of pmol/min/μg or calculated as 
percent change (%OCR) from the third basal  measurement for each group.  
To analyze the mitochondrial response towards free curcumin and CNGs, a 96-well 
plate seeded with 35,000 cells/well was treated with curcumin/CNG (synthesized with 
5 mg/ml as feed reactant concentration) at equivalent curcumin concentrations of 1 and 
5 µg/ml. After 24 hours of treatment, media was replaced with XF media for 1 hour at 
37° C. The plate was then subjected to the mitochondrial stress assay to analyze 
mitochondrial energetics and metabolic profile. Metabolic respiration rates were 
measured and quantified as OCR (pmol/min) at this step. After analyzing different 
concentrations of curcumin and CNGs having the same equivalent curcumin 
concentrations for mitochondrial respiration rates, viable concentrations of curcumin (1 
µg/ml) and CNGs (5 µg/ml) were used for further analysis of protective effect against 
OS. HUVECs in 96-well plates were first pre-treated with curcumin/CNGs at specified 
concentrations (1 and 5 µg/ml) for 0, 12 and 24 hours, then followed by the introduction 
of 0.25 mM H2O2 for 2 hours. Next, cells were washed and replaced with un-buffered 
DMEM media and kept at 37° C for 1 hour, followed by mitochondrial stress assay.  
5.2.10 Statistical Analysis 
Data for figures 5.1 (A), (B), 6.2 (A) and (C) is presented as mean ± St. Dev., while for 
figures 5.3 (A), (C), 6.4 (A), (B), (C) and 6.5 (A), (B) and (C) is presented as mean ± 
SEM. The statistically significant differences between the mean values were calculated 
using one-way ANOVA test followed by Bon-ferroni post hoc test with the help of 
SigmaPlot software. A p value of <0.050 was considered to be representative of the 
significant difference between the means under comparison. 
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5.3  Results 
5.3.1 Curcumin nanogel size, yield and morphology 
CA with 2 to 3 acrylate groups was set to react with TTD in acetonitrile under dilute 
conditions. Varying the feed concentration of CA and maintaining the total acrylate to 
total reactive hydrogen amine ratio resulted in self-precipitated nanogels with variable 
hydrodynamic diameter. Upon UV-Vis analysis of the supernatants obtained after 
centrifugation, reaction yield was calculated to be 62.7%. Increasing the reactant 
concentration resulted in an increase in diameter. As shown in figure 5.1 A, 
hydrodynamic diameters of 64 ± 8, 87 ± 3, 131 ± 5, 221 ± 4, 416 ± 31 nm were obtained 
for CA feed reactant concentrations of 0.75, 1.25, 2.5, 5, 10 mg/ml respectively. These 
will be abbreviated as CNG (0.75), CNG (1.25), CNG (2.5), CNG (5) and CNG (10) 
throughout this text.  
After the washing and purification step in anhydrous THF, CNG (5) was again analyzed 
on DLS giving the hydrodynamic diameter of 210 ± 20, similar to the pre-wash 
diameter of the nanogels (Figure 5.1 B). This suggests little to no aggregation and no 
morphological change of nanogels post purification steps. The spherical morphology 
of the nanogel system was further confirmed after electron microscopy imaging (Figure 
5.1 A inset) and an average diameter of 176 ± 26 nm was calculated using Image-J 
software.  
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Figure 5.1 Hydrodynamic diameter and SEM of precipitated CNGs after 24-hour 
reaction of CDA with TTD in acetonitrile 
(A) Different CDA feed reactant concentrations. Acrylate to reactive hydrogen amine 
ratio was kept constant at 1:1 for all the formulations Inset: SEM image of nanogels 
corresponding to 5 mg/ml feed concentration. (B) Hydrodynamic diameter of nanogels 
(5 mg/ml feed concentration) pre- and post-wash with THF as a purification step 
showing no significant difference at both the stages. N=3, error bars: std. dev. 
 
5.3.2 Degradation, curcumin release and its anti-oxidant activity 
Curcumin nanogels (CNG (5)) were suspended in 0.1% SDS-PBS buffer at a 
concentration of 100 µg/ml. To dissolve released curcumin, 0.1% SDS wt/vol was 
added. Released curcumin in the supernatant was quantified using a UV-Vis analytical 
method by recording the absorbance at 420 nm to determine sample concentration and 
cumulatively adding the obtained concentrations of each sample with increasing 
degradation time to obtain the degradation profile of CNGs. As shown in figure 5.2 A, 
90% of the total curcumin release was uniformly distributed over 36 hours, and the 
remaining 10% release was spread throughout the next 30 hours. Meanwhile, taking 
into account 62.7% wt/wt as the theoretical loading of curcumin to nanogels, 55.58±3% 
of the total curcumin loaded was recovered during degradation. This lag in recovered 
curcumin could be due to release of oligomeric/monoacrylated products and may be 
underestimated in quantification during UV-Vis analysis. HPLC analysis of the 
degradation products at characteristic wavelength of 420 nm showed elution of pure 
curcumin (peak at 7.9 minutes) as the major product, but also constituted a minute 
amount of other products (peaks at 2.9 and 11 minutes) also absorbing at 420 nm 
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(Figure 5.2 B). These small peaks could count towards added value to curcumin 
estimation but are not fully accurate due to peak shift artifacts commonly observed in 
UV-Vis. Carrying out  the TEAC assay on the released products supernatants gave an 
estimate of releasing curcumin’s antioxidant capacity over 70 hours. All the 
instantaneously collected samples were assayed for antioxidant activity and quantified 
as mM of equivalent trolox because known concentrations of trolox were used as the 
standards. Finally, equivalent trolox amount were cumulatively added with respect to 
the degradation time to obtain a uniform increase in the antioxidant activity profile with 
time from 0.031 mM at t = 0 to 0.502 mM trolox after 70 hours of incubation. This 
implies that at each time point of hydrolytic ester cleavage, released curcumin was 
active to scavenge free radicals. 
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Figure 5.2 Degradation of CNGs in PBS buffer with 0.1% SDS (pH=7.4) at 37°C in 
a shaker bath. 
(A) Curcumin release profile during hydrolytic degradation (B) HPLC chromatogram 
of nanogel released products recorded at 420 nm showing elution of pure curcumin 
with minor amount of monoacrylate.  (C) Equivalent trolox amount of the released 
products representing the antioxidant activity analyzed using TEAC assay. N=3, error 
bars: std. dev. 
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5.3.3 Dose dependent toxicity of CNGs on HUVECs and protection from 
oxidative stress 
HUVECs were treated with variable concentrations of CNG (5) with equivalent 
curcumin concentrations ranging from 0.5 to 70 µg/ml. HUVECs were simultaneously, 
yet separately, treated with pure curcumin as a control. After 24 hours treatment, pure 
curcumin started showing toxicity towards HUVECs at 5 µg/ml (IC50 = 5.3 µg/ml) 
while CNGs were non-toxic up to 20 µg/ml of equivalent curcumin and cells were still 
60% viable at a concentration of 70 µg/ml (Figure 5.3 A).  
 
Figure 5.3 Dose dependent cytotoxicity of CNGs towards HUVECs after 24 hours of 
treatment and comparison with free curcumin.  
(A) Cell viability calculated after carrying out the Calcein AM red-orange live cell 
tracer assay (B) Mitochondrial oxygen consumption rate profile of a typical 
mitochondrial stress assay conducted using the Seahorse XF96 instrument. (C) Basal 
respiration rates of curcumin and CNG (5) represented at pmol/min after the 
calculations as depicted in figure 5.3 B. (D) OCR (profile) of the controls and 
curcumin/CNG at different curcumin concentrations in response to mitochondrial 
stress assay reagents added in a series at selected time points. N=5, error bars: std. 
err. 
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5.3.4 Protection from cellular oxidative stress 
Cell viability for each treatment group was measured keeping non-treated control group 
as reference of 100% viability.  Only H2O2 treated groups after 24-hour exposure 
resulted in 53 ± 3 % viability, while only CNG treated groups showed no significant 
change with respect to the control with percent viability of 108 ± 4 (Figure 5.4). With 
simultaneous treatment of CNGs with 0.5 mM H2O2 exposure for 24 hours, 71 ± 4 % 
viability which is significantly higher than only H2O2 treated groups. In order to get an 
estimate of oxidative stress, amount of free radical generation was measured with DCF 
fluorescence. Only H2O2 treated groups gave a measured DCF fluorescence of 12250 
± 1220, which is significantly higher than non-treated control group with fluorescence 
measurement of 8620 ± 1198.  Only CNGs treated group did not result in major 
difference w.r.t controls with DCF fluorescence of 7913 ± 980. Fluorescence 
measurement of CNGs+H2O2 group demonstrated suppression in oxidative stress due 
to H2O2 with lower values of DCF values of 8358 ± 1350 as compared to only H2O2 
group. 
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Figure 5.4 HUVECs cell viability and suppression in DCF fluorescence due to CNGs 
(5 mg/ml feed concentration system) with simultaneous treatment of 0.5 mM H2O2.  
DCF fluorescence and viability both were measures after 24 hours treatment with CNGs 
and H2O2. CNGs with equivalent concentration of 5 µg/ml of loaded curcumin were 
administered to the cells. ‘*’ significantly different from rest of the groups, p<0.05. 
 
5.3.5 Protection from mitochondrial oxidative stress 
To assess the potential of CNGs toward mitochondrial OS protection and its 
comparison with pure curcumin, HUVECs were incubated with both CNGs and 
curcumin at two different concentrations for 24 hours. This incubation was followed by 
basal respiration rate measurements and a mitochondrial stress test. Basal respiration 
rates, ATP-linked respiration, proton leak, maximum respiration and spare respiratory 
capacity were calculated from the mitochondrial stress test drug-response OCR values 
according to the calculation scheme shown in figure 5.3 B. The curcumin treatment at 
1 µg/ml showed nominal OCR of 15.29 ± 0.73 pmol/min which is comparable to the 
non-treated controls: 13.7 ± 0.9 but at 5 µg/ml of curcumin exposure, OCR values 
dropped down drastically to 2.68 ± 0.35 (Figure 5.3 C). This clearly implies the 
mitochondrial dysfunction at curcumin concentrations of 5 µg/ml.  
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On the other hand, HUVECs treatment with CNG at 7.97 µg/ml having 
equivalent curcumin concentration of 5 µg/ml retained its OCR at 16.6 ± 1.0 pmol/min 
and showed no signs of mitochondrial dysfunction or damage to the cells. The overall 
response of the curcumin/CNG treated cells in the mitochondrial stress assay can be 
seen in figure 5.3 D, where a healthy response similar to non-treated controls was seen 
for 1 µg/ml curcumin and CNG (5µg/ml equivalent curcumin loading). Curcumin with 
5 µg/ml possessed no positive response towards the mitochondrial stress assay due to 
mitochondrial damage at that concentration.  
Therefore, all additional studies of mitochondrial oxidative stress protection, 
viable concentration i.e.  1 µg/ml for free curcumin and 5 µg/ml of equivalent curcumin 
for CNGs were used. To assess and test the prolonged protection of CNGs against 
mitochondrial oxidative stress, two standards were set for the design of the experiment: 
1) antioxidant treatment concentrations as stated above; and 2) concentration and 
exposure time to cells of oxidative stress inducer, H2O2 which is 0.25mM and 2 hours. 
This parameter was set so only mitochondrial bioenergetics were disturbed due to 
exposure but not the onset of cell necrosis/apoptosis which could result in added 
artifacts during OCR recordings. Mitochondrial respiration rate was measured as OCR 
(pmol/min) and the bioenergetics parameters are represented as basic OCR (pmol/min) 
as well as % OCR (after baseline normalization) to eliminate the effect of any variation 
in starting cell density as shown in figures 5.5 and 5.6.  Two hours H2O2 exposure by 
itself led to a drop in basal respiration, ATP-linked and maximal respiration 
respectively to 34.5 ± 3.0%, 21.6 ± 3.6% and 34.8 ± 11.3% OCR from 76.1 ± 6.0%, 
60.7 ± 5.7% and 149.6 ± 20.0% of the non-treated controls as shown in Figure 5.6 A, 
B and C. Curcumin treatments at 0, 12 and 24 hours prior to H2O2 addition did not aid 
in recovery of the OCR, basal respiration or maximal respiration, which were observed 
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to be 19.8 ± 10.2%, 25.0 ± 5.7% and 37.0 ± 26.7% respectively. In other words, viable 
concentrations of curcumin did not show any effective protection against mitochondrial 
OS. On the other hand, CNG (5) showed an enhanced OCR post H2O2 treatment at all 
exposure times giving basal OCR: 47.17 ± 3.93, 60.0 ± 2.0, 94.3 ± 10.0 as %OCR, 
ATP-linked OCR: 31.2 ± 7.5, 40.0 ± 14, 52.8 ± 5.2 and maximum respiration rates of 
336.5 ± 12.5, 198.6 ± 37.3 and 161.7 ± 11.7 respectively for 0, 12 and 24 hours of prior 
nanogel treatment.  
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Figure 5.5 Mitochondrial function parameters after pre-treatment of curcumin/CNG 
for 0, 12 and 24 hours followed by 2-hour exposure of 0.25 mM H2O2. 
Cells were subjected to mito stress assay with real-time OCR measurements using 
Seahorse XF96 instrument. (A) Basal respiration. (B) ATP-linked to mitochondria. (C) 
Maximum respiration. All OCR values are displayed as pmol/min. N=5, error bars: 
std. err. 
 
5.3 Discussion 
Significant efforts have been made to improve the delivery of mitochondria OS 
targeting drugs (e.g., MitoQ) with the help of nanocarriers, for the purpose of 
suppressing mitochondrial OS and reducing mitochondrial dysfunction [212, 213]. 
MitoQ is an ubiquinol moiety linked to a lipophilic triphhenylphosphonium (TPP) by a 
ten-carbon alkyl chain. A part of the TPP chain helps in the rapid cellular uptake of the 
drug loaded carrier across the cell membrane and further accumulation in mitochondria 
[214]. In vivo, MitoQ and its analogs (MitoVitE, MitoPBN) have shown positive results 
against Mito OS by inhibiting lipid peroxidation, ROS/RNS generation etc. [215]. TPP 
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based targeted antioxidant delivery approaches are most effective in rapid accumulation 
of antioxidants within the mitochondria, where the toxicity of the hydrophobic moiety 
(TPP) can result in nonspecific mitochondrial dysfunction, resulting in disruption of 
membrane integrity, respiration, and ATP production rate. This nonspecificity further 
depends on the amount of compound internalized. Therefore, the constraint is the 
amount of drug that can be delivered with TTP based nanocarrier so as to reach 
therapeutic levels before reaching disruptive concentrations [202, 216, 217]. Also, the 
ubiquinol based approaches may increase protection against peroxynitrite and 
superoxide radicals, but their efficacy has been reported to be small to negligible for 
one of the most significant oxidants (hydrogen peroxide H2O2) in cellular physiology 
[218].   
As an alternative, a number of studies have demonstrated the protective effect 
of curcumin towards mitochondrial dysfunction and mitochondrial OS [219, 220]. Most 
research has concentrated on neurodegenerative diseases and finding new therapeutics 
for Alzheimer’s [221, 222]. Curcumin has been shown to inhibit the depolarization of 
mitochondrial membrane potential as well as decreasing the levels of the pathological 
marker for the Alzheimer’s disease amyloid-β [223, 224]. Similar results were observed 
in aluminum induced mitochondrial dysfunction studies, malate induced OS commonly 
known as nephropathy etc. [206] [225]. These positive results and outcomes from such 
approaches are reported only from in vitro models, but there is very little evidence of 
positive results in vivo. Faster in vivo metabolism and the inability of curcumin to reach 
therapeutic concentration in the targeted micro-locations may be the cause of success 
in vivo rather than in vitro.  
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Figure 5.6 Mitochondrial function parameters presented as % OCR post total protein 
content normalization. 
 Pre-treatment of curcumin/CNG (5) for 0, 12 and 24 hours followed by 2-hour 
exposure of 0.25mM H2O2, subsequently subjected to mitochondrial stress assay with 
real-time OCR measurements using Seahorse CF96 instrument. (A) Basal respiration. 
(B) ATP-linked to mitochondria. (C) Maximum respiration. All OCR values are 
calculated as pmol/min. N=5, error bar: std. err. 
 
Using synthesized PβAE conjugated curcumin nanogels, our aim was to improve the 
delivery of curcumin in its active and stable form at therapeutic, yet non-toxic 
concentration, with enough time to treat the site of action before being metabolized. 
With a mere change in monomer concentrations keeping the molar ratio constant, the 
nanogel diameter could be varied from 50 to 250 nm, and the spherical nature was 
confirmed by scanning electron microscopy (Figure 5.1 A). As no other competing 
monomer in front of curcumin acrylate was present to react with the tetra-functional 
amine (TTD), we expect the theoretical starting monomer composition of nanogel 
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reaction to be the final composition of synthesized nanogel, which when calculated 
gives 62.8% curcumin loading by mass. To our knowledge, this was the highest 
curcumin loading ever reported in nanocarriers.  
These nanogels were synthesized by functionalizing the alcoholic group of 
curcumin into an acrylate conjugated into cross-linked PβAEs. At this point, hydrolysis 
released curcumin in its original structural form (Figure 5.2 B). This functionalization 
and conjugation step permits the structural stability of curcumin and prevents it from 
metabolized until released, potentially solving one of the in vivo limitations. Adding to 
the stability advantage, slow and uniform degradation of CNGs avoids the occurrence 
of any burst release, even at initial time points as shown in Figure 5.2 A (15% of the 
total released in first 10 hours or 28% release in first 20 hours). This is an important 
point to consider because burst release from drug carriers or high bolus doses of free 
curcumin start a pro-oxidant effect and, rather than act as a treatment drug, can be toxic 
in vitro to healthy tissues/endothelial cells. The uniform release profile of curcumin 
during degradation also helped increase the safety limit for curcumin treatment, giving 
IC50 values of more than 100 µg/ml as compared to free curcumin with IC50 values of 
5.3 µg/ml, observed after 24 hours of treatment with HUVECs (Figure 5.3 A). This 
would provide an option to treat an injury at higher and more effective dosage levels. 
Antioxidant potential of these nanogels with respect to time during degradation 
was initially analyzed by carrying out the TEAC antioxidant activity assay on all 
degradation samples. The cumulative increase in equivalent trolox content over time 
confirmed the protection of curcumin from losing its antioxidant activity in aqueous 
media until hydrolyzed from the polymer matrix (Figure 5.2 C). In other words, the 
functionality of the drug was kept intact until released. 
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Mitochondrial functional levels confirmed lower dose dependent cytotoxicity 
compared to free curcumin and prolonged active antioxidant release of CNGs. Seahorse 
XF96 analyzer recorded real time mitochondrial OCR in response to the treatments 
and/or mitochondrial stress assays specifically developed to determine basal respiration 
rates, ATP production, spare respiratory capacity, and maximal respiration. The dose 
dependent response post 24-hour treatment with 1 and 5 µg/ml of equivalent curcumin 
in CNGs showed no negative impact on OCR levels at either concentration. However, 
mitochondrial function/OCR was completely shut down with free curcumin at 5 µg/ml 
while 1 µg/ml was observed to be a safe concentration for mitochondria (Figure 5.3 C 
and Figure 5.3 D). These results comply with the cell viability assay (50% cell death at 
5 µg/ml) but show a more acute response, thus providing an opportunity to analyze our 
material at more sensitive levels. With this understanding, non-fatal curcumin and 
curcumin nanogel concentrations, 1 and 5 µg/ml respectively (Figure 5.3 C and 5.4 D), 
were used to specifically observe any change in mitochondrial function upon induced 
OS injury without causing cell death. 
We used H2O2 for mitochondrial OS insult because H2O2 is believed to induce 
mitochondrial dysfunction via sudden increase of ROS inside the mitochondria. This 
activity results in OS initiating cell necrosis and apoptotic processes. For the Seahorse 
XF96 studies, concentration and exposure time of H2O2 were selected to affect 
mitochondrial function without reaching the cells’ necrotic or apoptotic state. This 
allowed mitochondrial respiration and energy production potential to be monitored with 
no cell death effects. H2O2 concentration of 0.25 mM with 2-hour exposure was enough 
to show a decrease in ATP production (% OCR) from 60.8 ± 5.7 to 21.6 ± 3.6, drop 
down of mitochondrial respiration from 76.0 ± 6.0 to 34.5 ± 3.0 (Figure 5.6 A and B). 
Oligomycin, FCCP and antimycinA/rotenone were used as the titrant substrates 
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(mitochondrial stress test assay) to analyze the functional state of the mitochondria post 
H2O2 ± CNG/curcumin treatment. Interestingly, upon pre-treating the cells with CNGs 
(5 µg/ml) or curcumin (1 µg/ml) for 0, 12, 24 hours before the 2-hour exposure to 0.25 
mM H2O2, curcumin nanogels were able to retain and maintain the basal respiration 
rates, leveling to non-treated controls. Also, ATP-linked and maximum respiration 
analyzed after running stress assays for all treatment time scales was also higher than 
the H2O2 injury control group. In contrast, groups with 0, 12 and 24 hours of curcumin 
pre-treatment did not help the mitochondrion maintain basal respiration, ATP-linked 
production rates or maximum respiration rates, but were similarly low compared to 
H2O2 treated groups at those treatment times. As seen in Figures 5.4 and 5.5 A, B and 
C, mitochondrial bioenergetics worsened in curcumin groups simultaneously treated 
with H2O2 (t = 0), relapsing to H2O2 levels pretreatment time increased. A synergistic 
effect of curcumin and H2O2, where the pro-oxidant effect might have increased in the 
presence of another oxidant, may explain this. At t=0, when curcumin is at 20% 
concentration of its IC50 concentration i.e., 1 µg/ml along with H2O2 starts showing the 
pro-oxidant effect which decreases as curcumin active content starts reducing down 
with time due to curcumin molecular degradation and by 24 hour, cells would encounter 
the instant effect of H2O2 only. All this suggests that CNGs are benign to both the 
mitochondrion as a PβAE polymer matrix by itself and at a higher equivalent curcumin 
loading. This is due to the slow, steady curcumin release property of CNGs. Prolonged 
protection from Mito OS for at least 24 hours confirms the release of active curcumin 
when compared to no therapeutic effects shown by free curcumin. Therefore, a 
continuous supply of active antioxidant at therapeutically effective yet non-fatal 
concentrations would be capable of scavenging excess free radicals and suppressing 
mitochondrial oxidative stress and cell apoptosis. 
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5.4  Conclusion 
Curcumin conjugated PβAE nanogels (CNGs) were synthesized, resulting in a slow and 
steady release of active curcumin molecule and an increased limit for the safe 
concentration of the drug. This work demonstrates the importance of delivery and 
controlled release upon the functional impact of biologically unstable compounds such 
as polyphenolic antioxidants. These spherical nanogels effectively suppressed 
mitochondrial OS over a 24 hour period, which was confirmed by real-time 
mitochondrial respiration state using Seahorse XF96 analyzer.   
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6 PROTECTION FROM COPLANAR AND NON-PLANAR PCBS INDUCED 
TOXICITY USING CURCUMIN CONJUGATED PβAE NANOGELS 
Abstract 
Curcumin-PβAE nanogels (CNGs) were analyzed for their therapeutic potential against 
PCB induced toxicity/oxidative stress. Extensive studies conducted by the 
Environmental Protection Agency (EPA) with these chlorinated aromatic compounds 
have shown clear evidence of their carcinogenic and toxic effects on the immune 
system, reproductive and also nervous system to count a few. As such PCBs falls into 
two categories, coplanar and non-coplanar congeners and induce immunotoxicity 
through activation of different cellular receptors. The protective effect of slow 
curcumin releasing CNGs was analyzed against both coplanar (PCB 126) and non-
coplanar PCBs (PCB 153). Since, mitochondria are a more sensitive marker to such 
environmental toxicant exposure, real time mitochondrial bioenergetics were analyzed 
in response to PCB ± CNGs exposure. A dose dependent effect of both PCB 126 and 
153 was observed after 24-hour exposure with compromised mitochondrial function as 
well as overall cellular toxicity in endothelial cells. It was also observed that PCB 153 
induced higher toxicity to endothelial cells than PCB 126. As a potential treatment 
strategy, prior treatment with curcumin-PβAE nanogels before PCB exposure resulted 
in the restoration of mitochondrial bioenergetics and cell viability. This protective 
response with curcumin-PβAE nanogels was seen with both PCB 126 and PCB153. 
These results indicate that in spite of having different mechanisms for inducing toxicity, 
oxidative stress plays an important role in both manifestations and progression of the 
adverse effects. The fact that slow curcumin releasing CNGs protected cellular and 
mitochondrial function from PCB induced oxidative stress makes them a more versatile 
approach for PCB remediation. 
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6.1 Introduction 
Concern about environmentally persistent polychlorinated biphenyls (PCBs) mediated 
chronic health effects is continuously increasing over the years [226]. A number of case 
studies have shown that prolonged exposure to these chlorinated aromatic compounds 
can result in the development of symptoms related to cancer and neurotoxicity [227-
229]. Owing to these discoveries, PCB usage in industries was banned since 1976. But 
significant quantities of these compounds persist in soil, water, sea animals and in the 
human population as well [230, 231]. One of the underlying mechanisms for the PCB 
induced metabolic toxicity is thought to be oxidative stress, which is increased 
production of reactive oxygen species (ROS) than required for normal metabolic 
activity [232]. The continuous increased production of ROS can lead to cellular and 
mitochondrial membrane dysfunction, DNA damage, and disruption of membrane 
potentials leading to uncontrolled transfer of cytosolic nutrients and other components, 
resulting in total cell disruption, apoptosis and unwanted mutations [233]. Coplanar 
PCBs such as PCB 126 are thought to exert cellular toxicity via activation of aryl 
hydrocarbon receptor (AhR) followed by uncoupling of cytochrome P450 1A1 
(CYP1A1), a potential reason for increased ROS production [234, 235]. On the other 
hand, exposure to non-coplanar PCBs activates the nuclear receptor proteins: PXR and 
CAR. Continuous activation of these proteins can lead to cellular toxicity and other 
adverse effects leading to unwanted mutations [236]. Studies have also shown evidence 
of increase in mitochondrial superoxide (O2.−) in MCF-10A and RWPE-1 epithelial cells 
post PCB 153 exposure. This again proves the increased ROS production and also 
mitochondrial dysfunction during the exposure time [237]. PCB 77, 126 and even 153 
post 6-hour exposure also induced oxidative stress in endothelial cells specifically, 
human umbilical vein endothelial cells (HUVECs). Because of the oxidative stress 
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involvement with PCB induced toxicity, antioxidants like resveratrol, quercetin, N-
acetyl cysteine, catalase, and epigallocatechin-3-gallate (EGCG) have shown potential 
to suppress oxidative stress and hence PCB induced inflammation when cells were pre-
exposed to these antioxidants before PCB administration [238-240]. An in vivo study 
performed with continuous supplements of green tea extract to mice during PCB 126 
exposure showed a significant decrease in oxidative stress markers after 12 weeks of 
exposure as compared to non-green tea extract control [241]. These findings suggest 
that metabolic PCB toxicity includes the incidence of oxidative stress significantly 
where increased mitochondrial ROS or mitochondrial oxidative stress (mito OS) plays 
an important part and that antioxidant supplementation can serve as a remedy treatment 
to the exposed subjects by suppressing oxidative stress. To further explore this PCB 
response in HUVECs, we studied the effect of coplanar PCB 126 and non-coplanar 153 
on overall cellular viability post 24-hour exposure to both kinds of PCBs and more 
importantly real time mitochondrial bioenergetics such as ATP production, maximal 
respiration rate. Response of human umbilical vein endothelial cells (HUVECs) was 
analyzed. Both of these studies showed a dose dependent decrease in viability and 
mitochondrial bioenergetics upon PCB administration. Also, pre-exposure of slow 
curcumin releasing curcumin-PβAE nanogels  (CNGs) showed significant recovery in 
cell viability as well as mitochondrial respiration upon 12 and 24-hour prior treatment, 
demonstrating the anti-inflammatory properties against PCBs (both coplanar and non-
coplanar) for a long period of time.  
6.2 Materials and methods 
6.2.1 Reagents  
 Curcumin was purchased from Chem-impex Int’l ‘Inc, (Wood Dale, IL). 4, 7, 10-
Trioxatridecane-1, 13-diamine (TTD), acryloyl chloride, triethylamine (TEA) and 
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potassium carbonate were bought from Sigma-Aldrich (St. Louis, MO). Sodium 
chloride, potassium phosphate, sodium phosphate and sodium dodecyl sulfate (SDS) 
were purchased from Fisher Scientific (Fair Lawn, NJ). Human Umbilical Vein 
Endothelial Cell line (HUVECs), EBM-2 basal medium and its growth factors were 
purchased from Lona, (Walkersville, MD). All solvents were purchased from Pharmco-
aaper (Shelbyville, KY) and were used as received unless specified. All media kit and 
cell culture plates for XF96 Seahorse experiments were purchased from Seahorse 
Bioscience (Massachusetts, USA). Calcein AM red-orange tracer was bought from 
Invitrogen (Grand Island, NY). PCB 126 and PCB 153 were bought from Accustandard. 
6.2.2 CA monomer and curcumin PβAE nanogels synthesis 
Curcumin acrylate monomer was synthesized by reaction of curcumin with acryloyl 
chloride at room temperature for 15 hours in the dark. The protocol for the reaction and 
purification was adopted as described in section 5.2.2  To synthesize curcumin PβAE 
nanogels, dried monomer product (CA) was dissolved in anhydrous acetonitrile at a 
concentration of 5 mg/ml.  A stock solution of TTD in acetonitrile at a concentration of 
1 g/ml was prepared and 11.5 µl (11.5 µg TTD), was added to 10 ml of CA solution. 
The system was allowed to react and precipitate into self-stabilized nanogels for 15-16 
hours in the dark. The nanogel suspension in acetonitrile was purified by diluting the 
suspension in anhydrous THF in the ratio of 1:4. After 2 washes, nanogels were 
suspended again in acetonitrile, centrifuged and the pellet was freeze-dried overnight 
to obtain dried nanogels. 
6.2.3 In vitro PCB toxicity 
In vitro cytotoxicity of PCB 126 and 153 on HUVECs was analyzed at three different 
concentrations after 24-hour exposure. HUVECs were seeded in a 96-well plate to 
about 80% confluency before the PCB administration. A 10 mM stock solution of both 
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the congeners (PCB 126 and PCB 153) was prepared in DMSO followed by dilution in 
EBM-2 media to a concentration of 15, 30 and 50 µM. Cells in each defined group were 
treated with 200 µl of PCB 126 and 153 solutions at the given concentration for 24 
hours.  After the treatment, incubation media was removed and all the wells were 
washed with fresh media followed by addition of 200 µl of 1 µM Calcein AM red-
orange live cell tracer. After 1 hour of incubation with live cell tracer, media was 
removed from each well and fresh media was added. Fluorescence for the plate was 
read with excitation/emission wavelengths of 540/590 nm using BioTek Synergy Mx, 
Gen5 2.0, Winooski, VT fluorescence spectrophotometer to determine the viability of 
the cells post PCB exposure.  
6.2.4 Effect of CNG treatment on PCB induced toxicity 
Protection from PCB induced toxicity or cell death with the help of CNG was also 
analyzed after different antioxidant pre-exposure times. HUVECs were pre-treated with 
10 µg/ml of CNGs for 0, 12 and 24 hour followed by 24-hour exposure to 50 µM PCB 
126 or 153. Cells were subjected to Calcein AM red-orange fluorescence assay post 
exposure to analyze the cell death due to PCB ± CNG after different pre-treatment 
times. 
6.2.5 Measurement of real-time mitochondrial bioenergetics due to PCB 
exposure, with and without CNG  
Seahorse XF-96 Flux Analyzer (Seahorse Bioscience, North Billerica, MA) was used 
to monitor real-time respiration rates of mitochondrion after PCB 126 and 153 exposure 
for 24 hours and also any protective effect due to CNG treatment. By measuring oxygen 
consumption rates (OCR) and extracellular acidification rates (ECAR) with time, 
various mitochondrion respiratory parameters of treated cells were analyzed including 
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basal respiration, ATP production rate, maximum respiration rates and spare respiratory 
capacity using mitochondrial stress assay.  
To carry out the experiment, HUVECs were 1st seeded in a Seahorse 96-well tissue 
culture plate at a seeding density of 35000 cells/well. Cells were allowed to adhere 
overnight, after which different combinations of PCB ± CNGs treatment were given.  
6.2.5.1 Effect of PCB exposure on HUVECs 
As a first step, HUVECs were treated with 15, 30 and 50 μM of PCB 126 or 153 for 24 
hours, after which cells were subjected to the mitochondrial stress assay. Prior to the 
assay, cells were washed and the medium was replaced with 175 μL of FX media (FX 
Assay Modified DMEM from Seahorse Bioscience with 5.5 mM Glucose, 1 mM 
Pyruvate, and 2 mM Glutamix). Cells were incubated at 37° C in CO2 free incubator 
after which the cells were subjected to the stress assay. The mitochondrial stress assay 
consists of series of injections of inhibitor drugs: (A) Oligomycin A (1 µM), which act 
as ATP synthase inhibitor; (B) FCCP (1 µM), an uncoupling agent; and (C) a mixture 
of 1 µM Rotenone and 1 µM Antimycin A, each used as inhibitors for mitochondrial 
respiratory chain complex I and III to shut down the mitochondrial oxygen 
consumption. OCR and ECAR were measured for 3 minutes with 3 minutes interval 
cycles. The inhibitor drugs were injected in series of A, B and C after the 3rd cycle of 
the previous one. 
After the measurement was completed, the protein content in each sample was 
determined using BCA assay (Thermo Scientific, Rockford IL). Therefore, post stress 
assay, media was removed from all the wells and replaced with 25 µL of cell lysis buffer 
containing 0.32 mM Sucrose, 2 mM EDTA, 2 mM EGTA, 20 mM HEPES, pH 7.4, 
containing protease inhibitors 4 μg/mL leupeptin, 4 μg/mL pepstatin, 5 μg/mL 
111 
 
  
aprotinin, and 0.2 mM PMSF and plates were stored in -20o C overnight to lyse the cell 
membrane. 
Plates were taken out the next day and thawed to room temperature and put on an orbital 
shaker for an hour. Known amounts of protein standards (2.5 μg, 5.0 μg, 10 μg etc.) 
were added in the background wells of the plate to construct an optical density standard 
curve. Unknown protein levels of the samples were determined by measuring optical 
density using an iMark plate reader (Bio-Rad, Hercules, CA). Finally, the obtained 
OCR values as pmol/min were normalized to protein levels as pmol/min/μg and finally 
calculated as percent change (%OCR) from the third basal measurement for each group.  
6.2.5.2 Analysis of protective effect of CNGs against PCB induced mitochondrial 
toxicity 
To analyze the protective effect of CNGs against PCB-induced cytotoxicity or cellular 
oxidative stress, HUVECs seeded at a density of 35000 cells/well were first pre-
incubated with 5 μg/ml of CNGs suspended in EBM-2 media for 12 and 24 hours. 
Media from the well plates was removed and a solution of PCB 126 or PCB 153 
prepared in EBM-2 media at a concentration of 30 μM was added to the pre-treated 
cells for 24 hours. Cells were then subjected to the mitochondrial stress assay. The same 
protocol for mito stress assay was followed as discussed in section 6.3.4.1 for just PCB 
exposure. Basal respiration, ATP production, maximum respiration and spare 
respiratory capacity for each treatment groups were again calculated in terms of percent 
OCR after protein normalization. 5 μg/ml concentration of CNG was used after 
verifying it to be a viable concentration for mitochondrial bioenergetics, while 30 μM 
of PCBs was used in order to disturb the mitochondrial bioenergetics but not shut down  
down the cellular metabolism completely. 
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6.3 Results 
6.3.1 Measurement of cell toxicity after 24 hour PCB 126 and 153 exposure 
6.3.1.1 Cell viability 
After 24-hour exposure of PCB 126 or 153 to HUVECs, dose dependent toxicity was 
observed for both PCB congeners. Cell viability of PCB 126 exposure at 15, 30 and 50 
μM was calculated to be 93 ± 4.7, 89 ± 2.5 and 79.8 ± 5 % of non-treated controls 
respectively (Figure 6.1). On the other hand, PCB 153 was found to show higher 
toxicity than PCB 126 at the same concentrations and cell viability post exposure was 
found to be 97.9 ± 2.5, 74.4 ± 0.6 and 45.6 ± 4.5 % of non-treated controls for 15, 30 
and 50 μM respectively (Figure 6.1).  
 
Figure 6.1 HUVECs viability after 24-hour PCB 126 and 153 exposures. 
Cell Viability was determined using Calcein AM red-orange live cell tracer. Dose 
dependent exposure showed a decrease in viability with an increase in PCB 
concentrations. N=5, error bars: std. dev. 
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6.3.1.2 Mitochondrial bioenergetics 
A more acute response on mitochondrial bioenergetics was observed at 30 and 50 μM 
after 24-hour exposure with basal respiration, ATP production rates, maximum 
respiration and spare respiratory capacity as well, when compared with cell viability at 
similar exposure concentrations. Here also, PCB 153 showed more acute response than 
PCB 126 at same concentrations (Figure 6.3). While basal respiration rates for PCB 
126 as percent OCR were 76 ± 5, 53 ± 6 and 60 ± 5 after 24-hour exposure of 15, 30 
and 50 μM respectively, PCB 153 exposure under similar conditions resulted in an 
intense response of 74 ± 3, 49 ± 7 and 0 % OCR at given increasing concentrations 
(Figure 6.3). These OCR values for 30 and 50 μM were found to be significantly lower 
than the non-treatment control with basal respiration of 78 ± 5. In the case of ATP-
linked with mitochondrial respiration, % OCR of 47 ± 7, 40 ± 3 and 28 ± 3 for PCB 
126; for PCB 153, 59 ± 4, 15 ± 12 and 0 was calculated after 15, 30 and 50 μM exposure 
respectively (Figure 6.3). Calculating maximum respiration gave the value of 183 ± 6, 
145 ± 6 and 161 ± 3 for PCB 126; 179 ± 10, 82 ± 38 and 0 for PCB 153 with increasing 
concentrations mentioned above (Figure 6.3). Spare respiratory capacity was also 
calculated as % OCR 116 ± 10, 77 ± 12 and 78 ± 6 for PCB126; 104 ± 10, 53 ± 21 and 
0 for PCB153 at increasing concentrations of 15, 30 and 50 μM respectively (Figure 
6.3).  
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Figure 6.2 Mitochondrial oxygen consumption rate profile observed during 
mitochondrial stress assay.  
All the bioenergetics shown in figure 6.3 and 6.5 were calculated according to the 
schematic shown in this figure.  
 
 
Figure 6.3 Mitochondrial bioenergetics parameters of HUVECs after 24-hour 
exposure to variable concentrations of PCB 126 or PCB 153.  
The cells were subjected to the mito stress assay measuring real-time OCR values using 
Seahorse XF96 instrument. All the parameters after the assay were calculated in 
accordance with figure 6.2. N=5, error bars: std. err. 
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6.3.2 Protection from PCB 126 and 153 induced toxicity using CNG 
6.3.2.2 Cell viability  
A higher concentration of PCBs (i.e. 50 μM) was used in an in vitro cell viability assay 
in order to get a significant difference in response with respect to non-treated controls. 
As seen in figure 6.4, PCB 126 after 24-hour exposure resulted in 50% cell death while 
PCB 153 showed 98% cell death. Increasing cellular viability was observed with 
increase in CNG pre-exposure time and with 24-hour pre-exposure, cell viability was 
increased to 83 ± 6% for PCB 126 exposed cells and 11 ± 2 for PCB 153 exposed cells.  
 
Figure 6.4 HUVECs viability analyzed after 0, 12 and 24-hour exposure to CNGs 
followed by 24-hour exposure to 50 μM PCB 126 or PCB 153.  
Viability was determined using Calcein AM red-orange live cell tracer. 24-hour CNGs 
pre-exposure significantly increased % live cells post PCB 126 or 153 exposures 
showing effective protection against PCB induced toxicity. N = 5, error bars: std. dev. 
 
6.3.2.3 Mitochondrial bioenergetics 
To analyze the protective effect of CNG on mitochondrial function due to PCB 126 and 
153 exposures, HUVECs were exposed to 5 μM  (equivalent curcumin loading) CNGs 
for 12 and 24 hours, post which cells were washed and incubated with 30 μM of PCB 
for another 24-hour (Figure 6.5). CNGs after both 12 and 24-hour pre-exposure showed 
partial restoration of healthy mitochondrial functions for all its bioenergetics properties. 
Table 6.1shows the % OCR values for basal respiration, ATP-linked to the 
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mitochondrion, maximum respiration rates and spare respiratory capacity for the treated 
samples.  
 
Figure 6.5 Mitochondrial bioenergetics of HUVECs after 12 and 24-hour exposure 
of CNGs followed by 24-hour exposure to 30 μM PCB 126 or 153.  
CNG were washed off the wells prior to PCB incubation. The cells were subjected to 
mito stress assay measuring real-time OCR values using Seahorse XF96 instrument. 
All the parameters after the assay were calculated in accordance with figure 7.2. N = 
5, error bars: std. err. 
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Table 6.1 Mitochondrial bioenergetics after PCB ± CNGs exposure to HUVECs as 
% OCR after protein normalization.  
CNGs pre-exposure for 12 and 24 hours resulted in partial restoration of healthy 
mitochondrion function showing the protective effect of CNGs on PCB induced toxicity. 
N = 5, error bars: std. err. 
 
  - CNGs + CNGs 
  CNG pre-exposure time   12 h 24 h 
Basal 
respiration 
Control 71 ± 5 -  80 ± 10 
PCB 126 54 ± 5 65 ± 6 62 ± 2 
PCB 153 47 ± 4 60 ± 12 65 ± 4 
  
ATP linked 
Control 49 ± 3  - 54 ± 7 
PCB 126 37 ± 6 52 ± 5 43 ± 3 
PCB 153 28 ± 8 44 ± 7 47 ± 11 
  
Maximum 
respiration 
Control 194 ± 4  - 207 ± 23 
PCB 126 134 ± 10 180 ± 13 188 ± 11 
PCB 153 126 ± 21 174 ± 12 218 ± 26 
  
Spare 
respiratory 
capacity 
Control 122 ± 2  - 166 ± 34 
PCB 126 80 ± 6 113 ± 7 118 ± 6 
PCB 153 58 ± 24 114 ± 13 116 ± 12 
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Figure 6.6 Mechanism of free radical production due to intracellular PCB 
metabolism for coplanar PCBs resulting in mitochondrial oxidative stress and finally 
cell death. 
6.4 Discussion 
PCB induced toxicity is not an immediate or acute effect but a long term event of slow 
cellular dysfunction that aggravates over time and leads to major metabolic disorder 
eventually. This is because it is found at very low concentrations in soil, water, air and 
sea animals. The underlying cause for this chronic response is due to development of 
119 
 
  
an oxidative stress (OS) condition via different activation pathways. OS is an 
imbalanced metabolic redox state in the body with increased oxidants or free radical 
species/reactive oxygen species (ROS) concentrations. A simple mechanism is depicted 
in figure 6.6, where superoxide anion produced due to enzymatic action 1st results in 
mitochondrion OS (most prone sight for increased free radical production), dysfunction 
of which ultimately leads to cell death. 
To analyze the oxidative damage due to PCB exposure, HUVECs were subjected to 
PCB 126 and 153 exposure for 24-hour at variable concentrations, which resulted in 
increased toxicity with increasing concentrations (Figure 6.1). A more acute response 
was observed at a mitochondrial level as compared to overall cellular function (Figure 
6.3). This is because, oxidative stressed induced mitochondrial dysfunction occurs prior 
to overall cellular toxicity. Therefore, monitoring mitochondrial bioenergetics served 
as a sensitive marker to study the acute response due to these chemical pollutants. Use 
of Seahorse Bioscience XF96 further aided the analysis because of its ability to monitor 
mitochondrial respiration in real time, a novel and non-invasive strategy for the in vitro 
systems.  
Further, the loss in mitochondrial function was more severe with PCB 153 (non-
coplanar) as compared to PCB 126 (coplanar), where at 50 μM, cells completely lost 
its mitochondrion function shutting down the metabolic activities. This is opposite to 
few studies in the literature showing more acute toxic effects due to coplanar PCBs 
(PCB 77, 126 etc) than non-coplanar ones.  A possible explanation to these observations 
could be because most studies concentrated on analyzing the response by quantification 
of AhR activation, which is well known and induction path for coplanar PCBs but not 
for non-coplanar [242] [243]. But there have been other evidence showing toxic nature 
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of PCB 153 via nuclear receptor proteins, chronic activation of which can result in 
various disease syndrome and has been associated with breast cancer etc [227, 244].  
As both the toxicity induction routes involve excess production of ROS, administration 
of curcumin through conjugated prodrug PβAE nanogels (CNGs) system served as a 
potential solution to prevent oxidative damage. These nanogel formulations are 
hydrolytically degradation systems with steady and prolonged drug release kinetics. 
Therefore, treating HUVECs with CNGs prior to PCB exposure showed reduced 
toxicity as compared to only PCB treated controls (Figure 6.4). The effect was more 
pronounced at the mitochondrial level, where partial to full recovery of mitochondrial 
bioenergetics (basal respiration, ATP-linked, maximum respiration, spare respiratory 
capacity) was seen with CNGs pre-treated groups (Figure 6.5). Also the fact that CNG 
administration was able to inhibit mitochondrial as well as cellular toxicity due to both 
coplanar and non-coplanar PCBs indicates the presence of oxidative stress in the injury 
path, irrespective of the different receptors being activated. Hence, administration of 
curcumin via CNGs becomes an adaptable approach to remediate cellular toxicity due 
to all kinds of PCBs.  
Another possible pathway behind inhibition of PCB induced toxicity would be direct 
capturing of PCBs by polyphenolic curcumin via pi-pi bond interactions. This will 
inhibit the interaction of chlorinated compounds with cellular components, thereby 
reducing the possibility of fatal metabolic response.    
6.5 Conclusion 
PCB 126 and PCB 153 both showed toxic effects towards HUVECs, compromising 
mitochondrial function after 24-hour exposure at variable concentrations. PCB 153 
showed more acute response than PCB 126 which complies with a few studies in the 
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literature while opposes most of the other studies with toxicity comparisons of coplanar 
and non-coplanar. Irrespective of this difference, curcumin conjugated PβAE nanogels 
(CNGs) with the slow and steady curcumin release property were able to suppress both 
mitochondrial as well as overall cell toxicity. This response is thought to be through 
either or a combination of two mechanisms, which includes suppression of oxidative 
stress due to antioxidants and capturing of PCBs by curcumin through physical pi-pi 
interactions. 
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7 SYNTHESIS AND CHARACTERIZATION OF CURCUMIN PβAE GEL 
MICROPARTICLES TO TREAT ORAL MUCOSITIS 
Based on the research article to be submitted: 
 Prachi Gupta, Sandeep Ramineni, J. Zach Hilt, Thomas Dziubla, Joseph Wyse, 
Nihar Shah, Curcumin conjugated Poly (β-Amino Esters) gel microparticles to treat 
oral mucositis (Biomaterials) (to be submitted) 
Note: The information in this chapter is the intellectual property of Bluegrass Advanced 
Materials LLC., not be disclosed in public. 
Abstract 
Oral mucositis (OM) is a very common and serious side effect of anti-cancer radiation 
and chemotherapies that manifests as deep and painful mouth ulcers. Oxidative stress 
(OS) is one of the key underlying mechanism in the development of OM. Therefore, 
curcumin (an antioxidant) has been extensively studied as an antioxidant and anti-
inflammatory agent towards OS treatment. In the case of OM, it has shown positive 
signs towards delaying the onset and also reducing the severity of OM. However, it 
requires about 4-5 rinses per day, a total dosage ranging from 1-3 g per day, to stay in 
the therapeutic window for treatment. This is because of a combination of fast 
metabolism, rapid degradation and poor aqueous solubility of the hydrophobic 
antioxidant. In order to improve the bioavailability of this drug in buccal tissues and 
improve patient compliance, curcumin was converted into biodegradable curcumin-
poly(beta-amino ester) (PβAE) polymer (poly(curcumin)) microparticles. These 
poly(curcumin) microparticles provide slow sustained release of the original active 
curcumin.  Synthesized via Michael addition, acrylate functionalized curcumin 
(curcumin acrylate (CA)), PEGDA (co-monomer), and TTD (primary diamine 
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crosslinker) were reacted together into a PβAE polymer film and cryogenically milled 
into microparticles in the range of 20-25 μm. Poly(curcumin) formulations were 
prepared with different co-monomer molar ratios (CA v/s PEGDA) showed variable 
release profiles of active curcumin. Poly(curcumin) microparticles with a molar ratio 
of 70:30 CA:PEGDA and RTAAP of 1.0 showed the best combination of drug release 
profile and adhesion to buccal tissues. This selected formulation further showed 
prolonged protection against H2O2 induced oxidative stress in vitro with normal human 
dermal fibroblasts. A preliminary in vivo study in Syrian hamsters induced with OM in 
their cheek pouches showed that treatment with poly(curcumin) microparticles reduced 
the severity of induced OM, protein carbonyl content, and epithelial layer damage. 
7.3 Introduction 
Oral mucositis is a pathological condition in patients undergoing cancer treatments 
resulting in inflammation of oral mucosa, which manifests as oral ulceration, erythema, 
and severe pain. The discomfortness is a long-term and persistent response to patients 
undergoing chemo- and/or radiation therapies as anti-cancer treatments [245]. This 
response usually occurs after 7-10 days of undergoing anti-cancer treatment, peaks at 
about 7-9 weeks after beginning of the therapy and persists for up to 2-10 weeks after 
the end of the treatment depending on the patient’s physical conditions and type of 
therapy [245, 246]. Though a side effect, this oral pain impacts the food intake of the 
patient, leads to oral infections, dehydration, weight loss, sometimes requiring extended 
hospitalization and even forcibly stalling the cancer treatment in between. On an 
average about 5-15% of the patients undergoing any kind of anti-cancer therapy suffer 
from OM. More acutely, 40% of the subjects getting treated with 5-fluorouracil and 
about 50% with radiotherapy tend to get OM [247]. The severity increases with patients 
suffering from head and neck cancer where 100% of the patients receiving cancer 
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treatment suffer from this condition of OM [248]. Therefore, there has been a 
continuous need for treatment and prevention of OM. Though the standard care 
procedures include the use of palliatives including intravenous narcotic analgesics, 
lubrication and analgesic mouth rinses (lidocaine), these have shown poor efficacy and 
low patient compliance [249-251]. Palifermin has been the only drug approved by FDA 
to be administered to the patients undergoing anti-cancer therapy [252]. Palifermin, 
which is keratinocyte growth factor-1 (KGF-1), is thought to inhibit epithelial cell 
damage, down-regulating pro-inflammatory cytokines as well as enhancing the growth 
rate of epithelial cells during the infectious state [253, 254]. Besides being selectively 
effective in patients suffering from hematological malignancies, Palifermin is an 
expensive drug with an average cost of about 8000 euros per treatment for a 70 kg 
patient over 6 days [255]. Other palliative treatments are also provided to patients, like 
Mugard and NeutraSal in the form of oral rinse or gels.  These can temporarily soothe 
the oral discomfort conditions and provide primarily pain management solutions but 
not treatment or curing solutions [256-258]. Practically no single preventive or curative 
measure without side effects or limitations yet effective for the diverse population has 
been found and approved towards oral mucositis while research still continues to find 
the basic cause and solution to the problem. 
Studies have shown that the long duration curve of this disease shows some lasting 
effects or morphological changes in the tissues apart from the acute toxicity resulting 
in instant cell death.   The longer effect of OM is thought to be arising via a complex 
trajectory of biomolecular, cellular changes leading to epithelial layer damage and sub-
epithelial cells damage associated with upregulation of nuclear factor kappa beta 
(NFkB) and interleuken-1 [259, 260]. These phenomena can be considered as a sensor 
to oxidative stress (OS) where the physiological environment or the cellular matrix 
125 
 
  
encounters an increased production of free radicals or ROS. The increased ROS 
production is a cyclic cascading event resulting in an imbalanced redox state of the cell. 
This leads to DNA, cellular membrane damage and finally cell apoptosis and necrosis, 
inhibiting epithelial layer proliferation ultimately resulting in ulceration [261]. Hence, 
OS is one of the base causes of the initiation and propagation of the OM until the body 
comes into its state of fighting OS naturally or by providing enough antioxidants to 
restore the redox balance [262]. 
A few studies have shown that certain drugs/molecules with antioxidant properties like 
hyaluronic acid (HA), vitamin E, curcumin and green tea extracts like epicatechin can 
control the symptoms of OM. For example, a human trial with Gelclair (0.2% HA 
containing gel) showed occurrence of fewer ulcers after day 5 of treatment as compared 
to placebo. The underlying mechanism for this response is thought be due to the anti-
inflammatory nature of HA which upon rinsing coats the oral mucosa, enhances tissue 
hydration and helps in decreasing inflammation [263]. Similarly, curcumin, extracted 
from the spice turmeric has also been investigated for its antioxidant effect towards 
treatment and prevention of OM. In a recent pre-clinical trial with beta-radiated rats, 
administration of curcumin via oral gavage showed reduced incidence and severity of 
OM due to inhibition of the activation of NF-kB factor [264, 265]. Similarly a recent 
human clinical trial with subjects given turmeric mouth rinses showed delayed as well 
as reduced intensity of radiation-induced OM at all times during the treatments as 
compared to the placebo controls due to the presence of curcuminoid elements in 
turmeric. But this treatment required multiple dosage regimes of oral rinsed  4 times a 
day every 4 hours to see the effective treatment against OM [266-268]. Curcumin as a 
polyphenolic molecule undergoes rapid metabolization and shows low bioavailability 
once administered into the physiological environment [269-272]. This quick loss of 
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drug upon administration force the patient to go for multiple dosing frequency in order 
to stay in the therapeutic window. This becomes a cumbersome treatment process for 
patients already undergoing cancer therapy and can sometimes become a barrier during 
chemo or radiation treatments. Therefore, as a proposed solution, in this work we have 
aimed at formulating a mucoadhesive system with hydrolytically biodegradable PβAE 
poly (curcumin) gel microparticles,  These polymer microparticles are tuned to release 
curcumin uniformly over 12-16 hours in order to fight and protect against oxidative 
stress  induced OM during cancer therapies. The prolonged delivery would increase the 
efficacy in treating OM and improve the patient compliance in the long run, decreasing 
the dosage frequency to as low as once a day. To formulate the curcumin conjugated 
PβAE microparticles, phenolic groups of curcumin were 1st functionalized into 
acrylates forming curcumin acrylate (CA). CA was then covalently conjugated with 
TTD and its co-monomer PEGDA into PβAE gel films via Michael addition reaction. 
The advantage of using PΒAE chemistry lies behind (i) its property of getting 
hydrolyzed in an aqueous environment (ii) ability to tune polymer degradation based 
on the hydrophilic/hydrophobic nature of the monomers and (iii) protection of the 
active alcoholic groups of curcumin until released due to ester hydrolysis. Further 
synthesized gel films were cryo-ground into microparticles and suspended in a 
mucoadhesive solution, which served as a mouth rinse carrier to deliver the 
poly(curcumin) microparticles. These micron-sized particles showed tunable 
degradation properties by varying the molar ratios between curcumin acrylate and 
PEGDA. A continuous and steady release of active curcumin ranging from 12-24 hours 
was observed for different PΒAE gel microparticle formulations. The poly(curcumin) 
microparticles were observed to be relatively less toxic than free curcumin towards 
normal human dermal fibroblasts (NHDF). Also, they did not show any negative or side 
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effect when administered to healthy hamsters for 10 days, implying a viable nature of 
the system in vivo. Adding to this, these microparticles showed protection against 
induced oxidative stress, in vitro for over 36 hours. Suspending the microparticles in a 
pre-formulated mucoadhesive solution allowed ease for local delivery of curcumin to 
buccal tissues of hamsters. Giving a daily rinse of this suspension over 10 days showed 
reduced severity of OM in chemotherapy-induced OM hamsters. 
7.4 Materials 
All the solvents received were ACS/HPLC grade and were used as received. Other 
chemicals were also used as received without any further purification. Curcumin was 
purchased from Chem-Impex International, Inc, Wood Dale, IL. 4,7,10-
Trioxatridecane-1,13-diamine (TTD) (97% purity), poly(ethylene glycol) diacrylate 
(PEGDA, average molecular weight 575), acryloyl chloride (≥97%, ~400 ppm 
phenothiazine stabilizer), anhydrous potassium carbonate, magnesium stearate, 2,2′-
azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), Trolox, 2,7-
dihydrodichlorofluorescein (H2DCFDA), 2,4-dinitrophenylhydrazine (DNPH), 
trichloroacetic acid (TCA), guanidine hydrochloride, and bovine serum albumin (BSA) 
were bought from Sigma-Aldrich, St. Louis, MO. Sodium chloride, potassium 
phosphate, sodium dodecyl sulfate (SDS) and potassium thiocyanate was purchased 
from Fisher Scientific. Sodium hydroxide was purchased from EMD Millipore, 
Billerica, MA. Potassium chloride, potassium phosphate monobasic, sodium phosphate 
dibasic heptahydrate, calcium chloride dihydrate, and citric acid were purchased from 
Amresco, Solon, OH. Sodium phosphate dibasic dodecahydrate and triethylamine 
(TEA) (99%) was purchased from Acros Organics, NJ. Ham’s F-12 media with L-
glutamine and without phenol red was purchased from Caisson Laboratories Inc., 
Smithfield, UT. Pen/strep/fungizone as a media supplement was purchased from Lonza, 
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Walkersville, MD. Calcein AM red-orange was purchased from Life Technologies, 
Carlsbad, CA, All solvents were purchased from Pharmco-Aaper, Shelbyville, KY and 
were used in anhydrous form by drying over 4Å molecular sieves. Noveon AA-1 and 
Carbomer 971P NF were generously gifted by Lubrizol Corporation, Cleveland, OH. 
Eudragrit L100 was gifted by Evonik Industries, Tippecanoe, IN.  Porcine buccal 
tissues were obtained from Animal Technologies Inc., Tyler, TX. 
7.5 Methods 
7.5.1 Synthesis of curcumin acrylate 
Functionalization of hydroxyl (-OH) groups of curcumin into acrylate esters was done 
by reacting curcumin with acryloyl chloride as described in Wattamwar et al [178] with 
few process variations. Briefly, acryloyl chloride (19.8 ml, 0.2442 moles) was added 
dropwise to a solution of curcumin (30 g, 0.0814 moles) and trimethylamine (TEA, 
34.1 ml, 0.2442 moles) in anhydrous tetrahydrofuran (THF), stirring continuously at 
300 rpm. The reaction vessel was kept in an ice bath during the addition of acryloyl 
chloride in order to dissipate heat generated from the exothermic reaction of acryloyl 
chloride with curcumin. After purging the reaction vessel with ultrahigh purity nitrogen, 
the reaction was allowed to proceed for about 16-18 hours in dark at room temperature. 
The resultant product was vacuum filtered to remove the TEA-Hydrogen chloride salt. 
The THF was evaporated under vacuum to obtain a semi-dry orange to a light brown 
impure product. The product was re-dissolved in dichloromethane (DCM) and washed 
with 3x volume excess of hydrochloric acid (0.1 M in DI water) followed by potassium 
carbonate (0.1 M in DI water) to remove excess TEA and acryloyl chloride respectively. 
Residual water was removed by adding anhydrous magnesium sulfate to the DCM 
solution, which was removed by vacuum filtration at the end. The DCM was evaporated 
using vacuum for 16-18 hours to obtain dry, crystalline, orange colored microparticles 
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of curcumin acrylate (CA). The CA product was stored desiccated at -20°C until further 
use. The CA was characterized using reverse-phase HPLC (Shimadzu Prominence) 
with a Phenomenex Luna C18 column (4.6 x 250 mm, 5 µm particles) with 0.1% w/w 
phosphoric acid in DI water and acetonitrile as the mobile phase. The products (residual 
free curcumin, monoacrylate, diacrylate and triacrylate) were detected at 420 nm using 
a UV-Vis detector (SPD-20A) attached to the HPLC. 
7.5.2 Synthesis of poly(curcumin) film 
Crosslinked poly(curcumin) PβAE films were synthesized via a single-step Michael 
addition reaction between curcumin acrylate and the primary diamine crosslinker, 4, 7, 
10-Trioxatridecane-1, 13-diamine (TTD). PEGDA was added as a diacrylate co-
monomer to control the hydrophilicity and hence the degradation characteristics of the 
resulting films. Poly(curcumin) films with four different ratios of CA: PEGDA with 
respect to number of acrylate groups, 60:40, 70:30, 90:10 and 100:0, were synthesized. 
For example, in the 60:40 film, 60% of the acrylate groups were contributed by CA 
versus 40% by PEGDA. These films and subsequently their microparticles will be 
abbreviated as C60, C70, C90 and C100 respectively. The molecular weight of CA was 
taken as 476.47 g/mole which is the molecular weight of its diacrylate form. Finally, 
the amount of TTD required to synthesize the films was calculated based on three 
different ratios of total acrylate groups to amine protons (RTAAP) of 0.8, 1.0 and 1.2. 
As an example, a C60 poly(curcumin) film with RTAAP of 1.0 and target mass of 2 g 
was synthesized by dissolving 0.913 g of CA in 1.5 ml of anhydrous methyl ethyl 
ketone (MEK). PEGDA (0.735 g) and TTD (0.352 g) were reacted together for 5 
minutes in 1.5 ml of MEK separately. After 5 minutes, the CA solution was quickly 
added to the reacting PEGDA-TTD solution while gently vortexing the PEGDA-TTD 
solution at low rpm. This reacting solution was quickly poured into an aluminum dish, 
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covered with foil and allowed to react for 1 hour at room temperature. After 1 hour, the 
aluminum dish was incubated at 50° C for another 23 hours, after which the crosslinked 
poly(curcumin) film was peeled off from the dish for further processing. A similar 
procedure was followed to synthesize C70, C90 and C100 PΒAE films with three 
different RTAAP values (0.8, 1.0 and 1.2). 
7.5.3  Washing and cryogenic milling of poly(curcumin) Films 
7.5.3.2 Extraction of leachables 
All freshly synthesized poly(curcumin) films were washed in anhydrous acetone to 
leach out any unreacted monomers and un-crosslinked components. Each film was 
placed in a 50 ml centrifuge tube, filled with 20 ml of acetone and covered with foil. 
The sealed tube was rotated at 25 rpm for 4 hours with the acetone replaced every hour. 
Every hour, an aliquot of the acetone containing the leachable from each tube was 
stored at -20° C for quantification of the lost curcumin using UV-Vis 
spectrophotometry. After washing, the films were lyophilized to remove residual 
solvent. 
7.5.3.3 Cryogenic milling 
The washed and lyophilized poly(curcumin) films were milled into microparticles 
under cryogenic conditions using a SPEX SamplePrep 6770 Freezer/Mill. Briefly, a 
film was cut into smaller pieces and loaded into the grinding vial assembly along with 
1% w/w magnesium stearate (as a glidant). The loaded sample was pre-cooled under 
liquid nitrogen for 2 minutes followed by milling for 10 minutes with the stainless steel 
impactor moving at a speed of 15 cycles per second. After the milling cycle was 
complete, the vial assembly containing the poly(curcumin) microparticles was wrapped 
in paper towels and allowed to equilibrate to room temperature for about 1 hour. The 
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microparticle sample was then retrieved and the mass noted. The microparticle samples 
were stored desiccated at -20° C until further use. 
7.5.4  Particle size characterization 
The particle size distribution of the poly(curcumin) microparticle formulations was 
analyzed using a Shimadzu SALD-7101 UV particle size analyzer operated using 
WingSALD software (ver. 1.02, Shimadzu). The refractive index was set to 1.4. The 
quartz cuvette was filled with DI water and used to blank calibrate the instrument. Next, 
about 2-3 mg of microparticle sample was added to the cuvette, mixed with the provided 
L-shaped stirrer and then sonicated for 2 minutes. The sample was measured in the 
instrument under stirring. The instrument software automatically provided the mean 
particle size and the size distribution for each sample. Each sample was measured in 
triplicate. 
7.5.5 Poly(curcumin) microparticle degradation and curcumin release 
Five milligrams of the poly(curcumin) microparticle sample were suspended in 10 ml 
of phosphate buffered saline (PBS, pH 7.4) by bath sonication for 2 minutes. Since 
curcumin has poor solubility in water, 0.1% w/w sodium dodecyl sulfate (SDS) was 
added to the PBS to ensure complete solubility of the released curcumin. The sample 
suspension was incubated at 37° C in a water bath with shaking at 70 rpm. Every 2 
hours, the suspension was centrifuged at 5000 rpm for 5 minutes and the supernatant 
was withdrawn and stored at -20° C for further analysis. The microparticle pellet was 
re-suspended in the same volume of fresh buffer. This step was repeated until 24 hours 
or until the poly(curcumin) sample had completely degraded. The collected 
supernatants were analyzed using a Varian Cary 50 Bio UV-Vis spectrophotometer 
with the absorbance measured at 420 nm (peak absorbance wavelength of curcumin). 
A few of the supernatant samples were also analyzed using HPLC to verify the release 
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of the original curcumin molecule by comparison with the chromatogram of curcumin 
standards. 
7.5.6  Antioxidant activity of released curcumin 
We utilized the trolox equivalent antioxidant capacity (TEAC) assay to quantify the 
antioxidant activity of the curcumin released after degradation of the poly(curcumin) 
microparticle formulations [273]. The TEAC assay is a colorimetric assay used to 
determine the antioxidant capacity of samples based on the suppression of the 
absorbance of 2, 2’-azinobis-(3-ethylbenzothiazoline-6-sulfonate) (ABTS●+) radical 
cations by antioxidants. Briefly, a 7 mM ABTS●+ radical solution was prepared by 
reacting equal volumes of solutions of ABTS (8 mg/ml) and potassium persulfate (1.32 
mg/ml) in DI water for 16-20 hours. The ABTS●+ radical solution was diluted in PBS 
to obtain an absorbance not exceeding 0.4 at 734 nm for a 200 µl sample in a 96-well 
plate. This diluted solution was used as the working solution for the assay. For the 
assay, 10 µl of trolox standard solutions (concentrations ranging from 0-0.225 mM) 
prepared in PBS and the degradation samples were added to individual wells of a 96-
well plate. To these wells, 200 µl of the ABTS●+ working solution was added and 
allowed to sit for 5 minutes in dark. After 5 minutes, absorbance was measured at 734 
nm. The absorbance of the trolox standards was used to generate a standard calibration 
curve, which was used to calculate the equivalent trolox concentration for the 
poly(curcumin) degradation samples. 
7.5.7 In vitro cytotoxicity assay 
Primary normal adult human dermal fibroblasts (NHDF) bought from PromoCell 
GmbH, Heidelberg, Germany were cultured in Ham’s F-12 medium supplemented with 
10% v/v fetal bovine serum (FBS) and 1% v/v Pen/Strep/Fungizone at 37° C in a 5% 
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CO2 incubator. NHDF that were purchased at passage 1 (P1) were grown until P4 and 
then used for experiments between P5 and P8. 
Cells were seeded at 8000 cells/well in a 96-well plate and incubated overnight. 
Poly(curcumin) microparticles with equivalent curcumin concentrations ranging from 
0 to 500 µg/ml were suspended in cell culture medium. Solutions of free curcumin at 
equivalent concentrations were also prepared in cell culture medium. 200 µl of test 
suspensions and solutions were pipetted onto the cells in the 96-well plates (n=5 per 
treatment group). After incubation for 24 hours at 37° C in a 5% CO2 atmosphere, the 
cells were washed with fresh medium, followed by addition of 200 µl calcein AM red-
orange cell viability dye (1 µM in Ham’s F-12 medium) as a live cell tracer. Calcein 
AM red-orange is a mildly fluorescent molecule which upon internalization by cells is 
converted into the highly fluorescent calcein by cleavage of the acetoxymethyl ester 
group by intracellular esterases typically found only in live cells. Measurement of the 
fluorescence intensity can be used to quantify and compare the viability of the cells 
exposed to various treatments. After incubation for 1 hour, the cells were washed once 
more with fresh medium followed by addition of 200 µl of fresh medium for 
fluorescence measurements at 540/590 nm excitation/emission wavelengths using a 
plate reader(BioTek Synergy Mx, Gen5 2.0, Winooski, VT). 
7.5.8 In vitro oxidative injury assay 
Cells were seeded in a 96-well plate at a cell density of 8000 cells/well. Hydrogen 
peroxide (H2O2) was used as a model reagent to induce oxidative stress in NHDF.  
Poly(curcumin) microparticles and free curcumin suspensions in Ham’s F-12 media 
were prepared at two concentrations: 1 and 5 µg/ml of equivalent curcumin loading. 
0.5 mM of H2O2 was used as injury concentration. 10 mM of stock H2O2 was prepared 
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in media, 10 µL of which was added to the wells of interest to get a final concentration 
of 0.5 mM.  
The protection offered by the antioxidant potential of the poly(curcumin) microparticles 
against H2O2 injury was assessed with three different treatment regimens: (i) 
Poly(curcumin) microparticles and H2O2 added simultaneously at t=0 and kept for 24 
hours, (ii) Poly(curcumin) added at t=0 followed by H2O2 at t=12 hours, both kept until 
t=24 hours, (iii) Poly(curcumin) added at t=0 followed by H2O2 at t=12 hours, both kept 
until t=36 hours. At the end time points of each treatment regimen, cells were washed 
with fresh media and then incubated in 200 µl of 1 µM Calcein AM red-orange for 1 
hour. Cells were washed again and incubated in fresh media for fluorescence 
measurement as described in section 7.3.7 to determine the cell viability and indirectly 
the protection potential of the poly(curcumin) microparticles. The cell viabilities for 
each time regimen (24 and 36 hours) were calculated with their respect no treatment 
control groups. 
7.5.9 Pre-clinical study in a Hamster model of OM 
7.5.9.1 Study protocol and sampling 
All animal studies were conducted at the University of Kentucky in accordance with a 
protocol approved by the Institutional Animal Care and Use Committee. A total of 32 
male golden Syrian hamsters (Harlan Laboratories, Indianapolis, Indiana) weighing 90 
to 115 g were randomly divided into 4 groups as shown in table 7.1. Animals in the 
control groups (1 and 2) remained disease free. Oral mucositis was induced in animals 
in the OM groups (3 and 4) by administration of 5-flurouracil (5-FU, 60 mg/kg) 
intraperitoneally on day 0 and 2, followed by abrasion of the left cheek pouch. 
Treatments were administered into the left cheek pouches using needle-less syringes 
once daily from day 0 until euthanasia, under mild isoflurane anesthesia. The control 
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groups (1 and 3) received 200 μl of PBS while the treatment groups received 200 μl of 
10% w/w suspension of poly(curcumin) microparticles (C70 PβAE formulation) in the 
mucoadhesive vehicle. C70-PβAE microparticle formulation was selected because this 
formulation scored highest in mucoadhesive amongst the three formulations analyzed 
for curcumin release, where C70 gave a uniform 12-15 hour curcumin release profile. 
On day 3, under ketamine (100 mg/kg) and xylazine (10 mg/kg) anesthesia, the left 
cheek pouches of the animals in the OM groups (3 and 4) were everted and mild 
erythema was created via dragging an 18 gauge needle in two 3 cm long parallel lines 
on the tissue surface. Once daily, all animals were weighed, their left cheek pouches 
were digitally photographed, and also visually scored for OM severity according to 
table 7.2 [274]. Animals were given 0.1-0.2 mg/kg buprenorphine once or twice daily 
as needed. Animals with excessive inflammation of the cheek pouches or those under 
significant distress (indicated by drastically reduced food intake and activity) were 
euthanized before the end of the study. At the end of the study on day 11, all remaining 
animals were euthanized by CO2 asphyxiation. The treated (left) and control (right) 
cheek pouches were then excised. Half of the total number of cheek pouches were flash 
frozen in liquid nitrogen and immediately stored at -80°C for the tissue biomarker 
assays (TEAC and protein carbonyl, discussed later). The other half of the cheek 
pouches were processed for histological examination as described below. 
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Table 7.1 Pre-clinical study design and treatment plan 
No. Group No. of Animals 
Injury 
Day 
5-FU 
Injection 
Days 
Treatment (200 μl), Daily 
1 
No OM, 
Control 
(NOC) 
5 None None PBS 
2 
No OM, 
Treatment 
(NOT) 
5 None None 10% w/w poly(curcumin) suspension 
3 
OM, 
Control 
(OMC) 
11 3 0 & 2 PBS 
4 
OM, 
Treatment 
(OMT) 
11 3 0 & 2 10% w/w poly(curcumin) suspension 
 
Table 7.2 Scoring guidelines for visual observation of mucositis assessment of 
hamster pouch 
Score Observation 
0 No erosion or vasodilation 
1 Erythema but no evidence of mucosal erosion 
2 Severe erythema, vasodilation and superficial erosion 
3 Formation of ulcers in one or more places, not covering more than 25% of the surface area 
4 Cumulative ulcer formation, about 50% of pouch surface area 
5 Complete ulceration of pouch mucosa. Loss of pliability 
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7.5.9.2 Protein carbonyl content of cheek tissues 
Oxidative stress in tissues can damage proteins by oxidation resulting in the formation 
of carbonyl groups in the protein chemical structure. The protein carbonyl content of 
the cheek tissues was quantified using the 2, 4-dinitrophenylhydrazine (DNPH) assay 
according to the manufacturer protocol (Cayman Chemicals). DNPH on reaction with 
carbonyls forms the corresponding hydrazone, which can be detected 
spectrophotometrically. Briefly, 200-500 mg of each tissue sample was homogenized 
in PBS (200 mg tissue per ml) followed by centrifugation at 3000 rpm for 10 min. 200 
µl of the supernatant was mixed with 800 µl DNPH and incubated for 1 hour in dark at 
room temperature. An equal volume of supernatant was mixed with 800 µl of 2.5 M 
HCl instead of DNPH as the control group. After 1 hour, the protein was precipitated 
by adding 20% trichloroacetic acid (TCA) solution while incubating the samples in an 
ice bath. After 5 minutes, the samples were centrifuged and the supernatant discarded 
to remove excess DNPH. This precipitation step was repeated once more after which 
the protein pellets were re-suspended in 1:1 ethanol/ethyl acetate mixture. The samples 
were again centrifuged and the supernatant discarded. The protein pellets were re-
suspended in guanidine hydrochloride and centrifuged once more. The supernatants 
were transferred into a 96-well plate (220 μl per sample per well) and absorbance was 
measured at 360 nm using a Varian Cary 50 Bio UV-Vis spectrophotometer. The 
protein carbonyl concentration (in nmol/ml) was calculated as follows: 
 𝑃𝑃𝑟𝑟𝑜𝑜𝑎𝑎𝐹𝐹𝑜𝑜𝑛𝑛 𝐶𝐶𝑎𝑎𝑟𝑟𝑎𝑎𝑜𝑜𝑛𝑛𝑎𝑎𝑎𝑎 �𝑑𝑑𝑛𝑛𝑎𝑎𝑡𝑡
𝑛𝑛𝑡𝑡
� = � 𝐴𝐴
0.011
� ∗ 2.5  
Where ‘A’ is the absorbance of the samples. 
The protein carbonyl content was finally reported as nmol carbonyl per mg of total 
protein. Total protein content was quantified by treating the control (HCl) samples with 
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guanidine hydrochloride solution in the ratio of 1:10 v/v, and then measuring the 
absorbance at 280 nm. Solutions of bovine serum albumin (BSA) were used as the 
standards to determine the total protein concentration. 
7.5.9.3 Histopathological analysis 
The freshly dissected cheek tissues (described above) were spread and pinned down to 
Sylgard dishes and fixed in 4% paraformaldehyde solution in PBS for 24 hours. Tissues 
were cryoprotected in 30% sucrose solution for 24 hours followed by embedding in 
Tissue-Tek O.C.T. compound. Embedded tissues were then cryosectioned at 10 μm 
thickness, mounted on slides and stained with hematoxylin and eosin (H&E). The 
sections were observed and imaged using a Nikon Ti-U inverted optical microscope 
(Melville, NY) attached to a Nikon DS-RI1 12 MP color CCD camera at a 
magnification of 400x. All the section images were closely analyzed for any visible 
injury. Following that, ImageJ software was used to measure the thickness of the 
epithelial layer (outermost tissue layer) for each tissue as any disintegration and/or 
disruption in the epithelial layer is an important marker of inflammation. About 10-12 
thickness measurements were made for each tissue and the mean thickness for each 
tissue was plotted against the respective OM score given during the study. 
7.6 Results 
7.6.1 Poly(curcumin) microparticles characterization 
The curcumin conjugated PΒAE gel synthesis process was optimized by Patil et. al. 
[275] with respect to the reaction temperature, reaction time, solvent selection and 
concentration to achieve a high cross-link density, uniform poly(curcumin) film. 
During poly(curcumin) film synthesis via reaction of CA, PEG(575)DA and TTD, the 
reaction mixture was kept for 1 hour at room temperature prior to incubation ay 50°C 
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in order to achieve an extent of reaction before the solvent evaporation process starts at 
higher temperature with simultaneous progression of the reaction. Solvent evaporation 
is an important phenomenon in this synthesis as we want to achieve a significant 
crosslink density which would be possible with gradual loss of reaction medium 
resulting in increased concentration with time giving higher probability of the 
intermolecular reaction. Washing of poly(curcumin) films was an important 
intermediate step in order to remove any unreacted monomers and other un-crosslinked 
chains that could unpredictably impact the physical and chemical properties of the 
polymers. Wash supernatants were analyzed using UV-Vis to quantify the loss of 
curcumin and/or its acrylates from the polymers. Measurement of mass loss of the 
polymer films and UV-Vis analysis of the supernatants post washing confirmed that 
CA, PEGDA and TTD were lost in almost the same ratio as the starting stoichiometry 
(data not shown). 
The cryogenic milling process to obtain poly(curcumin) microparticles was also 
optimized with respect to milling time (10 min), sample loading (2 g), milling speed 
(15 cps) and magnesium stearate content (1% w/w) to obtain consistent particle size 
distribution irrespective of the polymer formulation. Various poly(curcumin) 
microparticle formulations were suspended in DI water and analyzed for their particle 
size using a Shimadzu SALD-7101 laser diffraction particle size analyzer with a 375 
nm UV laser source. Figure 7.1 shows the particle size distribution of the C60, C70 and 
C90 poly(curcumin) microparticles measured after 2 minutes bath sonication. All three 
groups show similar particle size distributions with average particle diameters of 
20.7±4.3, 20.8±2.7 and 22.7±0.28 µm respectively. 
140 
 
  
 
Figure 7.1 Particle size analysis of the poly(curcumin) microparticles with variable 
CA to PEGDA molar ratios.  
For analysis, particles were suspended in DI water and ultrasonicated for 2 minutes. 
Variable CA to PEGDA molar ratios (60, 70 and 90%) did not affect the particle size 
with an average size in the range of 22.5 µm to 25.0 µm.  
 
7.6.2 Poly(curcumin) powder hydrolytic degradation and curcumin release 
profile 
Three poly(curcumin) microparticle formulations, C60, C70 and C90 were degraded 
under physiological condition to study the impact of the polymer composition (i.e. CA 
to PEGDA ratio) on the release profile of curcumin. The PBS was supplemented with 
0.1% SDS in order to ensure the solubility of the released hydrophobic curcumin. 
Figure 7.2 (A) shows the cumulative curcumin release profiles versus time for the three 
formulations. All the formulations analyzed for curcumin release due to PβAE ester 
hydrolysis showed steady and uniform release. It was observed that C60 
poly(curcumin) microparticles showed rapid release of curcumin within 12 hours while 
C70 took 15 hours and C90 took 24 hours to completely hydrolyze and release 
curcumin. Analysis of the degradation samples using HPLC confirmed the presence of 
pure curcumin post hydrolysis as shown in figure 7.3, where peaks eluting from the 
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microparticle degradation coincide with those of a curcumin standard at 7.3, 7.7 and 
8.1 minutes. 
7.6.3 Antioxidant activity of the poly (curcumin) powder released products 
The TEAC assay was employed to confirm and quantify the antioxidant capacity of 
released curcumin for the three aforementioned formulations at every time point. As 
can be seen in figure 7.2(B), the cumulatively trolox concentrations over time for each 
formulation follow the release profiles of curcumin discussed above. A cumulative 
equivalent trolox concentrations of 21.2, 23.3 and 14.2 µM  at 12, 15 or 24 hours for 
C60, C70 and C90 respectively was calculated showing the presence of active 
degradation products in the supernatants (Figure 7.2 (B)).   
 
Figure 7.2 Degradation profile of poly(curcumin) microparticles  
(A) Curcumin release by hydrolytic degradation of poly(curcumin) microparticles. 
Sustained release of curcumin over 10, 14, and 24 hours was observed for C60, C70 
and C90, respectively, clearly showed a direct relationship between polymer 
hydrophobicity and hydrolytic degradation. (B) Anti-oxidant activity profile of released 
curcumin using TEAC assay. Plot represents the equivalent concentration of trolox 
versus time, confirming retention of the antioxidant activity of the released curcumin. 
(N=3, error bars are ± std. dev.) 
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Figure 7.3 HPLC analysis of the products from degradation of poly(curcumin) 
microparticles collected at 26 hours. 
Peaks identical to a free curcumin standard at 7.21, 7.58 and 8.00 mins were observed 
for degradation products as well, confirming the release of pure curcumin after 
polymer degradation. 
 
7.6.4 Tissue adhesion studies with porcine buccal tissue 
Poly(curcumin) microparticle adhesion properties towards porcine buccal tissue were 
analyzed in Bluegrass Advanced Materials LLC. laboratory in order to sort out 
formulation with best adhesive nature based on the CA v/s PEG(575)DA molar ratio 
and stoichiometric ratios (RTAAP). After analyzing the pictures post tissue-drip 
experiment with the help of visual ranking obtained from random subjects, it was 
inferred that C70 microparticles with RTAAP of 1.0 were best amongst other in 
adhesive properties. The methods with detailed results and discussion is not included 
in this document.  
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7.6.5 Dose dependent NHDF cytotoxicity (In vitro) 
NHDF were treated with various concentrations of poly(curcumin) microparticles 
(C70, RTAAP 1.0) and free curcumin at equivalent curcumin concentrations for 24 
hours to compare and quantify their relative cytotoxicity. Figure 7.4 shows the 
cytotoxicity profile of poly(curcumin) microparticles and free curcumin versus the 
equivalent curcumin concentrations. A sigmoidal curve fit (using SigmaPlot version 
12.0) to the dose-dependent viability gave a TC50 value of about 12 µg/ml for curcumin 
and 99 µg/ml for poly(curcumin) microparticles.  
 
Figure 7.4 Dose dependent cytotoxicity of free curcumin and poly(curcumin) 
microparticles towards normal human dermal fibroblasts (NHDF) after 24 hours of 
exposure.  
Cell viability was determined using Calcein AM red-orange cell-permeant fluorescent 
dye with excitation/emission wavelength of 540/590 nm. Poly(curcumin) microparticles 
resulted higher viability than free curcumin at corresponding same equivalent 
curcumin concentrations, demonstrating safer nature of the drug conjugated polymer 
system than free drug. N=5, error bars are ± std. dev. 
 
7.6.6 Protection against H2O2 induced injury (In vitro) 
Based on the results of the cytotoxicity assay above, non-toxic equivalent curcumin 
concentrations of 1 and 5 µg/ml were selected to ensure that the inherent toxicity of the 
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particles and free curcumin does not interfere with the oxidative injury assay. This was 
confirmed via lack of cytotoxicity observed in the control groups treated with only 
poly(curcumin) microparticles and free curcumin for 24 and 36-hour exposure but 
without oxidative injury (Figure 7). NHDF cells, when treated simultaneously with 0.5 
mM H2O2 and poly(curcumin) microparticles at 1 and 5 µg/ml equivalent curcumin 
concentrations, showed significantly higher viability of 27.0±7.7% and 60.5±17.2% 
respectively versus only 1.7±0.3% and 21.5±5.9% for cells treated with free curcumin, 
after 24 hours of exposure (Figure 7.5). For the second regimen wherein the antioxidant 
treatment (poly(curcumin) and free curcumin) was started 12 hours prior to the H2O2 
exposure for 12 hours, cell viability increased from 57.3 ± 3.6% (unprotected control 
group) to 97.6 ± 4.8% and 112.3 ± 4.5% for poly(curcumin) microparticles at 1 and 5 
µg/ml respectively. In contrast, an insignificant increase in viability was observed with 
free curcumin of 59.9 ± 2.3% and 68 ± 4.0% at 1 and 5 µg/ml respectively. In the third 
regimen when the H2O2 exposure was extended to 24 hours post 12-hour pre-treatment 
with the antioxidants, poly(curcumin) again increased viability to 54.5 ± 9.6% and 70.6 
± 4.0% at 1 and 5 µg/ml respectively. On the other hand, curcumin at the same 
concentrations increased viability to a meager 10.2 ± 2.9% and 24.6 ± 3.1% 
respectively. 
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Figure 7.5 NHDF viability analyzed after exposure to poly(curcumin) 
microparticles/free curcumin and H2O2 to show protection against oxidative 
injury.  
The x-axis from top to bottom shows 1) the equivalent curcumin concentrations (µg/ml), 
2) the timescale of antioxidant (AO) (Poly(curcumin) microparticles or free curcumin) 
exposure, and 3) timescale of 0.5 mM H2O2 exposure. Poly(curcumin) controls at both 
the concentrations did not show any toxicity after 24 and 36-hour exposure. Similar 
observations were made with free curcumin except 24-hour of 5 µg/ml showed 25% 
cell death. 12-hour AO pre-treatment resulted in higher cell viability than AO + H2O2 
simultaneous treatment. For all the different treatment schemes, poly(curcumin) 
microparticles showed superior protection than free curcumin with H2O2 induced OS. 
N=5, error bars are ±Std. dev.; ‘*’ represents statistically significant difference 
between the treatment groups with p<0.050. 
 
7.6.7 Pre-clinical study in a Hamster model of OM 
The efficacy and safety of poly(curcumin) microparticles locally delivered to the cheek 
pouches was evaluated towards the prevention and treatment of OM in a hamster model. 
The control group without OM injury treated with DI water (NOC) or poly(curcumin) 
microparticles (NOT) did not show any sign of vasodilation or pouch erosion giving a 
score of 0 on the scale of 0-5 on day 11 (0: no injury, 5: complete ulceration of the 
pouch mucosa). The animal group with OM injury but without microparticle treatment 
(OMC) on day 11 showed erythema and swelling surrounding the scratched area giving 
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a score of 3.5 ± 1.8. On the contrary, the group with OM injury and treated with 
poly(curcumin) (OMT) scored 0.5 ± 0.5 on day 11. 
7.6.7.1 Protein carbonyl content of cheek tissue 
The ability of the poly(curcumin) microparticle treatment to inhibit protein oxidation 
in the tissues was analyzed using the DNPH based protein carbonyl assay. Protein 
oxidation or indirectly carbonyl content is considered to be a major marker of oxidative 
stress in tissues. According to the figure 7.6, tissues from the NOC and NOT groups 
showed total protein carbonyl content of 0.4 ± 0.3 and 1.0 ± 0.2 nM carbonyls/mg of 
protein. Tissues from the OMC group showed significantly higher level of protein 
carbonyl at 3.9 ± 2.8 nM carbonyl/mg of protein. Interestingly, the OMT tissues showed 
a significant decrease in the carbonyl content to 2.0 ± 0.8 nM carbonyl/mg of protein. 
Figure 7.6 Protein carbonyl content in hamster cheek tissues. 
Carbonyl content was calculated by reaction of carbonyls with DNPH followed by UV-
Vis absorption analysis of reaction products at 360 nm. Carbonyl content in OMC was 
8 times higher than non-treated controls (NOC) while with the injury group treated 
with poly(curcumin) microparticles (OMT) showed a significant decrease (half of OMC 
or 4 times that of NOC). NOT also showed some increase in carbonyl content probably 
due to metabolic signaling in tissues upon administration of a foreign substance, but 
was lower than both the injury groups. N=3, error bars are ± SEM. 
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7.6.7.2 Histopathological analysis of cheek pouch tissues and effect on epithelial 
layer thickness post OM injury 
The epithelial layer thickness of the hamster cheek pouch was analyzed after OM 
induced injury (OMC) and compared with the hamsters treated with poly(curcumin) 
post OM injury. Figure 7.7 shows the histology images of cross-sections of cheek 
tissues corresponding to NOC, NOT, OMC and OMT. For the NOC and NOT groups, 
tissue from only one animal per group was analyzed as the remaining tissues were used 
for the biomarker assays. For the OMC and OMT groups, tissues from at least 2 animals 
per group were analyzed. ImageJ analysis determined the average epithelial layer 
thickness of NOC and NOT tissues to be 35.9 ± 5.3 and 45.2 ± 3.2 µm respectively. 
Figures 7.7 and 7.8 shows the disintegration of the epithelial layer in the OMC group 
tissues, with an average thickness of 16.1 ± 10.2 µm and 30.0 ± 8.6 µm for OMC I and 
OMC II respectively. The OMT tissues gave an average epithelial layer thickness of 
35.7 ± 4.0 and 26.3 ± 6.4 µm for OMT I and OMT II respectively.  
    
NOC      NOT     
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OMC I      OMC II 
    
OMT I      OMT II 
Figure 7.7 Histopathological sections of hamster left cheek pouches.  
Optical microscopy images of cheek tissue sections stained with H&E taken at 200x 
magnification.  NOC: No OM controls, OMC: Oral mucositis controls, NOT: No OM 
treatment, OMT: Oral mucositis treated with C70 microparticles. Dark arrows depict 
partially damaged or thinning layer with a disintegrating corneal layer of oral mucosa. 
NOC group shows completely intact epithelium while NOT histoimage is folded and 
shows very slight corneal disintegration. OMC group images shows instances of both 
partial disintegration and completely damaged epithelium. OMT group shows either 
intact or only partially disintegrated epithelium. Scale bars: 100 µm. 
 
Intact epithelial 
Disintegrating/thinning epithelial 
Damaged epithelial 
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Figure 7.8 Epithelial layer thickness with corresponding animal scoring on day 11.  
Poly(curcumin) treated control without injury (NOT) showed an increase in thickness 
as compared to NOC indicating epithelium proliferation. OMT stained tissue showed 
an average higher thickness as compared to OMC samples indicating protection from 
inflammation or healing of the inflammation. Epithelial layer thickness also complies 
with the visual scoring for each tissue, i.e. higher the inflammation scoring, lesser the 
thickness. Epithelial thickness was measured using ImageJ software. The bars 
represent the average thickness measurements of at least 10 different locations per 
stained tissue section. (Error bars: std. dev.) 
 
7.7 Discussion 
A recent human trial showed significantly delayed the onset and reduced severity of 
OM after continuous turmeric (a source of curcumin) rinses without any added side 
effects [276]. As the development of OM has been linked to the presence of oxidative 
stress, the therapeutic significance of curcumin towards the treatment of this 
uncomfortable, painful and currently unmanageable OM condition could be clearly 
identified [277]. It was shown that slight increment of ROS production during cancer 
therapies would result in activation of NF-kB. This would lead to the release of tissue-
damaging cytokines, which in turn again increase ROS production [278]. This results 
in a cascading cell apoptosis cycle, inhibiting oral epithelial cell proliferation, 
consequently resulting in the formation of ulcers. Curcumin carrying both anti-oxidant 
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and anti-inflammatory properties inhibits NF-kB, scavenges excess free radicals and 
hence overall halts the cell apoptotic process, a possible prevention to the incidence of 
OM. But its structural properties associated with poor bioavailability, rapid 1st pass 
metabolism due to its poor aqueous solubility and structural stability would require 
higher and frequent dosage quantities for OM treatment [279].  But increased dosage 
still may not be effective due to aqueous solubility limitations. Converting the 
polyphenolic antioxidant, curcumin into a crosslinked biodegradable PβAE polymer 
matrix (poly(curcumin)) via Michael addition structurally protects the curcumin from 
premature degradation, thus preserving its activity until released [178, 280]. 
Poly(curcumin) synthesized via a single-step reaction between CA, PEGDA and TTD 
releases curcumin in its original structural form via hydrolysis of the ester bond present 
in the polymer backbone. In addition to protecting a useful drug, the polymerization 
process also enables controlled and sustained release of curcumin for extended time. 
Since these polymers undergo hydrolytic degradation, it is logical that the 
hydrophobicity of the polymer network would govern the rate of polymer degradation, 
and hence the rate of drug release [281, 282]. Our goal was to identify formulations that 
release curcumin continuously for 12 to 24 hours in a steady and uniform fashion. This 
was readily achieved by varying the ratio of CA (hydrophobic) to PEGDA (hydrophilic) 
during polymer synthesis. Films with different ratios of CA to PEGDA with respect to 
a total number of acrylate groups were synthesized. For example, formulation C70 
would have 70% of the acrylate groups contributed by CA, while the remaining 30% 
contributed by PEGDA. Cryogenic milling was chosen to micronize the 
poly(curcumin) films for two primary reasons: 1) to embrittle the polymer for effective 
micronization, and 2) to prevent heat-induced degradation of the polymer. Additionally, 
magnesium stearate, a widely used pharmaceutical excipient [283, 284], was added as 
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a dry lubricant to reduce clumping. Cryogenic milling of the C60, C70 and C90 
formulations yielded microparticles with an average diameter of about 25 ± 4, 23 ± 3 
and 22 ± 1  µm respectively, implying that the polymer composition had minimal, if 
any, effect on the milling process and particle size. Micronization of the bulk PβAE 
polymer films was an important step for the intended application. Formulating into 
microparticles followed by suspension in a mucoadhesive solution would allow ease in 
local delivery through oral mouth rinse. It would also allow higher mucosal surface 
coverage during rinses. Particulate morphology over bulk would minimize the 
incidence of diffusion based curcumin release but largely hydrolytic degradation based 
drug release.  
Degrading the poly(curcumin) microparticles under simulated physiological conditions 
showed a CA loading dependent release profile of curcumin. The polymer formulation 
synthesized with the highest CA amount, C90, degraded the slowest in 24 hours, 
presumably because of the higher hydrophobicity from the higher curcumin content. 
The formulation with lower CA amount, C60, with relatively lower curcumin content, 
completely degraded within 12 hours due to faster hydrolysis. HPLC analysis of the 
degradation products detected the original curcumin confirming that the ester bond 
hydrolysis occurring adjacent to curcumin molecule within the polymer does release 
the pure polyphenol. The ability of tunable, sustained release of curcumin from the 
poly(curcumin) microparticles enables development of clinically relevant antioxidant 
delivery formulations.  This is because longer release would reduce the dosage and 
treatment frequency thereby giving minimum possible treatment interference to the 
patients undergoing life-saving cancer treatments. Therapeutic application of curcumin 
has been limited with in vivo trials because of its rapid metabolism. It has been shown 
that increasing the amount of dosage has not improved total absorbed because of 
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solubility limitation. This restricts the percent bioavailability of curcumin irrespective 
of the dosage amounts [285]. Steady curcumin release with no major burst effect would 
alleviate the solubility limitation of the highly hydrophobic drug and minimize the 
overall systemic metabolism thereby giving an opportunity to utilize the major part of 
the release towards OS suppression.  It was important to analyze the antioxidant activity 
of the poly(curcumin degradation products as that would decide the efficacy of the 
system towards core function of serving as an antioxidant throughout the release. 
Antioxidant activity was determined by analyzing the potential of degradation products 
to scavenge the ABTS●– radical and reported as equivalent trolox concentration, a 
widely used standard for such assays [162, 286]. The continuous increase in equivalent 
trolox amount through the degradation time span confirmed the presence of active 
compounds capable of suppressing OS. This indirectly implies the release of active 
curcumin at all times and also proves the concept theory of preserving the structural 
integrity of the labile molecule in the polymer matrix and protection from premature 
deactivation prior to release.    
The C70 poly(curcumin) microparticles showed dose dependent toxicity on human 
dermal fibroblast (NHDF), with a TC50 value of 227 µg/ml of suspended microparticles 
(99 µg/ml of equivalent curcumin dose) against TC50 of only 12 µg/ml for pure 
curcumin. Two key observations can be drawn from the more than 8-fold higher TC50 
values of the poly(curcumin) microparticles compared to pure curcumin: (i) within 
appropriate dosage limits, the degradation products from the polymer backbone are 
non-toxic towards fibroblasts, and (ii) the slow release of small doses of curcumin upon 
degradation of the polymer is less cytotoxic than the traditional bolus delivery method 
of free curcumin. More importantly, sustained release of active curcumin actually 
improves protection of cells against oxidative injury. As shown in figure 7.5, in the case 
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of all three treatment regimens, cells treated with poly(curcumin) followed by H2O2 
exposure show significantly higher viability than just those treated with free curcumin. 
In particular, 12-hour pretreatment with free curcumin shows minimal to no reduction 
in cell death after H2O2 injury, while pretreatment with poly(curcumin) microparticles 
had a significantly higher number of viable cells. Delivery of curcumin from polymer 
microparticles is not only effective in suppressing oxidative stress-related injury but, in 
fact, is more efficacious and less toxic than free curcumin. As explained earlier, one of 
the key causes of the onset and incidence of the OM condition arises due to the 
development of oxidative stress conditions, which is excess production of free radicals.   
The in vitro results if translated towards OM management would imply both (i) 
prophylactic action against oxidative stress during chemo and radiation therapy as well 
as (ii) treatment of OM by suppressing OS via simultaneous treatment during the 
developmental stage of the oral injury. 
The viable or non-destructive nature of the poly(curcumin) microparticles were further 
tested in vivo with a hamster model. No increase in protein carbonyl content, intactness 
of epithelium observed with histopathological analysis for only poly(curcumin) 
microparticle treated control groups (NOT) demonstrated the safe nature of 
microparticles in vivo with no side effects or inflammation.  Adding to this, higher 
epithelium thickness of NOT groups (45.2 µm) as compared to NOC (no OM, no 
treatment) control groups (35.87 µm) demonstrates the epithelium proliferation in the 
presence of curcumin (figures 7.7 and 7.8).  Though NOT showed some increase in 
carbonyl content with reference to NOC group but this could be probably due to 
metabolic signaling in tissues upon administration of a foreign substance, but was 
significantly lower than both the injury groups. The Effect of poly(curcumin) on the 
hamster pouch with induced OM condition  though did not show full protection from 
154 
 
  
the injury but showed a significant difference against inflammation with an average 
OM score of 0.5 on day 11, lower total protein carbonyl content and more intact  
epithelium when compared with the OM injury (OMC) control group with an average 
score of 3.5 (Figures 7.6, 7.7 and 7.8). The results from the preliminary in vivo study 
are not very concrete with a clear conclusion on the efficacy of the poly(curcumin) 
microparticles towards OM prevention and treatment. The underlying cause of 
variability might be arising due to the presence of human error during needle scratching 
of hamster pouch and high death rate due to adverse systemic effects arising from the 
strong 5-FU administration. In spite of these experimental irregularities, we did see 
results indicating the protective effect of slow and steady releasing microparticles 
developed in the form of oral rinse suspension for better patient compliance.  
7.8 Conclusions 
Curcumin conjugated PβAE gel microparticles (poly(curcumin) microparticles) were 
synthesized for the application of treatment and prevention of oral mucositis. These 
microparticles obtained by cryomilling PβAE gel films showed the uniform release of 
active curcumin with no burst effect. PEGDA used as a co-monomer to CA during gel 
film synthesis helped in tuning the curcumin release timescale ranging from 12 to 24 
hours. The C70 poly(curcumin) microparticle system was selected for further in vitro 
and in vivo application after testing various formulations for best mucoadhesive 
properties. Protection against H2O2-induced oxidative stress was seen with both 
simultaneous and pre-treatment of poly(curcumin) demonstrating preventive as well as 
treating potential of the microparticle system. Both in vivo and in vitro studies 
demonstrated the safe and viable nature of the product. In vivo administration of 
poly(curcumin) through oral rinse to OM induced hamsters showed decreased protein 
carbonyl content, intact epithelium and less severity of ulcers observed visually in 
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comparison to non-treated OM controls. The microparticle containing mouth rinse 
suspension would allow local and sustained delivery of antioxidant curcumin, increase 
overall bioavailability and reduced dosage frequency thereby minimizing the 
interruptions during cancer therapies. These synthesized poly(curcumin) microparticles 
can serve as a treatment superior to just barrier rinse or free curcumin rinse towards the 
management of OM. 
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8 SYNTHESIS AND CHARACTERIZATION OF RESVERATROL 
CONJUGATED PβAE GEL MICROPARTICLES FOR PROTECTION 
FROM UV MEDIATED OXIDATIVE STRESS 
Note: The information in this chapter is the intellectual property of Bluegrass 
Advanced Materials LLC., not to be disclosed in public 
Abstract 
As induction of oxidative stress through UV radiation from sunlight is considered to be 
one of the reasons for skin disorders, including sunburn, skin cancer and premature skin 
aging, incorporation of resveratrol with its antioxidant properties could serve as a 
protective strategy in topical application products. In order to consider this as a viable 
approach for daily use, it is required for the UV-protective compound to act against 
radiation-induced injury for at least 12-14 hours. However, the instability of resveratrol 
under UV exposure results in its rapid deactivation and apparent depletion without 
performing the intended function. A proposed solution to overcome these limitations is 
to structurally protect the resveratrol via the PβAE conjugation approach and 
subsequently release the bioactive compound uniformly for a longer duration of time. 
To implement this idea, resveratrol was covalently conjugated into hydrolytically 
degradable PβAE gels via reaction of acrylate functionalized resveratrol (RTA) with a 
multifunctional amine (TTD). These gels were further cryomilled into microparticles 
for easier fusion into cosmetic or dermatological products. Incorporation of PEGDA as 
a co-monomer allowed tunable degradation of these gels (6-8 hours) and control over 
the fast reaction kinetics of RTA with TTD. These microparticles also showed 
protection against H2O2-induced oxidative stress in human dermal fibroblasts 
equivalent to free resveratrol. Therefore, these microparticle systems have the potential 
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to be considered for dermal application products but a more uniformly distributed and 
longer resveratrol release profile (10-12 hours) is desired for intended action. 
8.1 Introduction 
With the incidence of skin cancer, premature skin aging, and topical erythema the 
damaging effects of the UV part of solar radiation on skin are generally well known. 
[287-289]. UV radiation is broken into three distinct bands, UVA (315-400 nm), UVB 
(280-315 nm) and UVC (100-280 nm). While UVC is blocked by the atmospheric 
ozone layer, we get sunlight radiation composed of about 95% UVA and roughly 5% 
as UVB [290]. Both types of UV radiation serve as contributing factors to skin aging 
and development of skin cancers. UVA penetrates to the dermis, increases reactive 
oxygen species production, indirectly inducing DNA damage followed by mutagenesis 
[291]. On the other hand, UVB is known to be the cause of non-melanoma cancer, is 
absorbed at the epidermis level of the skin and results in direct DNA damage [292, 
293].  
While induction of oxidative stress is considered to be one of the reasons for skin 
damage, application of antioxidants is a well-known remedy to suppress oxidative 
stress and can be a possible solution to remediate UV exposed damage and prevent 
degenerative biochemical processes [294].  Antioxidant molecules used in cosmetic and 
dermatological formulations to protect skin from damage and premature aging include, 
but are not limited to, vitamin E, curcumin, resveratrol, quercetin, and ascorbic acid. In 
particular, resveratrol has gained a special interest in recent years as an antioxidant and 
anti-aging compound [295]. Topical application of this antibacterial compound in 
preventing UV-mediated oxidative and skin damage has been widely studied and has 
shown promising results [296]. Recent studies have also shown that it has 17 times 
greater antioxidant capacity than idebenone, an antioxidant widely used in anti-aging 
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skin products [297]. But one of the greatest technical difficulties for the use of the above 
antioxidant compounds is their instability under UV leading to molecular isomerization 
and inactivation [298]. The strong chemical activation energy derived from ultraviolet 
radiation induces hydrolytic reactions and degrades the antioxidant indiscriminately. 
This results in exponential loss of the antioxidant without performing the action it was 
intended to. This reduces the filtering and protection capacity of the cosmetic 
formulation over time. A reduction of UVB filtering capacity leads to a reduction in 
SPF of the formulation, and therefore to a higher burn risk. On the hand, the reduced 
capacity to filter UVA radiation results in a greater risk of adverse chronic effects, 
which might go unnoticed at initial stages.  
 A proposed solution to overcome these limitations is to structurally protect the 
resveratrol until it is made available to protect the skin from injury. This idea was 
implemented by converting antioxidants into biodegradable poly(beta-amino ester) 
(PβAE) polymers. Specifically, polyphenolic resveratrol with three alcoholic groups 
was first converted into its acrylate ester form (Figure 8.1). The phenol acrylate 
(resveratrol triacrylate (RTA)) was then reacted with a primary diamine crosslinker, 
like 4, 7, 10-Trioxa-1, 13-tridecanediamine (TTD), via the Michael addition to yield 
crosslinked resveratrol conjugated PβAE (R-PβAE) gels. The hydrophilicity of the 
polymer, and thus its degradation rate was controlled by including a diacrylate co-
monomer like poly(ethylene glycol) diacrylate (PEGDA, MW 575) in desired 
proportions during the reaction. The gel films were further cryomilled to obtain R-
PβAE microparticles. Hydrolytic degradation of these gel microparticles demonstrated 
resveratrol release in a sustained fashion. 
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By going through this route, (1) resveratrol was structurally protected from premature 
degradation compared to encapsulation/complexation technologies; (2) high resveratrol 
loadings, exceeding 20 wt. % of the polymer were obtained, (3) tunable sustained 
release durations ranging from 2 to 10 hours, (4) original, active resveratrol was 
released upon hydrolysis of the polymer. 
8.2 Methods  
8.2.1 Resveratrol triacrylate (RTA) synthesis (Process developed by Bluegrass 
Advanced Materials LLC.) 
Resveratrol (20 g) dissolved in 160 ml of anhydrous THF was allowed to react with 
21.36 ml of acryloyl chloride (molar ratio of 3:1 with respect to resveratrol), which was 
added to resveratrol-THF solution dropwise (exothermic reaction). Triethylamine 
(TEA) (36.64 ml) was added to the reaction mixture in the molar ratio of 3:1 w.r.t 
resveratrol in order to capture released HCl forming TEA-HCl salts. The reaction was 
allowed to proceed for 2 hours under the nitrogen purge at room temperature in the dark 
(aluminum foiled). During the reaction, acryloyl chloride reacts with alcoholic groups 
of resveratrol forming acrylate groups. Post reaction, the mixture in THF was first 
filtered out to remove TEA-HCl salts and then was subjected to vacuum evaporation to 
evaporate THF using liquid nitrogen vacuum trap. Following the complete evaporation 
of THF, the obtained product was re-dissolved in 40 ml of ethyl acetate (EA). As EA 
and water are immiscible solvents, product dissolved in EA was washed with 0.1 M 
HCl solution in DI water (1:3 v/v-EA/HCl solution) in order to remove any unreacted 
TEA in the product. After HCl wash, the product was subjected to base wash using 0.1 
M K2CO3 solution to remove excess acrylic acid with the same EA/ K2CO3 ratio as for 
EA/HCl wash. Any residual water after the washes was removed by adding magnesium 
sulfate (MgSO4) until the bubbling stops. The hydrated MgSO4 was removed via 
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filtration and the EA solution containing RTA was subjected to vacuum drying with 
liquid nitrogen trap under stirring conditions to remove EA and get a semi-viscous RTA 
product. RTA was stored at -80oC before further use. All solvents used were anhydrous. 
The final product was run through HPLC to identify the nature of the resveratrol 
acrylate obtained. 
 
 
Figure 8.1 Reaction scheme of acrylate functionalization of resveratrol to resveratrol 
triacrylate (RTA) via reaction with acryloyl chloride. 
There is a possibility of all three kinds of acrylate; mono, di and tri as shown in the 
figure. Three different forms of mono and diacrylate will exist depending upon the 
location of acrylation. 
 
8.2.2 Resveratrol-PEGDA (R- PβAE) film synthesis and microparticles 
formulation 
a. R-PβAE film synthesis (synthesized by Bluegrass Advanced Materials LLC.) 
R-PβAE films were synthesized with different molar ratios of RTA (mol. wt. 390.39) 
v/s PEGDA (mol. wt. 575) as the acrylate monomers. The amine monomer for the 
Michael addition reaction used was a tetra functional amine; 4, 7, 10-Trioxa-1, 13-
tridecanediamine (TTD) (mol. wt. 220 gm/mol). The total acrylate to total amine proton 
ratio (RTAAP) was kept at 1:1. Films with 20, 40, 60 and 80% RTA (molar ratio w.r.t. 
total RTA+PEGDA) were prepared. As a sample example, for 80% RTA film (R80- 
PβAE), 905 mg of RTA was dissolved in 1.88 ml of DCM and vortexed thoroughly.  
161 
 
  
To the RTA-DCM solution, 500 mg of PEGDA was added and again mixed thoroughly. 
To this mixture, 479 mg of TTD separately dissolved in 1.88 ml of DCM was added 
while vortexing and the reaction solution was quickly transferred to an aluminum dish 
and was kept in an oven for 24 hours at 50o C. After the reaction was completed, a firm 
thin crosslinked gel film was obtained, which was peeled off the aluminum dish and 
subjected to acetone wash to remove any unreacted monomers or uncross-linked 
oligomers. The washing solvent, acetone was removed and replenished every one hour 
followed by mild mixing in the rotary shaker. After the 4th wash, most of the acetone 
was removed and the film was lyophilized using freeze-dryer overnight. 
b. R-PβAE film micronization 
Dry film obtained from Bluegrass Advanced Materials LLC. was weighed out and 
was cut into small pieces of dimensions less than 0.5x0.5 inch. The pieces were 
added to the cryomilling tube with 3% wt/wt of magnesium stearate and an impactor 
was inserted in the tube and closed. The film was subjected to cryomilling with the 
milling frequency of 15 cps, 2 minutes sample precool, 10 minutes of milling and 
2 minutes of post cool setup. After milling, microparticles was allowed to warm up 
and come to room temperature after which microparticles were collected in a tube 
for freeze drying to remove any solvent or condensed water. Dried microparticles 
were stored at -20oC for further characterization (Figure 8.2). 
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Figure 8.2 Photographic schematic of R- PβAE film to microparticle formation. 
8.2.3 R-PβAE microparticle degradation  
Degradation was carried out in a dissolution apparatus with a speed of 100 rpm at 37°C 
in PBS buffer with 0.1% SDS. All formulations (R20, R40, R60 and R80) were 
subjected to degradation. The amount of microparticle powder required for degradation 
studies was calculated such that the final resveratrol concentration was 10 mg/L. A total 
of 1-liter suspension was prepared for each formulation and the study was carried out 
in replicates of three. Table 8.1 shows the total mass/liter required for each formulation 
to get 10 μg/ml of loaded resveratrol.  
Table 8.1 R-PβAE microparticles composition and degradation calculations 
R-PβAE formulation % Resveratrol loading 
Mass of R-PβAE 
microparticles/liter 
for 10 mg/L 
resveratrol (mg) 
R20 4.89 204.50 
R40 10.88 91.80 
R60 18.40 54.36 
R80 28.09 35.60 
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8.2.4 Dose dependent toxicity and protection against H2O2 induced oxidative 
stress towards normal human dermal fibroblasts (NHDF) 
Dose dependent cell toxicity due to resveratrol and R80-PβAE exposure towards 
normal human dermal fibroblasts (NHDF) was analyzed after 24-hour treatment using 
Calcein AM red-orange live cell trace assay. Briefly, NHDF were seeded in a 96-
wellplate and allowed to grow overnight. The next day, resveratrol/R80-PβAE 
microparticles were suspended in the Ham’s-12 medium at different concentrations. 
The suspensions were added to the seeded well plate and allowed to incubate for 24 
hours at 37º C, 5% CO2. 
Cells were then washed and incubated with 1 µM Calcein AM red-orange for an hour. 
All the wells were then washed, replenished with fresh medium and the fluorescence of 
all the groups was measured at 540/590 nm as excitation/emission wavelengths (BioTek 
Synergy Mx, Gen5 2.0, Winooski, VT plate reader). Fluorescence intensities were used 
to quantify percent viable cells and compared with different treatment groups. 
Inhibition of H2O2 induced toxicity was also analyzed using the same live cell tracer 
with 0 and 12-hour antioxidant pre-exposure followed by 12 or 24 hours of 0.5 mM 
H2O2 exposure. Figure 8.3 shows the treatment sequence for three different 
resveratrol//R80-PβAE microparticles + H2O2 exposure combinations. 
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Figure 8.3 Treatment sequence timeline of resveratrol/R80-PβAE microparticles + 
H2O2 exposure to NHDF. 
NHDF cells were used as the treatment substrate to analyze the protective effect against 
H2O2 induced oxidative stress. 
 
8.3 Results 
8.3.1 Analysis of RTA and R-PβAE microparticles size 
HPLC elution of the acrylated product of resveratrol i.e. resveratrol triacrylate (RTA) 
showed no peak elution coinciding with the free resveratrol residence time (Figure 8.4). 
This clearly indicated that the final product did not contain any unreacted resveratrol. 
Three distinct peaks were observed in the elution, with the major peak eluting at 37.7 
minutes corresponding to triacrylate. This peak contributed 91% of the total product 
based on area under the curve calculations. Other two peaks are assumed to be of mono 
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and diacrylate and there can be three different structural forms of mono and di acrylate 
depending upon the location of phenol conjugation. 
Cryomilling of all different compositions of RTA-PEGDA-TTD conjugated gels gave 
microparticles in the range of 6-8 µm (data not shown). The amount of magnesium 
stearate content during cryomilling did not show any effect on the particle size. 
 
 
Figure 8.4 HPLC of RTA and resveratrol  
Gradient method file of 70% aqueous mobile phase (DI water with 0.1% phosphoric 
acid) to 30% over 40 minutes against acetonitrile organic phase was used.  
 
8.3.2 Degradation of R-PβAE microparticles and antioxidant activity of the 
released products 
Hydrolytic degradation under physiological conditions (PBS, 37º C) showed a similar 
release trend with a degradation time varying from 6-8 hours for microparticles of 
different chemical compositions (Figure 8.5). Performing the TEAC assay on the 
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degradation products demonstrated sustained antioxidant potential during degradation, 
reported as equivalent trolox (mM) (Figure 8.6). 
 
Figure 8.5 Degradation of all R-PβAE microparticles  
Microparticles were suspended in PBS buffer with 0.1% SDS under physiological 
conditions: 37°C, in a dissolution apparatus. N=3, error bars: std. dev. 
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Figure 8.6 Antioxidant activity profile of R-PβAE microparticles  
Antioxidant capacity was analyzed using TEAC assay and represented as trolox 
equivalents in mM. N=3, error bars: std. err. 
 
8.3.3 Dose dependent toxicity and protection against H2O2 induced oxidative 
stress towards normal human dermal fibroblasts (NHDF) 
Normal human dermal fibroblasts were exposed to a variable concentration of R80-
PβAE microparticles and free resveratrol at similar concentrations for 24 hours. Dose 
dependent cell viability curve showed more viable nature of R80-PβAEs compared to 
free resveratrol at similar resveratrol loading (Figure 8.7). While TC50 value for free 
resveratrol exposure was calculated to be 12.3 µg/ml, R80-PβAE microparticles 
showed lower toxicity with TC50 of 52 µg/ml (resveratrol loading).  
All three different sequences of resveratrol/R80-PβAE treatment did show significant 
protection from 0.5 mM H2O2 toxicity. R80-PβAE did not show any superior properties 
than free resveratrol in the form of cell toxicity (Figure 8.8 and 8.9). 
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Figure 8.7 Dose dependent NHDF toxicity after 24-hour exposure to resveratrol or 
R80-PβAE microparticles.  
Cell viability was determined using Calcein AM red-orange live cell tracer. TC50 values 
were calculated using 4-parameter sigmoidal curve model. N=5, error bars: std. dev. 
 
 
Figure 8.8 Protection against H2O2 induced toxicity due to R-PβAE microparticles 
exposure.  
NHDF treated with 0 or 12-hour resveratrol/R80-PβAE pre-treatment were exposed to 
0.5mM H2O2 for 24 or 12 hours respectively followed by Calcein AM red-orange cell 
viability assay. N=5, error bars: std. dev. 
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Figure 8.9 Protection against H2O2 induced toxicity.  
NHDF pre-treated with resveratrol/R80- PβAE for 12 hours were exposed to 0.5mM 
H2O2 for 24 hours followed by Calcein AM red-orange cell viability assay. N=5, error 
bars: std. dev. 
 
8.4 Comments and future directions 
Utilizing the PβAE chemistry for conjugating resveratrol into the PβAE matrix, we 
were able to formulate prodrug gel microparticles in the range of 6-7 µm. These 
microparticles did show composition dependent release kinetics, where high PEG 
content (R20- PβAE) result in faster degradation within 5-6 hours. But resveratrol 
release from microparticles with the lowest PEG content i.e. R80-PβAE could only be 
extended to 8 hours. To be considered for a cosmetic application such as for sunblock 
products, a 10-12 hour release would be desired for sustained protection against UV-
induced damage. Antioxidant activity of the degradation products shows the radical 
scavenging potential for an extended period time showing the release of active 
resveratrol upon ester cleavage. Also, R80-PβAEs are more viable in nature as 
compared to free resveratrol and show protection against H2O2 induced cellular 
oxidative stress. But, these systems did not show protective nature superior to free 
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resveratrol for the different treatment experiments done. This could be because 
resveratrol itself is a relatively stable antioxidant compared to many others in 
physiological environments until attacked by free radicals. Therefore, given that total 
resveratrol administered was same via free resveratrol and through conjugated systems, 
both showed similar protection against induced cellular oxidative stress. More 
experiments with different combinations of chemical compositions and experimental 
design needs to be carried out in order to better understand the protective mechanism 
of these gel microparticles. One proposed experimental design would be to 
continuously expose the system to free radicals and then analyze the scavenging 
potential of resveratrol conjugated PβAEs and its free form. 
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9 CONCLUSIONS AND FUTURE DIRECTIONS 
In this work, PβAE chemistry was explored as a platform to develop antioxidant 
conjugated crosslinked networks for effective drug delivery. The system was developed 
for three different polyphenolic antioxidants, which are therapeutically significant but 
difficult to administer effectively due to their 1) poor aqueous solubility, 2) structurally 
fragile nature and hence 3) extremely low bioavailability. PβAEs are biodegradable 
polymer networks hydrolytically degradable through their ester linkages. This 
characteristic was utilized as a release mechanism for covalently conjugated 
antioxidants. In the current approach, direct conjugation of antioxidants into PβAE 
crosslinked networks through their –OH groups served as a method to structurally 
protect the molecule and release antioxidants in their active form upon hydrolytic 
degradation. Optimization of reaction and processing parameters allowed us to 
transform the crosslinked prodrug chemistry into micro or nanogel formulations, 
creating a more adaptable technology for drug delivery applications.  
a. PβAE reaction chemistry under dilute conditions resulted in a self-precipitated 
antioxidant nanogel suspension, which was amenable to formulate antioxidants 
quercetin as well as curcumin conjugated system. Use of such synthesis method 
eliminated the requirement of a surfactant for stabilization, which otherwise becomes a 
controlling factor towards nanoparticle toxicity. A uniform release profile of 
functionally active antioxidants, with little to no burst effects further helped in apparent 
reduction of antioxidant toxicity. These physiochemical properties led to the 
demonstration of prolonged protection against induced oxidative stress in endothelial 
cells.  
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The mechanism of protective action could be through (i) cellular internalization 
followed by degradation of nanogels or (ii) extracellular degradation followed 
by diffusion of free antioxidant. The existence of the 1st case would imply high 
cytoplasmic concentrations of the antioxidants, which would be beneficial for 
the treatment of acute damage but could also be a cause of local cellular toxicity. 
Therefore, more insight into the working mechanism is needed to understand 
drug response in a better manner. 
b. Aimed as a treatment solution to neurodegenerative disorders, curcumin-PβAE 
nanogels further demonstrated their ability to suppress mitochondrial oxidative stress 
without any mitochondrial specific targeting. Increased safety window of curcumin 
through nanogel administration was one of the critical factors towards this result, which 
allowed the administration of curcumin at therapeutic levels in a sustained fashion.  
c. The ability of curcumin-PβAE nanogels to mitigate cellular and mitochondrial 
oxidative damage was further explored with the polychlorinated biphenyls (PCBs). The 
analysis showed that pre-treatment of endothelial cells with curcumin-PβAE nanogels 
helped in reducing PCB induced excess ROS production and restoration of otherwise 
affected mitochondrial respiration. This observation was made with the exposure of 
both coplanar (PCB 126) and non-coplanar (PCB 153) PCBs.  
Although, curcumin-PβAE nanogels act against PCBs irrespective of the 
different oxidative damage through different activation paths, the mechanism of 
action needs to be analyzed in detail. Curcumin being a polyphenolic molecule 
can capture PCBs through pi-pi interaction and inhibit the damaging action or 
through scavenging of excess ROS/RNS. 
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Further, nanogel synthesis via the method used in this work can be further 
explored with other polyphenolic compounds with two or more –OH groups. 
This will create a universal synthesis approach for antioxidant delivery through 
nanosystems of high drug loading. 
d. Apart from nanogels, the curcumin-PβAE crosslinked system was also 
formulated into microparticles. Being able to develop the same drug conjugated 
systems in different size dimensions indicates the adaptable nature of the conjugated 
PβAE chemistry in drug delivery. Use of PEGDA as a co-monomer in the synthesis 
process added the ability to control hydrophobicity/hydrophilicity of the networks and 
hence a degradable system with a tunable release profile. These microparticles also 
successfully showed in vitro protection against induced oxidative stress, superior to free 
curcumin. In an in vivo trial, a daily rinse of the microparticle suspension over 10 days 
showed indications of reduced severity of oral mucositis (OM) in chemotherapy-
induced OM hamsters (5 FU/needle scratch injury induction).  
This injury model incorporates a high percent of human error and administration 
of 5-FU drug results in systemic side effects, which indirectly interferes with 
OM analysis. Therefore, a better design of experiment with least human error 
and relatively less lethal injury model, such as γ-radiation, would allow better 
assessment of curcumin-PβAE microparticles as a potential solution for OM 
treatment. 
e. The antioxidant conjugated PβAE gel microparticle synthesis process was 
further extended with another anti-inflammatory drug, resveratrol. Acrylate 
functionalized resveratrol was successfully conjugated into the backbone of the PβAE 
network and was further cryomilled to obtain microparticles. With the goal of 
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developing a slow and steady resveratrol releasing system to prevent topical UV-
induced oxidative damaged, different polymer compositions were tried and analyzed 
for their release profile. As such, these microparticle systems showed in vitro protection 
against H2O2 but did not show properties superior to free resveratrol. 
Although, some control over release kinetics was achieved (6-8 hours of resveratrol 
release), an optimization and modification in synthesis process is required for 
longer release profile (10-12 hours). Selection of different co-monomers or reacting 
amine could lead to improved physicochemical properties of the gel matrix and help 
attain better control over the release profile. Also, a more robust design of 
experiment to demonstrate the UV-protection potential is needed. A proposed idea 
is to continuously expose microparticle loaded systems with free radicals and study 
the scavenging potential of UV light and compare with free resveratrol. 
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APPENDIX 
Based on the research article 
Prachi Gupta, Caroline Lacerda, Vinod Patil, Dipti Biswal, Paritosh 
Wattamwar, J. Zach Hilt and Thomas D. Dziubla, ‘Degradation of 
poly(β-amino ester) hydrogels in alcohols through transesterification: A 
method to conjugate drugs to hydrogel matrices. (to be submitted) 
Abstract 
Poly(β amino ester) polymers have received growing attention in the literature, owing 
to their ease of synthesis, versatile co-monomer selection, and highly tunable 
degradation kinetics. As such, they have extensive potential in many biomedical 
applications.  In this work, it is demonstrated for the first time that PβAE polymers 
containing primary and secondary amine groups can undergo degradation by primary 
alcohols through a transesterification process. While this work demonstrates an 
important aspect of solvent compatibility limitation to these networks, it also represents 
an interesting, simple mechanism for post synthesis drug incorporation, with riboflavin 
conjugation being demonstrated as a model compound. 
Introduction 
Poly(beta-amino ester) (PβAE) hydrogels are hydrolytically degradable systems due to 
the presence of β-amino ester linkages. This is one of the central features for their 
applicability in biomedical applications such as gene and drug delivery and tissue 
engineering considering it as a biodegradable system [299, 300]. Synthesized via 
Michael addition reaction of an acrylate molecule with a primary or secondary amine, 
the degradation rate of these polymers is considered to be dependent on several 
structural and degradation medium factors. As such they have been shown to degrade 
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faster in the presence of primary and secondary amines in the hydrogel matrix because 
of the catalyzing action of amines [301, 302]. We have previously published a single-
step PβAE hydrogel synthesis reaction based upon primary diamine precursors that 
serve as crosslinkers during polymerization.  These networks were found to hydrolyze 
much more rapidly than gels prepared by a two-step crosslinking system, which is 
straight chain polymer synthesis followed by radical catalyzed cross-linking of acrylate 
end-groups [303].  It was theorized that this effect was a result of unmodified amines 
in the network backbone catalyzing the hydrolysis reaction [304, 305].   
Based upon this observation, we hypothesize that these PβAE crosslinked networks 
would also be sensitive to nucleophilic attack by primary alcohols and will highly 
depend on the nature of alcohols. Herein, we report the first demonstration of PβAE 
hydrogel degradation by alcohols through a transesterification mechanism, establishing 
the effect of acrylate to amine ratio, alcohol chain length and degree of carbon 
substitution on the degradation kinetics. This mechanism also permitted the post 
synthesis modification of the hydrogels with alcohol functionalized drug molecules, 
allowing for an easy approach to couple hydroxyl compounds into the backbone of the 
polymer.  Such modifications would allow for the gels to serve as drug release vehicles 
for molecules having the -OH group.   
Materials 
Poly (ethylene glycol) 400 diacrylate (PEG400DA) was purchased from Polysciences 
Inc., 4, 7, 10-Trioxa-1, 13-tridecane diamine (TTD) and riboflavin were obtained from 
Sigma-Aldrich (St. Lois, MO). All organic solvents were either purchased from Sigma-
Aldrich or Pharmco-aaper (Shelbyville, KY) and were used as received. All the other 
chemicals were used as received without further purification.     
Methods 
177 
 
  
Poly(β-amino ester) hydrogel synthesis  
A one-step Michael addition reaction between acrylates and amines was used to 
synthesize PβAE hydrogels, as previously described [6, 301].  Figure 1 (A) and 1 (B) 
depicts the reaction mechanism and the schematic of the predicted crosslinked gel 
structure. Diacrylate monomer (PEG(400)DA) and primary diamine (TTD) were 
weighed and mixed in dichloromethane (DCM) at 50% wt/wt with respect to total 
monomers. This solution was transferred to an aluminum dish and monomers were 
allowed to react for 24 hours at 50°C in an oven. PβAE hydrogels were then washed in 
acetone 4 times with a cycle of 1-hour each to remove unreacted monomers followed 
by freeze-drying to eliminate any residual solvent. The initial ratio of total acrylate to 
reactive hydrogen amine groups (RTAAP) was varied from 0.6 to 1.65 to synthesize 
different grades of PβAE hydrogels (Table 1) Note: 1 mol of diacrylate monomer 
corresponds to 2 mol of reactive acrylate groups; 1 mol of primary diamine monomer 
corresponds to total 4 mol of primary/secondary reactive amine groups.   
Table 1. Different grades of PβAE hydrogels were synthesized by varying ratio of 
total acrylate to amine protons (RTAAP) 
 
Hydrogel 
Identification 
Code 
Diacrylate Diamine RTAAP 
R- 0.6 PEG(400)DA TTD 0.6 
R-1.2 PEG(400)DA TTD 1.2 
R-1.65 PEG(400)DA TTD 1.65 
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Figure 1 Synthesis of PEGDA-TTD PβAE cross-linked gels  
A. Reaction scheme of PβAE hydrogel formation via reaction of PEG(400)DA and TTD 
in DCM solvent. B. Schematic of transesterification of PβAE hydrogels in presence of 
an alcohol. Ester bond of the PβAE matrix undergoes substitution with the reacting 
alcohol forming another ester bond. 
 
 
PβAE degradation in alcohols 
Degradation of PβAE hydrogels was carried out in various alcohols at 37° C. 1 cm disc 
were cut from the bulk hydrogel films, weighed and were then incubated in different 
alcohols of interest such that discs were completely submerged. At given time points, 
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gels were removed from the solvent and dried under vacuum to remove residual solvent. 
The fraction of mass remaining was calculated from the ratio of the recorded final dry 
mass (Wd) and initial (W0) mass values. The swelling ratio of the selected hydrogel-
alcohol incubation system was also calculated by recording the mass of alcohol swollen 
hydrogels during degradation. Swelling ratio was calculated as the ratio of swollen gel 
mass (Ws) with initial mass (W0).  
𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅 𝐅𝐅𝐨𝐨 𝐦𝐦𝐅𝐅𝐦𝐦𝐦𝐦 𝐅𝐅𝐫𝐫𝐦𝐦𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐫𝐫 =
𝐖𝐖𝐝𝐝
𝐖𝐖𝟎𝟎
 
𝐒𝐒𝐒𝐒𝐫𝐫𝐒𝐒𝐒𝐒𝐅𝐅𝐅𝐅𝐫𝐫 𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅 =
𝐖𝐖𝐦𝐦
𝐖𝐖𝟎𝟎
 
A separate set of RT-0.6 gels were degraded completely in ethanol as well as in water. 
Degradation products were freeze dried under vacuum and were subjected to FTIR 
analysis. 
Conjugation of PβAE hydrogels with Riboflavin 
R-0.6 and R-1.2 PβAE hydrogel discs were cut in about 1-cm discs, weighed and 
incubated in 1mg/ml riboflavin-DMSO solution at 37° C and allowed to react for various 
durations of time up to 48 hours. After 6, 12, 24 and 48 hours, hydrogels were taken 
out, washed twice in DMSO to remove unreacted riboflavin followed by a single wash 
in acetone in order to leach out any residual DMSO. The hydrogel discs were then 
freeze-dried overnight to remove any residual solvents. The next day, each hydrogel 
disc sample was placed in separate wells of a 12-well plate and read at 444 and 600 nm 
using Varian Cary 50 Bio UV-Vis spectrophotometer. Absorbance at 600 nm was 
subtracted from absorbance value at 444 nm as a baseline correction to obtain the 
absorbance only due to riboflavin conjugation and not the disc thickness/optical 
density. 
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Next, the riboflavin conjugated hydrogel discs were degraded in PBS (35 mg gel/ ml of 
PBS) for hydrogels to undergo hydrolysis and release pure riboflavin. The degradation 
products in PBS were analyzed once again under UV-Vis at 444 nm and riboflavin 
concentrations were calculated using standard calibration curve.  
Results 
PβAE hydrogel synthesis 
PβAE hydrogels synthesized with RTAAP of 0.6 (RT-0.6) and 1.2 (RT-1.2) resulted in 
uniform gels while gels synthesized with RTAAP of 1.65 (RT-1.65) resulted in partial 
conjugation and hence a semi-solid product. Since a properly conjugated hydrogel 
wasn’t obtained with RT-1.65, further analysis of transesterification was limited to RT-
0.6 and RT-1.2. Post synthesis, gels were washed in acetone to remove unreacted 
products and mass loss analysis was performed by weighing the gels before and after 
washing (freeze-dried). Average mass loss of 4.87 ± 0.3% for RT-0.6 and13.1 ± 0.4% 
for RT-1.2 was calculated.  
PβAE degradation in alcohols (Mass loss and swelling ratio) 
a. Effect of RTAAP on degradation and swelling ratio using ethanol as a 
degradation medium 
RT-0.6 degraded via transesterification in 12-hours and showed a faster swelling rate, 
when compared to RT-1.2, with  the swelling ratio of 3.5 ± 0.08 at 8 hours. After 8 
hours of incubation, the gel started to lose mechanical integrity, suggesting the final 
stage of complete degradation, as shown in figure 2 A and 2 B.  On the other hand, RT-
1.2 showed very slow kinetics of transesterification derived hydrogel degradation, with 
no effective mass loss observed in 1st 12 hours. Even after 25 days of ethanol 
incubation, fraction of mass remaining was calculated to be 0.96 ± 0.01, which is 4% 
mass loss. RT-1.2 did show a swelling ratio of 1.46 ± 0.01 after the 1st day but only 
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increased to 1.65 ± 0.02 after 25 days implying extremely slow degradation kinetics in 
ethanol. 
A similar effect of unsubstituted amines on gel degradation, with water as the 
degradation medium has been reported earlier. PEGDA-TTD gels synthesized with 
RTAAP of 0.6 degraded within 40 minutes while gels with RTAAP of 1.2 degraded 
completely in 130 minutes [5]. 
 
Figure 2 Effect of RTAAP on transesterification controlled degradation of PβAE gels 
in 200-proof ethanol at 37o C.  
A.) Mass loss analysis of PβAE hydrogels (R-0.6 and R-1.2) presented as a fraction of 
mass remaining w.r.t. time. B.) Swelling ratio of R-0.6 and R-1.2 in ethanol w.r.t. time. 
Gels synthesized with RTAAP of 0.6 showed faster degradation and swelling than gels 
with RTAAP 1.2. N=3, error bars: std. dev. 
 
b. Effect of primary alcohol with different chain lengths 
As RT-1.2 possessed very slow degradation kinetics in ethanol, RT-0.6 PβAE gels were 
used to determine the impact of primary alcohols of different chain aliphatic lengths i.e. 
ethanol, n-propanol and n-butanol. As observed in figure 3, the degradation rate in 
ethanol and n-propanol was extended over 9-12 hours. However, n-butanol mediated 
degradation of RT-0.6 was slower extending up to 28-30 hours 
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Figure 3 Degradation of PβAE hydrogels in primary alcohols of different chain 
lengths.  
R-0.6 PβAE hydrogel was incubated in ethanol, n-propanol and n-butanol at 37o C. 
N=3, error bars: std. dev. 
 
c. Effect of Alcohol Class on Degradation Kinetics 
To elucidate the mechanism of gel degradation, the impact of primary, secondary, or 
tertiary substituted alcohol was conducted in two separate studies. First, RT-0.6 
degradation was carried out with alcohols containing the same number of carbon chains 
but different degree of substitution i.e. n-propanol (primary, 3-carbon) and iso-propanol 
(secondary, 3-carbon) (figure 4 and 5). It was observed that PβAE gel incubation in 
primary alcohol (n-propanol) degraded within 12 hours, which is significantly faster 
than in secondary alcohol (iso-propanol) showing only 50% mass loss in 13 days. In 
the second study, RT-0.6 was incubated in primary, secondary and tertiary alcohol with 
different chain lengths. Ethanol (primary, 2-carbon), iso-propanol (secondary, 3-
carbon) and tert-butanol (tertiary, 4-carbon) were used for transesterification. As the 
mass loss in tert-butanol was too slow to show significant differences over the study 
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time, swelling ratio for different alcohols was analyzed instead. As shown in figure 5, 
ethanol hydrogel incubation resulted in a swelling ratio of 3.5±0.08 within 8 hours after 
which it disintegrated. Iso-propanol resulted in slower kinetics giving a swelling ratio 
of 2.45±0.16 after 4 days and 4.61±0.6 after 9 days. Tert-butanol incubation showed 
even slower kinetics with swelling ratio of 1.94±0.05 after 4 days and 2.48±0.16 after 
9 days. Therefore, PβAE degradation kinetics was faster in ethanol than in iso-propanol 
than in tert-butanol. 
 
 
Figure 4 Effect of the degree of carbon substitution on degradation kinetics of R-0.6 
PβAE hydrogels in primary and secondary alcohols.  
Data presented as mass loss analysis of PβAE hydrogels degraded in n-propanol and 
iso-propanol at 37oC. N=3, error bars: std. dev. 
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Figure 5 Swelling ratio of R-0.6 PβAE hydrogels in primary, secondary and tertiary 
alcohols i.e. ethanol, iso-propanol and tert-butanol respectively. 
 Rate of swelling and degradation decreases with increase in chain length and degree 
of carbon substitution. N=3, error bars: std. dev. 
 
In a separate study, with RT-0.6 were hydrolyzed completely in ethanol and water. 
FTIR analysis of both the systems were compared to identify the nature of degradation 
products. The degradation products obtained from water showed the presence of strong 
acid peaks at around 1584cm-1 clearly indicating the hydrolysis to the corresponding 
acids. However, the presence of a peak near 1732cm-1 in ethanol degradation products 
confirmed the formation of the corresponding ester products (Figure 6). 
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Figure 6 FTIR spectra of PβAE hydrogel RT-0.6, and the degradation products 
obtained by the hydrolysis of in water and ethanol.  
Riboflavin conjugation to PβAE via transesterification 
To study whether the transesterification mechanism can be used to link primary alcohol 
containing compounds to already formed PβAE gels, naturally found riboflavin 
(vitamin B2) with 1-primary and 3-secondary alcohol functional group was used as a 
model compound to conjugate into RT-0.6 and RT-1.2 via transesterification process 
(figure 7 D). After incubating the gels in 1 mg/ml of riboflavin dissolved in DMSO for 
6, 12, 24 and 48 hours, it was observed that RT-0.6 showed higher conjugation than 
RT-1.2 as seen in figure 7. When conjugated discs were observed under UV-Vis, 
absorbances were collected at 444 nm and 600 nm (characteristic wavelength for 
riboflavin). Absorbance value at 600 nm is the measure of optical density for each gel 
due to its thickness. Hence, to get absorbance values due to only riboflavin, absorbance 
at 600 nm was subtracted as a baseline from 444 nm and presented as Δabs.  RT-0.6 
showed Δabs of 0.22 ± 0.02, 0.28 ± 0.04, 0.5 ± 0.05 and 0.48 ± 0.06 after 6, 12, 24 and 
186 
 
  
48 hours of incubation respectively. RT-1.2 had lower Δabs values than RT-0.6 of 0.15 
± 0.5, 0.13 ± 0.01, 0.14 ± 0.5 and 0.23 ± 0.05 at the same time points (figure 7 A). 
The riboflavin-conjugated gels were then subjected to hydrolytic degradation in PBS to 
recover the riboflavin. Degradation products were again read at 444 nm and collected 
absorbances gave a concentration of riboflavin in the solution using standard curve 
(figure 7 B and 7 C). 0.85 ± 0.03, 1 ± 0.04, 1.3 ± 0.33 and 1.86 ± 0.06 μg/ml of riboflavin 
was retrieved with RT-0.6 gels incubated for 6, 12, 24 and 48 hours respectively 
followed by PBS degradation. For RT-1.2, a lower amount of riboflavin was recovered 
as conjugation was less, which was 0.5 ± 0.01, 0.55 ± 0.15, 0.59 ± 0.16 and 1.1 ± 0.13 
respectively under time interval degradation as for RT-0.6. 
 
 
 
 
187 
 
  
 
Figure 7 Conjugation of riboflavin into R-0.6 and R-1.2 PβAE hydrogels by 
incubation in 1 mg/ml riboflavin solution in DMSO.  
A.) Δabs of the hydrogels discs measured after different time intervals of incubation in 
riboflavin at 37o C. Δabs = abs (444nm)-abs (600nm). Baseline subtraction at 600 nm 
was done for each sample separately to void the effect of optical density due to gel 
thickness. B.) Absorbance of degradation products of riboflavin conjugated PβAE 
hydrogels in PBS after different time intervals. C.) Concentration of riboflavin in PBS 
calculated after analyzing the degradation products under UV-Vis at 444 nm. R-0.6 
gels showed the higher characteristic absorbance of riboflavin in gels discs as well as 
degradation products as compared to R-1.2 gels. This complies with transesterification 
data obtained earlier in figure 2. N=3, error bars: std. dev. 
 
Discussion 
The degradation studies of PEG(400)DA-TTD based PβAE hydrogel synthesized at 
different RTAAPs were carried out in ethanol at 37ºC. It was initially observed that 
PβAEs synthesized using single step approach were unstable in ethanol. This was 
different from previously reported data, where ethanol was used as a stable washing 
solvent [306]. Originally, it was believed that degradation was due to the water 
content in the solvent. However, degradation still proceeded even with dried solvents. 
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This observation led to the theoretical conclusion that, β-amino ester bonds in the 
PβAE hydrogels undergo transesterification with the alcohol to form a new ester.  
It was hypothesized that if transesterification was a mechanism, then the unmodified 
amines contained within the network could serve as a base to catalyze the 
transesterification process. To test this hypothesis, the levels of unmodified amine were 
varied by changing the total acrylate to total reactive hydrogen amine protons (RTAAP: 
0.6 and 1.2). Lower RTAAP (0.6 in this case)  PβAE gels with higher unreacted amine 
content, catalyzed the transesterification reaction via activation of surrounding alcohol 
into a nucleophilic entity (C2H5OH to C2H5O-) [307]. The activated form, C2H5O- 
resulted in faster disintegration of PβAE matrix via substitution at the ester linkage 
(Figure 2).  
Additionally, if the degradation of the PβAE gels is a function of transesterification, 
then it would be expected that the rate of degradation would be dependent upon the 
reactivity of the alcohol. Hence, the rate of alcohol substitution will be different for 
alcohols of different chain lengths or degree of carbon substitution. To verify this 
hypothesis, degradation properties of PβAE hydrogels were analyzed with different 
alcohols at 37°C (Figures 3, 4 and 5). It was observed that the degradation of RT-0.6 
PβAE hydrogel occurred fastest in ethanol followed by n-propanol and slowest with n-
butanol amongst the three primary alcohols. The ethanol based transesterification 
reaction is typically much faster than propanol or butanol due to the high polar and 
acidic nature or lower carbon induced inductive effect due to shorter carbon chain 
length [308].  As the length of the carbon chain increases, nucleophilicity of the 
alkoxide anion decreases leading to a decrease in the reactivity of alkoxide anion. This 
causes the slower reaction rate in the order of n-butanol, n-propanol and ethanol and 
hence the degradation kinetics (figure 3). A similar trend was seen with the PβAE 
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hydrogel degradation in primary, secondary and tertiary alcohols because of the same 
concept of higher inductive effect with secondary as compared to primary alcohols. 
Therefore, iso-propanol being less acidic than n-propanol, shows slower 
transesterification kinetics than n-propanol (figure 4).  The combined effect of chain 
length and degree of substitution was seen with degradation carried out in ethanol, iso-
propanol and tert-butanol, where with tert-butanol, slowest degradation was observed 
amongst all the alcohols used because of the presence of three alkyl groups on the 
carbon-atom with –OH group and hence least acidic nature.  
To confirm the transesterification reaction of the PβAE hydrogels, the degradation 
products of the RT-0.6 obtained from water and ethanol were freeze dried and analyzed 
with the help of an ATR-FTIR (Varian e-spectrophotometer). It has been reported 
previously that PβAE hydrogels degrade via hydrolysis of ester groups in the crosslinks 
to lower molecular weight degradation products and chains of poly(β-amino acids) and 
diols [300, 309]. The presence of a broad acid peak at 1584 cm-1 in the water 
degradation products of RT-0.6  with a subsequent decrease in intensity of the ester-
C=O peak at 1732 cm-1 clearly indicates the formation of low molecular weight acids 
(Figure 6). The transesterification reaction of PβAE with alcohols was also confirmed 
by the re-formation of new ester peaks at around 1732cm-1 from the ethanol degradation 
products of RT-0.6.  
Taking advantage of transesterification of PβAE network by alcohols, compounds of 
medicinal value containing alcohol groups (e.g. riboflavin, ascorbic acid) can be 
conjugated to the PβAE network without the use of additional linkers or reagents. 
Riboflavin is a part of the Vitamin B family (Vitamin B2), naturally found in milk, 
yeast, leafy vegetables with metabolic functional significance in activating other 
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vitamins and reaction with flavoproteins [15, 310]. It contains one primary and three 
secondary alcohol groups in the molecular structure (Figure 7 D).  
The extent of riboflavin conjugation into PβAE could be analyzed using UV-Vis 
because of its characteristic wavelength at 444 nm. As shown in Figure 7, PβAE upon 
incubation in riboflavin solution was able to conjugate the alcoholic molecule into its 
matrix and the amount of conjugation increased with time showing the progression of 
transesterification. Higher conjugation was seen with RT-0.6 than RT-1.2 because of 
the faster transesterification kinetics complying with previous studies (Figure 2). This 
was observed at both levels, riboflavin conjugated gel discs (figure 7 A) and released 
riboflavin after complete degradation of the gels (7 B). 
Conclusion  
It was found that PβAE synthesized by the single step non-free radical polymerization 
method degrades in alcohol via a transesterification mechanism. Unreacted 
primary/secondary amines in the PβAE network catalyze this transesterification 
reaction and the rate of PβAE degradation in alcohol decreases with increase in 
RTAAP. The degradation rate of PβAE in alcohol decreases with increasing chain 
length of alcohol or in order of tertiary<secondary<primary alcohols. Taking advantage 
of alcohol induced transesterification reaction in the PβAE network, molecules of 
medicinal value with alcohol groups (e.g. riboflavin) can be covalently conjugated to 
the PβAE network and the amount to be conjugated can be controlled with incubation 
time until gel disintegration while release of riboflavin via water hydrolysis can be 
controlled by selecting the PβAE gels of different RTAAPs. 
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